R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, JAMA, vol.293, p.1653, 2005.

D. J. Schaer, P. W. Buehler, A. I. Alayash, J. D. Belcher, and G. M. Vercellotti, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, vol.121, pp.1276-1284, 2013.

F. F. Dutra and M. T. Bozza, Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014.

M. Frimat, Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013.

L. T. Roumenina, J. Rayes, S. Lacroix-desmazes, and J. D. Dimitrov, Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016.

J. D. Dimitrov, Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions, J. Biol. Chem, vol.282, pp.26696-26706, 2007.

L. T. Roumenina, J. Rayes, M. Frimat, and V. Fremeaux-bacchi, Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016.

M. J. Tracz, J. Alam, and K. A. Nath, Physiology and Pathophysiology of Heme: Implications for Kidney Disease, J. Am. Soc. Nephrol, vol.18, pp.414-420, 2007.

E. Tolosano, Defective Recovery and Severe Renal Damage After Acute Hemolysis in Hemopexin-Deficient Mice, Blood, vol.94, pp.3906-3914, 1999.

G. Ingoglia, Hemopexin counteracts systolic dysfunction induced by hemedriven oxidative stress. Free Radic, Biol. Med, vol.108, pp.452-464, 2017.

J. D. Belcher, Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014.

F. Vinchi, Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases, Circulation, vol.127, pp.1317-1329, 2013.

V. Audard, First evidence of subclinical renal tubular injury during sickle-cell crisis, Orphanet J. Rare Dis, vol.9, p.67, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00986267

N. Sundaram, Biomarkers for early detection of sickle nephropathy, Am. J

. Hematol, , vol.86, pp.559-566, 2011.

M. Kasztan, Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice, J. Am. Soc. Nephrol. ASN, p.2016070711, 2017.

J. A. Graw, Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red CellsClinical Perspective, Circulation, vol.134, pp.945-960, 2016.

J. H. Baek, Hemoglobin-driven pathophysiology is an in vivo consequence of the

, Clin. Invest, vol.122, pp.1444-1458, 2012.

B. D. Goldstein, M. G. Rozen, and R. L. Kunis, Role of red cell membrane lipid peroxidation in hemolysis due to phenylhydrazine, Biochem. Pharmacol, vol.29, pp.1355-1359, 1980.

J. W. Deuel, Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response, Cell Death Dis, vol.7, p.2064, 2016.

K. A. Nath, The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo, Am. J. Pathol, vol.156, pp.1527-1535, 2000.

I. C. Vermeulen-windsant, Hemolysis is associated with acute kidney injury during major aortic surgery, Kidney Int, vol.77, pp.913-920, 2010.

W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int, vol.62, pp.237-244, 2002.

J. S. Bond, R. J. Beynon, and . Meprin, A Membrane-Bound Metallo-endopeptidase, Current Topics in Cellular Regulation, vol.28, pp.263-290, 1986.

S. Djudjaj, Keratins are novel markers of renal epithelial cell injury, Kidney Int, vol.89, pp.792-808, 2016.

H. Yu, Alpha-1-microglobulin: an indicator protein for renal tubular function
DOI : 10.1136/jcp.36.3.253

URL : https://jcp.bmj.com/content/36/3/253.full.pdf

, Clin. Pathol, vol.36, pp.253-259, 1983.

M. Allhorn, T. Berggård, J. Nordberg, M. L. Olsson, and B. Akerström, Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and hemedegradation properties, Blood, vol.99, pp.1894-1901, 2002.

M. G. Olsson, Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for ?(1)-microglobulin, Antioxid. Redox Signal, vol.17, pp.813-846, 2012.

C. Herzog, Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta, Biochem. Biophys. Res. Commun, vol.379, pp.904-908, 2009.

T. R. Keiffer and J. S. Bond, Meprin Metalloproteases Inactivate Interleukin 6, J. Biol
DOI : 10.1074/jbc.m113.546309

URL : http://www.jbc.org/content/289/11/7580.full.pdf

, Chem, vol.289, pp.7580-7588, 2014.

Y. K. Lim, Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis, Kidney Int, vol.58, pp.1033-1044, 2000.

F. F. Dutra, Hemolysis-induced lethality involves inflammasome activation by heme, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4110-4118, 2014.

J. M. Herter, J. Rossaint, T. Spieker, and A. Zarbock, Adhesion molecules involved in neutrophil recruitment during sepsis-induced acute kidney injury, J. Innate Immun, vol.6, pp.597-606, 2014.

K. Singbartl, S. A. Green, and K. Ley, Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.14, pp.48-54, 2000.

K. J. Kelly, W. W. Williams, R. B. Colvin, and J. V. Bonventre, Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury, Proc. Natl

F. A. Wagener, E. Feldman, T. De-witte, and N. G. Abraham, Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.216, pp.456-463, 1997.

S. Meher, Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis, J. Biomark, vol.2015, pp.1-13, 2015.

T. Reinheckel, Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis. Free Radic, Biol. Med, vol.24, pp.393-400, 1998.

W. Druml, A. N. Laggner, K. Lenz, G. Grimm, and B. Schneeweiss, Ann. Hematol, vol.63, pp.39-41, 1991.

M. Dragon-durey, Clinical Features of Anti-Factor H AutoantibodyAssociated Hemolytic Uremic Syndrome, J. Am. Soc. Nephrol, vol.21, pp.2180-2187, 2010.

M. Saruç, An experimental model of hemolysis-induced acute pancreatitis. Braz

, J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol, vol.36, pp.879-886, 2003.

M. Saruc, N. Ozden, and H. Yuceyar, How hemolysis causes acute pancreatitis

, Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.8, pp.51-52, 2002.

M. Saruç, The role of heme in hemolysis-induced acute pancreatitis, Med. Sci

, Monit. Int. Med. J. Exp. Clin. Res, vol.13, pp.67-72, 2007.

R. T. Figueiredo, Characterization of Heme as Activator of Toll-like Receptor 4

, J. Biol. Chem, vol.282, pp.20221-20229, 2007.

S. M. Camus, Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease, Blood, vol.125, pp.3805-3814, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01186628

G. Balla, G. M. Vercellotti, U. Muller-eberhard, J. Eaton, and H. S. Jacob, Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species, Lab. Investig. J. Tech. Methods Pathol, vol.64, pp.648-655, 1991.

, Intravascular hemolysis induces complement system activation mediated by heme and heme-loaded erythrocyte microvesicles

N. S. Merle, Viviane Gnemmi, vol.4, 2005.

, Sylvain Le Jeune, vol.11

, UPMC Univ Paris 06, F-75006

. Univ, . Lille, C. Inserm, and . Lille,

. Inserm,

P. Center-for-cardiovascular and . Research, INSERM UMR_S, vol.970

, Ecole Pratique des Hautes Études (EPHE), F-75014

, Hôpital Avicenne, F-93000

P. Assistance-publique--hôpitaux-de, Service de pathologie, Hôpital Necker enfants malades, F-75015

, INSERM UMRS 1138; 15 rue de l'Ecole de Medecine, entrance E, fl. 3, e-mail: lubka.roumenina@crc.jussieu.fr Conflict of interest N.B., T.G. and S.M are employees of CSL Behring. LTR receives research funding from CSL, vol.75006, pp.33-34

F. F. Dutra and M. T. Bozza, Heme on innate immunity and inflammation, Front Pharmacol, 2014.

L. T. Roumenina, J. Rayes, S. Lacroix-desmazes, and J. D. Dimitrov, Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol Med, vol.22, issue.3, pp.200-213, 2016.

K. A. Nath and R. P. Hebbel, Sickle cell disease: renal manifestations and mechanisms, Nat Rev Nephrol, vol.11, issue.3, pp.161-71, 2015.

J. W. Deuel, F. Vallelian, C. A. Schaer, M. Puglia, P. W. Buehler et al., Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity, Free Radic Biol Med, vol.89, pp.931-974, 2015.

S. M. Camus, D. Moraes, J. A. Bonnin, P. Abbyad, P. et al.,

J. D. Belcher, C. Chen, J. Nguyen, L. Milbauer, F. Abdulla et al.,

S. M. Camus, B. Gausserès, P. Bonnin, L. Loufrani, L. Grimaud et al.,

J. D. Belcher, P. H. Marker, J. P. Weber, R. P. Hebbel, and G. M. Vercellotti, Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion, Blood, vol.96, issue.7, pp.2451-2460, 2000.

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part I -Molecular Mechanisms of Activation and Regulation. Front Immunol, vol.6, 2015.

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina,

, Complement System Part II: Role in Immunity. Front Immunol, 2015.

M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, , vol.6

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al.,

V. Bacchi, Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, issue.2, pp.282-92, 2013.

D. S. Chudwin, C. Papierniak, T. F. Lint, and A. D. Korenblit, Activation of the Alternative Complement Pathway by Red Blood Cells from Patients with Sickle Cell Disease, Clin Immunol Immunopathol, vol.71, issue.2, pp.199-202, 1994.

C. Mold, J. D. Tamerius, and G. Phillips, Complement activation during painful crisis in sickle cell anemia, Clin Immunol Immunopathol, vol.76, issue.3, pp.314-334, 1995.

J. Chapin, H. S. Terry, D. Kleinert, and J. Laurence, The role of complement activation in thrombosis and hemolytic anemias, Transfus Apher Sci, vol.54, issue.2, pp.191-199, 2016.

R. H. Wang, G. Phillips, M. E. Medof, and C. Mold, Activation of the alternative complement Clin Invest, vol.92, pp.1326-1361, 1993.

M. E. De-paepe and M. Trudel, The transgenic SAD mouse: a model of human sickle cell glomerulopathy, Kidney Int, vol.46, issue.5, pp.1337-1382, 1994.

R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, JAMA, vol.293, p.1653, 2005.

J. W. Deuel, Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic, Biol. Med, vol.89, pp.931-943, 2015.

F. F. Dutra and M. T. Bozza, Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014.

L. T. Roumenina, J. Rayes, S. Lacroix-desmazes, and J. D. Dimitrov, Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016.

A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J. Immunol. Baltim. Md, vol.179, pp.5543-5552, 1950.

M. Frimat, Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013.

J. D. Dimitrov, L. T. Roumenina, V. R. Doltchinkova, and T. L. Vassilev, Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins, Scand. J. Immunol, vol.65, pp.230-239, 2007.

L. T. Roumenina, Heme interacts with c1q and inhibits the classical complement pathway, J. Biol. Chem, vol.286, pp.16459-16469, 2011.

M. A. Lindorfer, Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia, Clin. Immunol

, Orlando Fla, vol.171, pp.32-35, 2016.

D. Green, F. H. Furby, and M. C. Berndt, The interaction of the factor VIII/von Willebrand factor complex with hematin, Thromb. Haemost, vol.56, pp.277-282, 1986.

V. G. Nielsen, J. B. Cohen, S. N. Malayaman, M. Nowak, and K. Vosseller, Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report, Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb, vol.22, pp.443-447, 2011.

B. N. Setty, S. G. Betal, J. Zhang, and M. J. Stuart, Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia, J. Thromb. Haemost. JTH, vol.6, pp.2202-2209, 2008.

E. M. Sparkenbaugh, Excess of heme induces tissue factor-dependent activation of coagulation in mice, Haematologica, vol.100, pp.308-314, 2015.

J. D. Dimitrov, Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions, J. Biol. Chem, vol.282, pp.26696-26706, 2007.

J. D. Dimitrov, Antibody polyreactivity in health and disease: statu variabilis, J. Immunol. Baltim. Md, pp.993-999, 2013.

M. Hadzhieva, Relationship between natural and heme-mediated antibody polyreactivity, Biochem. Biophys. Res. Commun, vol.472, pp.281-286, 2016.

M. Hadzhieva, Mechanism and Functional Implications of the Heme-Induced Binding Promiscuity of IgE, Biochemistry (Mosc.), vol.54, pp.2061-2072, 2015.

G. Chen, Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease, Blood, vol.123, pp.3818-3827, 2014.

A. V. Graça-souza, M. A. Arruda, M. S. Freitas, . De, C. Barja-fidalgo et al., Neutrophil activation by heme: implications for inflammatory processes, Blood, vol.99, pp.4160-4165, 2002.

B. N. Porto, Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors, J. Biol. Chem, vol.282, pp.24430-24436, 2007.

F. Vinchi, Hemopexin therapy reverts heme-induced pro-inflammatory, 2015.

R. T. Figueiredo, Characterization of Heme as Activator of Toll-like Receptor 4

, J. Biol. Chem, vol.282, pp.20221-20229, 2007.

J. D. Belcher, Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014.

A. Poltorak, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998.

L. T. Roumenina, J. Rayes, M. Frimat, and V. Fremeaux-bacchi, Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016.

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front. Immunol, vol.6, 2015.

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part II: Role in Immunity. Front. Immunol, vol.6, 2015.

F. Tedesco, The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity, J. Exp

. Med, , vol.185, pp.1619-1627, 1997.

U. Amara, M. A. Flierl, D. Rittirsch, A. Klos, H. Chen et al., Molecular intercommunication between the complement and coagulation systems, J. Immunol. Baltim. Md, vol.185, pp.5628-5636, 1950.

K. E. Anderson, J. R. Bloomer, H. L. Bonkovsky, J. P. Kushner, C. A. Pierach et al., Recommendations for the diagnosis and treatment of the acute porphyrias, Ann. Intern. Med, vol.142, pp.439-450, 2005.

K. V. Anderson, L. Bokla, and C. Nüsslein-volhard, Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product, Cell, vol.42, pp.791-798, 1985.

S. O. Anim, R. C. Strunk, and M. R. Debaun, Asthma morbidity and treatment in children with sickle cell disease, Expert Rev. Respir. Med, vol.5, pp.635-645, 2011.

M. Arakawa, T. Kondo, H. Mitsui, S. Suzuki, and M. Shiba, , 1977.

, Nihon Yakurigaku Zasshi Folia Pharmacol. Jpn, vol.73, pp.541-547

P. Ascenzi, A. Di-masi, G. Fanali, and M. Fasano, Heme-albumin: an honorary enzyme, Cell Death Dis, vol.6, p.1895, 2015.

E. Asgari, G. Le-friec, H. Yamamoto, E. Perucha, S. S. Sacks et al.,

M. Aslan, T. M. Ryan, B. Adler, T. M. Townes, D. A. Parks et al., Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.15215-15220, 2001.

K. I. Ataga, A. Kutlar, J. Kanter, D. Liles, R. Cancado et al., Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease, N. Engl. J. Med, vol.376, pp.429-439, 2017.

V. Audard, S. Homs, A. Habibi, F. Galacteros, P. Bartolucci et al., Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc, vol.25, pp.2524-2529, 2010.

V. Audard, S. Moutereau, G. Vandemelebrouck, A. Habibi, M. Khellaf et al., First evidence of subclinical renal tubular injury during sickle-cell crisis, Orphanet J. Rare Dis, vol.9, p.67, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00986267

C. Auffray, D. Fogg, M. Garfa, G. Elain, O. Join-lambert et al., , 2007.

O. Augusto, K. L. Kunze, and P. R. Ortiz-de-montellano, N-Phenylprotoporphyrin IX formation in the hemoglobin-phenylhydrazine reaction. Evidence for a protein-stabilized iron-phenyl intermediate, J. Biol. Chem, vol.257, pp.6231-6241, 1982.

S. Baddam, I. Aban, L. Hilliard, T. Howard, D. Askenazi et al., Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis, Pediatr. Nephrol, vol.32, pp.1451-1456, 2017.

J. H. Baek, F. D'agnillo, F. Vallelian, C. P. Pereira, M. C. Williams et al., Clin. Invest, vol.122, pp.1444-1458, 2012.

M. S. Bajaj, M. N. Kuppuswamy, A. N. Manepalli, and S. P. Bajaj, Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues, Thromb. Haemost, vol.82, pp.1047-1052, 1999.

G. Bajic, L. Yatime, R. B. Sim, T. Vorup-jensen, and G. R. Andersen, , 2013.

, Natl. Acad. Sci. U. S. A, vol.110, pp.16426-16431

G. Bajic, L. Yatime, A. Klos, and G. R. Andersen, Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg, Protein Sci. Publ. Protein Soc, vol.22, pp.204-212, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02095673

G. Balla, G. M. Vercellotti, U. Muller-eberhard, J. Eaton, J. et al., Investig. J. Tech. Methods Pathol, vol.64, pp.648-655, 1991.

J. Balla, G. Balla, V. Jeney, G. Kakuk, H. S. Jacob et al., Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants, Blood, vol.95, pp.3442-3450, 2000.

J. Balla, G. M. Vercellotti, V. Jeney, A. Yachie, Z. Varga et al., , 2007.

H. Heme and F. Oxygenase, How the Vascular Endothelium Survives (and Dies) in an IronRich Environment, Antioxid. Redox Signal, vol.9, pp.2119-2138

M. L. Barilla-labarca, M. K. Liszewski, J. D. Lambris, D. Hourcade, and J. P. Atkinson, , 2002.

O. P. Barry, D. Praticò, R. C. Savani, and G. A. Fitzgerald, Modulation of monocyte-endothelial cell interactions by platelet microparticles, J. Clin. Invest, vol.102, pp.136-144, 1998.

D. Barthel, S. Schindler, and P. F. Zipfel, Plasminogen Is a Complement Inhibitor, J. Biol. Chem, vol.287, pp.18831-18842, 2012.

P. Bartolucci, A. Habibi, T. Stehlé, G. Di-liberto, M. G. Rakotoson et al., Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease, J. Am. Soc. Nephrol. JASN, vol.27, pp.1847-1853, 2016.

L. Baudino, S. Azeredo-da-silveira, M. Nakata, and S. Izui, Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies, 2006.

. Immunopathol, , vol.28, pp.175-184

E. J. Van-beers, M. C. Schaap, R. J. Berckmans, R. Nieuwland, A. Sturk et al., Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease, Haematologica, vol.94, pp.1513-1519, 2009.

J. D. Belcher, P. H. Marker, J. P. Weber, R. P. Hebbel, and G. M. Vercellotti, Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion, Blood, vol.96, pp.2451-2459, 2000.

J. D. Belcher, C. Chen, J. Nguyen, L. Milbauer, F. Abdulla et al., Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014.

H. S. Bennett, J. H. Luft, and J. C. Hampton, Morphological classifications of vertebrate blood capillaries, Am. J. Physiol, vol.196, pp.381-390, 1959.

M. E. Benoit, E. V. Clarke, P. Morgado, D. A. Fraser, and A. J. Tenner, , 2012.

, J. Immunol. Baltim. Md, vol.188, pp.5682-5693, 1950.

E. T. Berends, R. D. Gorham, M. Ruyken, J. A. Soppe, H. Orhan et al., Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes, BMC Biol, vol.13, p.93, 2015.

S. Berentsen, Role of Complement in Autoimmune Hemolytic Anemia, Transfus. Med. Hemotherapy, vol.42, pp.303-310, 2015.

S. Berentsen and T. Sundic, Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy, BioMed Res. Int, p.363278, 2015.

A. Berg, K. Otterdal, S. Patel, M. Gonca, C. David et al., Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria, J. Infect. Dis, vol.212, pp.1835-1840, 2015.

S. Bettoni, M. Galbusera, S. Gastoldi, R. Donadelli, C. Tentori et al., Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis, J. Immunol. Baltim. Md, pp.1021-1040, 2017.

F. Bexborn, P. O. Andersson, H. Chen, B. Nilsson, and K. N. Ekdahl, The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb), Mol. Immunol, vol.45, pp.2370-2379, 2008.

S. Bhakdi, G. Kuller, M. Muhly, S. Fromm, G. Seibert et al., Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect. Immun, vol.55, pp.206-210, 1987.

F. Bienaime, M. Dragon-durey, C. H. Regnier, S. C. Nilsson, W. H. Kwan et al., , 2010.

T. K. Blackmore, J. Hellwage, T. A. Sadlon, N. Higgs, P. F. Zipfel et al., , 1998.

C. Blanc, S. K. Togarsimalemath, S. Chauvet, M. Le-quintrec, B. Moulin et al., Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases, J. Immunol. Baltim. Md, pp.5129-5138, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01843975

A. Z. Blatt, S. Pathan, and V. P. Ferreira, Properdin: a tightly regulated critical inflammatory modulator, Immunol. Rev, vol.274, pp.172-190, 2016.

B. S. Blaum, J. P. Hannan, A. P. Herbert, D. Kavanagh, D. Uhrín et al., Structural basis for sialic acid-mediated self-recognition by complement factor H, Nat. Chem. Biol, 2014.

S. S. Bohlson, S. D. O'conner, H. J. Hulsebus, M. Ho, and D. A. Fraser, Complement, C1q, and C1q-Related Molecules Regulate Macrophage Polarization, Front. Immunol, vol.5, 2014.

J. S. Bond and R. J. Beynon, Meprin: A Membrane-Bound Metallo-endopeptidase, In Current Topics in Cellular Regulation, pp.263-290, 1986.

M. Bongrazio, A. R. Pries, and A. Zakrzewicz, The endothelium as physiological source of properdin: role of wall shear stress, Mol. Immunol, vol.39, pp.669-675, 2003.

N. Borregaard, Neutrophils, from Marrow to Microbes, Immunity, vol.33, pp.657-670, 2010.

F. Bossi, F. Fischetti, V. Pellis, R. Bulla, E. Ferrero et al., , 2004.

, Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex, J. Immunol. Baltim. Md, vol.173, pp.6921-6927, 1950.

J. Bralet, P. Beley, A. M. Bralet, and A. Beley, , 1983.

D. Bratosin, J. Mazurier, J. P. Tissier, J. Estaquier, J. J. Huart et al., Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review, Biochimie, vol.80, pp.173-195, 1998.

O. Brekke, D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes, The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood, J. Leukoc. Biol, vol.81, pp.1404-1413, 2007.

H. A. Brittain, J. R. Eckman, R. A. Swerlick, R. J. Howard, and T. M. Wick, , vol.81, pp.2137-2143, 1993.

R. A. Brodsky, Paroxysmal nocturnal hemoglobinuria, Blood, vol.124, pp.2804-2811, 2014.

R. A. Brodsky, Eculizumab: another breakthrough, Blood, vol.129, pp.922-923, 2017.

R. A. Brooimans, A. A. Van-der-ark, W. A. Buurman, L. A. Van-es, and M. R. Daha, Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1, J. Immunol. Baltim. Md, vol.144, pp.3835-3840, 1950.

F. Bu, N. C. Meyer, Y. Zhang, N. G. Borsa, C. Thomas et al., , 2015.

, Kidney Dis. Off. J. Natl. Kidney Found, vol.65, pp.968-969

D. Bubeck, The Making of a Macromolecular Machine: Assembly of the Membrane Attack Complex, Biochemistry (Mosc.), vol.53, pp.1908-1915, 2014.

A. M. Buhl, N. Avdi, G. S. Worthen, J. , and G. L. , Mapping of the C5a receptor signal transduction network in human neutrophils, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.9190-9194, 1994.

R. Bulla, C. Agostinis, F. Bossi, L. Rizzi, A. Debeus et al., decidual endothelium. Mol. Immunol, vol.45, pp.2629-2640, 2008.

G. Camejo, C. Halberg, A. Manschik-lundin, E. Hurt-camejo, B. Rosengren et al., Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages, J. Lipid Res, vol.39, pp.755-766, 1998.

L. Camous, L. Roumenina, S. Bigot, S. Brachemi, V. Frémeaux-bacchi et al., Complement alternative pathway acts as a positive feedback amplification of neutrophil activation, Blood, vol.117, pp.1340-1349, 2011.

A. K. Campbell, R. A. Daw, M. B. Hallett, and J. P. Luzio, , 1981.

S. M. Camus, B. Gausserès, P. Bonnin, L. Loufrani, L. Grimaud et al., , 2012.

S. M. Camus, J. A. De-moraes, P. Bonnin, P. Abbyad, S. Le-jeune et al., , 2015.

M. Capasso, L. G. Durrant, M. Stacey, S. Gordon, J. Ramage et al., , 2006.

, Costimulation via CD55 on human CD4+ T cells mediated by CD97, J. Immunol. Baltim. Md, vol.177, pp.1070-1077, 1950.

J. Cardone, G. Le-friec, P. Vantourout, A. Roberts, A. Fuchs et al., Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nat. Immunol, vol.11, pp.862-871, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00564091

J. Cardone, G. Le-friec, and C. Kemper, CD46 in innate and adaptive immunity: an update, 2011.

, Clin. Exp. Immunol, vol.164, pp.301-311

L. M. Carlin, E. G. Stamatiades, C. Auffray, R. N. Hanna, L. Glover et al., Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal, Cell, vol.153, pp.362-375, 2013.

D. F. Carney, C. H. Hammer, and M. L. Shin, Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+, J. Immunol. Baltim. Md, vol.137, pp.263-270, 1950.

B. Carragher, D. A. Bluemke, B. Gabriel, M. J. Potel, J. et al., , 1988.

M. C. Carroll and D. E. Isenman, Regulation of humoral immunity by complement, Immunity, vol.37, pp.199-207, 2012.

J. Cartron and J. Elion, Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea, Transfus. Clin. Biol. J. Soc. Francaise Transfus. Sang, vol.15, pp.39-50, 2008.

G. Castellano, A. M. Woltman, N. Schlagwein, W. Xu, F. P. Schena et al.,

, Immune modulation of human dendritic cells by complement, Eur. J. Immunol, vol.37, pp.2803-2811

F. Cattaneo, G. Guerra, M. Parisi, M. De-marinis, D. Tafuri et al., , 2014.

, Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors, Int. J. Mol. Sci, vol.15, pp.19700-19728

P. Chadebech, M. Michel, D. Janvier, K. Yamada, C. Copie-bergman et al., , 2010.

J. Chapin, H. S. Terry, D. Kleinert, L. , and J. , The role of complement activation in thrombosis and hemolytic anemias, Transfus. Apher. Sci, vol.54, pp.191-198, 2016.

A. K. Chauhan and T. L. Moore, T Cell Activation by Terminal Complex of Complement and Immune Complexes, J. Biol. Chem, vol.286, pp.38627-38637, 2011.

S. Chauvet, L. T. Roumenina, S. Bruneau, M. C. Marinozzi, T. Rybkine et al., A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H, J. Am. Soc. Nephrol, vol.27, pp.1665-1677, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02149496

C. Chen, W. , and R. , Stoichiometry of Complexes between Mannose-binding Protein and Its Associated Serine Proteases: DEFINING FUNCTIONAL UNITS FOR COMPLEMENT ACTIVATION, 2001.

, J. Biol. Chem, vol.276, pp.25894-25902

G. Chen, D. Zhang, T. A. Fuchs, D. Manwani, D. D. Wagner et al., , 2014.

M. Chen, J. V. Forrester, and H. Xu, , 2007.

Q. Chen, M. Wiesener, H. U. Eberhardt, A. Hartmann, B. Uzonyi et al., Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J. Clin. Invest, vol.124, pp.145-155, 2014.

X. Chen, Y. Yu, L. Mi, T. Walz, and T. A. Springer, Molecular basis for complement recognition by integrin ?X?2, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.4586-4591, 2012.

Z. A. Chen, R. Pellarin, L. Fischer, A. Sali, M. Nilges et al., Structure of Complement C3(H2O) Revealed By Quantitative Cross-Linking/Mass Spectrometry And Modeling, vol.15, pp.2730-2743, 2016.

J. Chi, H. Y. Chang, G. Haraldsen, F. L. Jahnsen, O. G. Troyanskaya et al., Endothelial cell diversity revealed by global expression profiling, Proc. Natl. Acad. Sci, vol.100, pp.10623-10628, 2003.

N. H. Choi, T. Mazda, and M. Tomita, A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes, Mol. Immunol, vol.26, pp.835-840, 1989.

D. S. Chudwin, A. D. Korenblit, M. Kingzette, S. Artrip, and S. Rao, Increased activation of the alternative complement pathway in sickle cell disease, Clin. Immunol. Immunopathol, vol.37, pp.93-97, 1985.

D. S. Chudwin, C. Papierniak, T. F. Lint, and A. D. Korenblit, , 1994.

D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman et al., Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, vol.91, pp.3527-3561, 1998.

E. V. Clarke, B. M. Weist, C. M. Walsh, and A. J. Tenner, , 2015.

, J. Leukoc. Biol, vol.97, pp.147-160

R. Cofiell, A. Kukreja, K. Bedard, Y. Yan, A. P. Mickle et al.,

, Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS, Blood, vol.125, pp.3253-3262

D. S. Cole and B. P. Morgan, Beyond lysis: how complement influences cell fate, Clin. Sci. Lond. Engl, vol.104, pp.455-466, 1979.

I. Del-conde, M. A. Crúz, H. Zhang, J. A. López, and V. Afshar-kharghan, Platelet activation leads to activation and propagation of the complement system, J. Exp. Med, vol.201, pp.871-879, 2005.

F. Corallini, F. Bossi, A. Gonelli, C. Tripodo, G. Castellino et al., The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis, Rheumatol. Oxf. Engl, vol.48, pp.293-298, 2009.

L. G. Coulthard and T. M. Woodruff, Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth, J. Immunol. Baltim. Md, pp.3542-3548, 2015.

P. Cristofaro and S. M. Opal, The Toll-like receptors and their role in septic shock, Expert Opin. Ther. Targets, vol.7, pp.603-612, 2003.

Á. I. Csincsi, A. Kopp, M. Zöldi, Z. Bánlaki, B. Uzonyi et al., Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation, J. Immunol. Baltim. Md, pp.4963-4973, 2015.

P. J. Daffern, P. H. Pfeifer, J. A. Ember, and T. E. Hugli, Exp. Med, vol.181, pp.2119-2127, 1995.

S. Danese, E. Dejana, and C. Fiocchi, Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation, J. Immunol. Baltim. Md, vol.178, pp.6017-6022, 1950.

D. S. Darbari, P. Kple-faget, J. Kwagyan, S. Rana, V. R. Gordeuk et al., , 2006.

D. S. Darbari, Z. Wang, M. Kwak, M. Hildesheim, J. Nichols et al., , 2013.

H. Dauchel, N. Julen, C. Lemercier, M. Daveau, D. Ozanne et al., Eur. J. Immunol, vol.20, pp.1669-1675, 1990.

A. E. Davis and D. M. Kenney, Properdin factor D: effects on thrombin-induced platelet aggregation, J. Clin. Invest, vol.64, pp.721-728, 1979.

A. E. Davis, R. A. Harrison, and P. J. Lachmann, Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g, J. Immunol. Baltim. Md, vol.132, pp.1960-1966, 1950.

D. Jong, P. E. Statius-van-eps, and L. W. , Sickle cell nephropathy: New insights into its pathophysiology, Kidney Int, vol.27, pp.711-717, 1985.

M. E. De-paepe and M. Trudel, The transgenic SAD mouse: a model of human sickle cell glomerulopathy, Kidney Int, vol.46, pp.1337-1345, 1994.

L. Deban, H. Jarva, M. J. Lehtinen, B. Bottazzi, A. Bastone et al., Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation, J. Immunol. Baltim. Md, vol.181, pp.8433-8440, 1950.

M. R. Debaun, S. A. Sarnaik, M. J. Rodeghier, C. P. Minniti, T. H. Howard et al., Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure, Blood, vol.119, pp.3684-3690, 2012.

A. C. Deciutiis, C. M. Peterson, M. J. Polley, and L. J. Metakis, Alternate Pathway Activation in Sickle Cell Disease and ?-Thalassemia Major, J. Natl. Med. Assoc, vol.70, pp.503-506, 1978.

S. Deem, J. Kim, B. N. Manjula, A. S. Acharya, M. E. Kerr et al., Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs, Circ. Res, vol.91, pp.626-632, 2002.

E. Dejana, Endothelial cell-cell junctions: happy together, Nat. Rev. Mol. Cell Biol, vol.5, pp.261-270, 2004.
DOI : 10.1038/nrm1357

M. Delvaeye, M. Noris, A. De-vriese, C. T. Esmon, N. L. Esmon et al., Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N. Engl. J. Med, vol.361, pp.345-357, 2009.

P. W. Dempsey, M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon, C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-350, 1996.

J. Desai and C. Broome, , 2016.

J. Desimone, S. I. Biel, and P. Heller, Stimulation of fetal hemoglobin synthesis in baboons by hemolysis and hypoxia, Proc. Natl. Acad. Sci. U. S. A, vol.75, pp.2937-2940, 1978.

J. Desimone, P. Heller, A. , and J. G. , Hemopoietic stress and fetal hemoglobin synthesis: comparative studies in vivo and in vitro, Blood, vol.54, pp.1176-1181, 1979.

J. Desimone, M. Biel, and P. Heller, Maintenance of fetal hemoglobin (HbF) elevations in the baboon by prolonged erythropoietic stress, Blood, vol.60, pp.519-523, 1982.

P. A. Detmers, D. Zhou, D. Powell, H. Lichenstein, M. Kelley et al., Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase, J. Immunol. Baltim. Md, vol.155, pp.2085-2095, 1950.

J. W. Deuel, F. Vallelian, C. A. Schaer, M. Puglia, P. W. Buehler et al., Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic, Biol. Med, vol.89, pp.931-943, 2015.

J. W. Deuel, C. A. Schaer, F. S. Boretti, L. Opitz, I. Garcia-rubio et al., Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response, Cell Death Dis, vol.7, p.2064, 2016.

J. Deux, V. Audard, P. Brugières, A. Habibi, E. Manea et al., Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises, Am. J. Kidney Dis. Off. J. Natl. Kidney Found, vol.69, pp.51-59, 2017.

D. V. Devine and W. F. Rosse, , 1987.

M. S. Diamond, J. Garcia-aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer, Biol, vol.120, pp.1031-1043, 1993.

C. A. Diebolder, F. J. Beurskens, R. N. De-jong, R. I. Koning, K. Strumane et al., Complement is activated by IgG hexamers assembled at the cell surface, Science, vol.343, pp.1260-1263, 2014.

J. D. Dimitrov, L. T. Roumenina, V. R. Doltchinkova, N. M. Mihaylova, S. Lacroix-desmazes et al., , 2007.

, J. Biol. Chem, vol.282, pp.26696-26706

J. D. Dimitrov, L. T. Roumenina, V. R. Doltchinkova, and T. L. Vassilev, , 2007.

, J. Immunol, vol.65, pp.230-239

J. D. Dimitrov, C. Planchais, L. T. Roumenina, T. L. Vassilev, S. V. Kaveri et al.,

, Antibody polyreactivity in health and disease: statu variabilis, J. Immunol. Baltim. Md, pp.993-999, 1950191.

S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse et al., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, vol.399, pp.601-605, 1999.

R. G. Discipio, P. J. Daffern, M. A. Jagels, D. H. Broide, and P. Sriramarao, J. Immunol. Baltim. Md, vol.162, pp.1127-1136, 1950.

S. Djudjaj, M. Papasotiriou, R. D. Bülow, A. Wagnerova, M. T. Lindenmeyer et al., Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma, Clin. Exp. Immunol, vol.89, pp.173-180, 1994.

J. Dobó, D. Szakács, G. Oroszlán, E. Kortvely, B. Kiss et al., , 2016.

A. Dobrina, M. Pausa, F. Fischetti, R. Bulla, E. Vecile et al.,

D. H. Doherty, M. P. Doyle, S. R. Curry, R. J. Vali, T. J. Fattor et al., , 1998.

M. P. Doyle, I. Apostol, and B. A. Kerwin, Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties, J. Biol. Chem, vol.274, pp.2583-2591, 1999.

M. Dragon-durey, S. K. Sethi, A. Bagga, C. Blanc, J. Blouin et al., Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome, J. Am. Soc. Nephrol, vol.21, pp.2180-2187, 2010.

W. Druml, A. N. Laggner, K. Lenz, G. Grimm, and B. Schneeweiss, Pancreatitis in acute hemolysis, Ann. Hematol, vol.63, pp.39-41, 1991.

G. Dumas, A. Habibi, T. Onimus, J. Merle, K. Razazi et al., , vol.127, pp.1062-1064, 2016.

A. G. Dupuy, C. , and E. , Integrin-dependent phagocytosis: spreading from microadhesion to new concepts, J. Cell Sci, vol.121, pp.1773-1783, 2008.

F. F. Dutra and M. T. Bozza, Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014.

F. F. Dutra, L. S. Alves, D. Rodrigues, P. L. Fernandez, R. B. De-oliveira et al., Hemolysis-induced lethality involves inflammasome activation by heme, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4110-4118, 2014.

G. W. Dykes, R. H. Crepeau, and S. J. Edelstein, Three-dimensional reconstruction of the 14-filament fibers of hemoglobin S, J. Mol. Biol, vol.130, pp.451-472, 1979.

V. Fremeaux-bacchi, F. Fakhouri, A. Garnier, F. Bienaimé, M. Dragon-durey et al., Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin. J. Am. Soc. Nephrol. CJASN, vol.8, pp.554-562, 2013.

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., , 2013.

L. G. Fritsche, N. Lauer, A. Hartmann, S. Stippa, C. N. Keilhauer et al., An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age, 2010.

, Hum. Mol. Genet, vol.19, pp.4694-4704

C. Fronticelli and R. Gold, , 1976.

M. Fujihara, M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma et al., Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex, Pharmacol. Ther, vol.100, pp.171-194, 2003.

D. P. Funda, L. Tuckova, M. A. Farre, T. Iwase, I. Moro et al., CD14 Is Expressed and Released as Soluble CD14 by Human Intestinal Epithelial Cells In Vitro: Lipopolysaccharide Activation of Epithelial Cells Revisited, Infect. Immun, vol.69, pp.3772-3781, 2001.

R. F. Furchgott and P. M. Vanhoutte, Endothelium-derived relaxing and contracting factors, 1989.

, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.3, 2007.

R. Van-furth and Z. A. Cohn, The origin and kinetics of mononuclear phagocytes, J. Exp. Med, vol.128, pp.415-435, 1968.

D. P. Gale, E. G. De-jorge, H. T. Cook, R. Martinez-barricarte, A. Hadjisavvas et al., , 2010.

M. D. Galvan, D. B. Foreman, E. Zeng, J. C. Tan, and S. S. Bohlson, , 2012.

J. Gao, H. Choe, D. Bota, P. L. Wright, C. Gerard et al., , 2003.

L. Garby and W. D. Noyes, Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man, J. Clin. Invest, vol.38, pp.1479-1483, 1959.

P. Garred, N. Genster, K. Pilely, R. Bayarri-olmos, A. Rosbjerg et al., , 2016.

, A journey through the lectin pathway of complement-MBL and beyond, Immunol. Rev, vol.274, pp.74-97

P. Gasque, S. K. Singhrao, J. W. Neal, O. Götze, and B. P. Morgan, Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system, Am. J. Pathol, vol.150, pp.31-41, 1997.

E. Gavriilaki, M. Mainou, I. Christodoulou, E. Koravou, A. Paleta et al., , 2017.

M. C. Gelfand, M. M. Frank, and I. Green, A receptor for the third component of complement in the human renal glomerulus, J. Exp. Med, vol.142, pp.1029-1034, 1975.

J. N. George, E. B. Pickett, S. Saucerman, R. P. Mcever, T. J. Kunicki et al.,

, J. Clin. Invest, vol.78, pp.340-348

A. Ghannam, J. Fauquert, C. Thomas, C. Kemper, and C. Drouet, Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation, Mol. Immunol, vol.58, pp.98-107, 2014.

S. Ghosh, O. A. Adisa, P. Chappa, F. Tan, K. A. Jackson et al., , 2013.

, Extracellular hemin crisis triggers acute chest syndrome in sickle mice, J. Clin. Invest, vol.123, pp.4809-4820

F. Ginhoux, J. , and S. , Monocytes and macrophages: developmental pathways and tissue homeostasis, Nat. Rev. Immunol, vol.14, pp.392-404, 2014.

T. L. Gioannini, A. Teghanemt, D. Zhang, N. P. Coussens, W. Dockstader et al., Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.4186-4191, 2004.

M. T. Gladwin and V. Sachdev, Cardiovascular Abnormalities in Sickle Cell Disease, J. Am. Coll. Cardiol, vol.59, pp.1123-1133, 2012.

M. T. Gladwin, J. H. Shelhamer, F. P. Ognibene, M. E. Pease-fye, J. S. Nichols et al., Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease, Br. J. Haematol, vol.116, pp.436-444, 2002.

M. T. Gladwin, R. J. Barst, J. S. Gibbs, M. Hildesheim, V. Sachdev et al., , 2014.

E. Goicoechea-de-jorge, C. L. Harris, J. Esparza-gordillo, L. Carreras, E. A. Arranz et al., Gain-offunction mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.240-245, 2007.

E. Goicoechea-de-jorge, J. J. Caesar, T. H. Malik, M. Patel, M. Colledge et al., Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.4685-4690, 2013.

B. D. Goldstein, M. G. Rozen, and R. L. Kunis, Role of red cell membrane lipid peroxidation in hemolysis due to phenylhydrazine, Biochem. Pharmacol, vol.29, pp.1355-1359, 1980.

M. S. Goligorsky, D. Patschan, and M. Kuo, Weibel-Palade bodies-sentinels of acute stress, Nat. Rev. Nephrol, vol.5, pp.423-426, 2009.

J. Gong, L. Dai, C. Liu, C. Wu, Y. Shi et al., Expression of CD14, 2002.

N. N. Gorgani, J. Q. He, K. J. Katschke, K. Y. Helmy, H. Xi et al., , 2008.

Z. Gouveia, A. R. Carlos, X. Yuan, F. Aires-da-silva, R. Stocker et al., Characterization of Plasma Labile Heme in Hemolytic Conditions, FEBS J, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01793489

R. Gozzelino, V. Jeney, and M. P. Soares, Mechanisms of cell protection by heme oxygenase, 2010.

, Annu. Rev. Pharmacol. Toxicol, vol.50, pp.323-354

A. V. Graça-souza, M. A. Arruda, M. S. Freitas, . De, C. Barja-fidalgo et al., , 2002.

, Neutrophil activation by heme: implications for inflammatory processes, Blood, vol.99, pp.4160-4165

E. Graido-gonzalez, J. C. Doherty, E. W. Bergreen, G. Organ, M. Telfer et al., , 1998.

, Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vasoocclusive sickle crisis, Blood, vol.92, pp.2551-2555

J. A. Graw, C. Mayeur, I. Rosales, Y. Liu, V. S. Sabbisetti et al., Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red CellsClinical Perspective, Circulation, vol.134, pp.945-960, 2016.

J. A. Graw, B. Yu, E. Rezoagli, H. S. Warren, E. S. Buys et al., , 2017.

, Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension, Am. J. Physiol, vol.312, issue.6, pp.1120-1127

D. Green, F. H. Furby, and M. C. Berndt, The interaction of the factor VIII/von Willebrand factor complex with hematin, Thromb. Haemost, vol.56, pp.277-282, 1986.

A. Gustavsen, S. Nymo, A. Landsem, D. Christiansen, L. Ryan et al., Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Tolllike Receptor 4-MD2 Complex, J. Infect. Dis, vol.214, issue.1, pp.140-150, 2016.

D. R. Gutsaeva, J. B. Parkerson, S. D. Yerigenahally, J. C. Kurz, R. G. Schaub et al.,

M. A. Hadders, D. X. Beringer, and P. Gros, Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense, Science, vol.317, pp.1552-1554, 2007.

M. A. Hadders, D. Bubeck, P. Roversi, S. Hakobyan, F. Forneris et al., Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9, Cell Rep, vol.1, pp.200-207, 2012.

M. Hadzhieva, T. L. Vassilev, L. T. Roumenina, J. Bayry, S. V. Kaveri et al., Mechanism and Functional Implications of the Heme-Induced Binding Promiscuity of IgE, Biochemistry (Mosc.), vol.54, pp.2061-2072, 2015.

M. Hadzhieva, T. Vassilev, J. Bayry, S. Kaveri, S. Lacroix-desmazes et al., Relationship between natural and heme-mediated antibody polyreactivity, Biochem. Biophys. Res. Commun, vol.472, pp.281-286, 2016.

M. Häger, J. B. Cowland, and N. Borregaard, Neutrophil granules in health and disease, J. Intern. Med, vol.268, pp.25-34, 2010.

D. Hamideh and O. Alvarez, Sickle cell disease related mortality in the United States, 1999.

. Pediatr, Blood Cancer, vol.60, pp.1482-1486

D. Hamideh, V. Raj, T. Harrington, H. Li, E. Margolles et al., Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia, Pediatr. Nephrol. Berl. Ger, vol.29, 1997.

W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int, vol.62, pp.237-244, 2002.

O. A. Harari, Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway, Circ. Res, vol.98, pp.1134-1140, 2006.

M. Harboe and T. E. Mollnes, The alternative complement pathway revisited, J. Cell. Mol. Med, vol.12, pp.1074-1084, 2008.

K. Hartmann, B. M. Henz, S. Krüger-krasagakes, J. Köhl, R. Burger et al., C3a and C5a Stimulate Chemotaxis of Human Mast Cells, vol.89, p.2863, 1997.

K. L. Hassell, J. R. Eckman, and P. A. Lane, , 1994.

R. Hattori, K. K. Hamilton, R. P. Mcever, and P. J. Sims, , 1989.

R. P. Hebbel, Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology, Blood, vol.77, pp.214-237, 1991.

R. P. Hebbel, Adhesive interactions of sickle erythrocytes with endothelium, J. Clin. Invest, vol.99, pp.2561-2564, 1997.

R. P. Hebbel, M. A. Boogaerts, J. W. Eaton, and M. H. Steinberg, , 1980.

R. P. Hebbel, O. Yamada, C. F. Moldow, H. S. Jacob, J. G. White et al., Abnormal Adherence of Sickle Erythrocytes to Cultured Vascular Endothelium, J. Clin. Invest, vol.65, pp.154-160, 1980.

M. Hebecker, J. , and M. , , 2012.

, Biol. Chem, vol.287, issue.23, pp.19528-19536

S. Heinen, A. Hartmann, N. Lauer, U. Wiehl, H. Dahse et al., Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation, Blood, vol.114, pp.2439-2447, 2009.

C. Héliès-toussaint, S. Gambert, P. Roller, S. Tricot, B. Lacour et al., Lipid metabolism in human endothelial cells, Biochim. Biophys. Acta, vol.1761, pp.765-774, 2006.

J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen et al., , 2002.

K. Y. Helmy, K. J. Katschke, N. N. Gorgani, N. M. Kljavin, J. M. Elliott et al., CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens, Cell, vol.124, pp.915-927, 2006.

J. M. Herter, J. Rossaint, T. Spieker, and A. Zarbock, , 2014.

C. Herzog, R. S. Haun, V. Kaushal, P. R. Mayeux, S. V. Shah et al., Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta, Biochem. Biophys. Res. Commun, vol.379, pp.904-908, 2009.

C. Hess and C. Kemper, Complement-Mediated Regulation of Metabolism and Basic Cellular Processes, Immunity, vol.45, pp.240-254, 2016.

P. Hillmen, N. S. Young, J. Schubert, R. A. Brodsky, G. Socié et al., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N. Engl. J. Med, vol.355, pp.1233-1243, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00599451

P. Hillmen, P. Muus, A. Röth, M. O. Elebute, A. M. Risitano et al., Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria, Br. J. Haematol, vol.162, pp.62-73, 2013.

V. W. Van-hinsbergh, Endothelium-role in regulation of coagulation and inflammation, 2012.

, Semin. Immunopathol, vol.34, pp.93-106

E. A. Hod, J. C. Zimring, and S. L. Spitalnik, Lessons learned from mouse models of hemolytic transfusion reactions, Curr. Opin. Hematol, vol.15, pp.601-605, 2008.

E. A. Hod, C. M. Cadwell, J. S. Liepkalns, J. C. Zimring, S. A. Sokol et al., , 2008.

E. A. Hod, N. Zhang, S. A. Sokol, B. S. Wojczyk, R. O. Francis et al., , 2010.

J. Hofer, A. Rosales, C. Fischer, and T. Giner, Extra-Renal Manifestations of ComplementMediated Thrombotic Microangiopathies, Front. Pediatr, vol.2, 2014.

R. Hoover, R. Rubin, G. Wise, W. , and R. , Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures, Blood, vol.54, pp.872-876, 1979.

D. E. Hourcade, The role of properdin in the assembly of the alternative pathway C3 convertases of complement, J. Biol. Chem, vol.281, pp.2128-2132, 2006.

D. Hourcade, M. K. Liszewski, M. Krych-goldberg, and J. P. Atkinson, Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1, Immunopharmacology, vol.49, pp.103-116, 2000.

L. L. Hsu, H. C. Champion, S. A. Campbell-lee, T. J. Bivalacqua, E. A. Manci et al., , 2007.

Y. Huang, F. Qiao, R. Abagyan, S. Hazard, and S. Tomlinson, Defining the CD59-C9 binding interaction, J. Biol. Chem, vol.281, pp.27398-27404, 2006.

M. Huber-lang, J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff et al., Generation of C5a in the absence of C3: a new complement activation pathway, Nat. Med, vol.12, pp.682-687, 2006.

M. Huber-lang, A. Barratt-due, S. E. Pischke, Ø. Sandanger, P. H. Nilsson et al., , 2014.

V. Hvidberg, M. B. Maniecki, C. Jacobsen, P. Højrup, H. J. Møller et al., Identification of the receptor scavenging hemopexin-heme complexes, Blood, vol.106, pp.2572-2579, 2005.

S. Hyvärinen, K. Uchida, M. Varjosalo, R. Jokela, and T. S. Jokiranta, , 2014.

K. Iida and V. Nussenzweig, Complement receptor is an inhibitor of the complement cascade, J. Exp. Med, vol.153, pp.1138-1150, 1981.

K. Ikeda, T. Sannoh, N. Kawasaki, T. Kawasaki, Y. et al., , 1987.

K. Ikeda, K. Nagasawa, T. Horiuchi, T. Tsuru, H. Nishizaka et al., C5a induces tissue factor activity on endothelial cells, Thromb. Haemost, vol.77, pp.394-398, 1997.

G. Ingoglia, C. M. Sag, N. Rex, L. De-franceschi, F. Vinchi et al., Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress. Free Radic, Biol. Med, vol.108, pp.452-464, 2017.

D. E. Isenman, D. I. Kells, N. R. Cooper, H. J. Müller-eberhard, and M. K. Pangburn, , 1981.

, Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry (Mosc.), vol.20, pp.4458-4467

C. J. Jaffe, J. P. Atkinson, and M. M. Frank, The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man, J. Clin. Invest, vol.58, pp.942-949, 1976.

H. Jarva, T. S. Jokiranta, J. Hellwage, P. F. Zipfel, M. et al., , 1999.

V. Jeney, J. Balla, A. Yachie, Z. Varga, G. M. Vercellotti et al., Prooxidant and cytotoxic effects of circulating heme, Blood, vol.100, pp.879-887, 2002.

H. P. Jersmann, C. S. Hii, G. L. Hodge, and A. Ferrante, Synthesis and Surface Expression of CD14 by Human Endothelial Cells, Infect. Immun, vol.69, pp.479-485, 2001.

H. Jiang, Y. Kuang, Y. Wu, W. Xie, M. I. Simon et al., Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.7971-7975, 1997.

Z. Jin, H. Ueba, T. Tanimoto, A. O. Lungu, M. D. Frame et al., , 2003.

E. Johnson and G. Hetland, Human Umbilical Vein Endothelial Cells Synthesize Functional C3, C5, C6, C8 and C9 In Vitro, Scand. J. Immunol, vol.33, pp.667-671, 1991.

T. S. Jokiranta, HUS and atypical HUS, Blood, vol.129, pp.2847-2856, 2017.

T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, M. et al., Chem, vol.275, pp.27657-27662, 2000.

C. C. Joneckis, R. L. Ackley, E. P. Orringer, E. A. Wayner, and L. V. Parise, , 1993.

J. Jonsen, E. Kass, and M. Harboe, Complement and complement components in acquired hemolytic anemia with high titer cold antibodies, Acta Med. Scand, vol.170, pp.725-729, 1961.

M. M. Jore, S. Johnson, D. Sheppard, N. M. Barber, Y. I. Li et al.,

, Structural basis for therapeutic inhibition of complement C5, Nat. Struct. Mol. Biol, vol.23, pp.378-386

N. Julen, H. Dauchel, C. Lemercier, R. B. Sim, M. Fontaine et al., In vitro biosynthesis of complement factor I by human endothelial cells, Eur. J. Immunol, vol.22, pp.213-217, 1992.

T. Kajander, M. J. Lehtinen, S. Hyvärinen, A. Bhattacharjee, E. Leung et al., Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.2897-2902, 2011.

M. Kalbitz, F. Fattahi, T. J. Herron, J. J. Grailer, L. Jajou et al., The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin. Exp. Immunol, vol.21, pp.109-114, 1975.

P. J. Lachmann, E. Lay, and D. J. Seilly, , 2017.

P. N. Lalli, M. G. Strainic, F. Lin, M. E. Medof, and P. S. Heeger, Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production, J. Immunol. Baltim. Md, vol.179, pp.5793-5802, 1950.

J. D. Lambris, Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack et al., Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J. Immunol. Baltim. Md, vol.156, pp.4821-4832, 1950.

R. Landmann, A. M. Reber, S. Sansano, and W. Zimmerli, Function of soluble CD14 in serum from patients with septic shock, J. Infect. Dis, vol.173, pp.661-668, 1996.

A. Langford-smith, A. J. Day, P. N. Bishop, and S. J. Clark, Complementing the sugar code: role of GAGs and sialic acid in complement regulation, Mol. Innate Immun, vol.6, p.25, 2015.

I. J. Laudes, J. C. Chu, M. Huber-lang, R. Guo, N. C. Riedemann et al., Expression and function of C5a receptor in mouse microvascular endothelial cells, J. Immunol. Baltim. Md, vol.169, pp.5962-5970, 1950.

S. K. Law and A. W. Dodds, The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci. Publ. Protein Soc, vol.6, pp.263-274, 1997.

L. Friec, G. Sheppard, D. Whiteman, P. Karsten, C. M. Shamoun et al., The CD46-Jagged1 interaction is critical for human TH1 immunity, Nat. Immunol, vol.13, pp.1213-1221, 2012.

K. J. Leath, S. Johnson, P. Roversi, T. R. Hughes, R. A. Smith et al., High-resolution structures of bacterially expressed soluble human CD59, Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun, vol.63, pp.648-652, 2007.

J. Leffler, A. P. Herbert, E. Norström, C. Q. Schmidt, P. N. Barlow et al., , 2010.

. Annexin-ii, DNA, and histones serve as factor H ligands on the surface of apoptotic cells, J. Biol. Chem, vol.285, pp.3766-3776

R. J. Lefkowitz, A brief history of G-protein coupled receptors (Nobel Lecture), Angew. Chem. Int. Ed Engl, vol.52, pp.6366-6378, 2013.

M. J. Lehtinen, A. L. Rops, D. E. Isenman, J. Van-der-vlag, and T. S. Jokiranta, , 2009.

, J. Biol. Chem, vol.284, pp.15650-15658

B. Lemaitre, J. M. Reichhart, and J. A. Hoffmann, Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.14614-14619, 1997.

M. A. Lett-brown and E. J. Leonard, Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J. Immunol. Baltim. Md, vol.118, pp.815-818, 1950.

L. A. Lewis, R. , and S. , Meningococcal disease and the complement system, Virulence, vol.5, p.98, 2014.

K. Li, J. Gor, and S. J. Perkins, Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem. J, vol.431, pp.63-72, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00517253

E. C. Lian and .. , Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond, Semin. Thromb. Hemost, vol.31, pp.625-632, 2005.

E. Liang, Y. N. Wong, I. Allen, R. Kao, M. Marino et al., Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function, J. Clin. Pharmacol, vol.43, pp.1361-1369, 2003.

C. Licht, F. G. Pluthero, L. Li, H. Christensen, S. Habbig et al., Platelet-associated complement factor H in healthy persons and patients with atypical HUS, Blood, vol.114, pp.4538-4545, 2009.

E. A. Lidington, D. O. Haskard, and J. C. Mason, , vol.96, pp.2784-2792, 2000.

A. P. Lillis, I. Mikhailenko, and D. K. Strickland, Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability, J. Thromb. Haemost. JTH, vol.3, pp.1884-1893, 2005.

S. K. Lim, B. Ferraro, K. Moore, and B. Halliwell, Role of haptoglobin in free hemoglobin metabolism, Redox Rep. Commun. Free Radic. Res, vol.6, pp.219-227, 2001.

Y. K. Lim, A. Jenner, A. B. Ali, Y. Wang, S. I. Hsu et al., Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazineinduced hemolysis, Kidney Int, vol.58, pp.1033-1044, 2000.
DOI : 10.1046/j.1523-1755.2000.00261.x

URL : https://doi.org/10.1046/j.1523-1755.2000.00261.x

T. Lin, Y. H. Kwak, F. Sammy, P. He, S. Thundivalappil et al., , 2010.

, Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll-Like Receptor Agonists and Is Blocked by Hemopexin, J. Infect. Dis, vol.202, pp.624-632

T. Lin, D. Maita, S. R. Thundivalappil, F. E. Riley, J. Hambsch et al., Hemopexin in severe inflammation and infection: mouse models and human diseases, Crit. Care, 2015.

M. A. Lindorfer, E. M. Cook, E. S. Reis, D. Ricklin, A. M. Risitano et al., , 2016.

, Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia, Clin. Immunol. Orlando Fla, vol.171, pp.32-35

A. M. Lipp, K. Juhasz, C. Paar, C. Ogris, P. Eckerstorfer et al., Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells, PloS One, vol.9, p.85934, 2014.

M. K. Liszewski, T. W. Post, and J. P. Atkinson, , 1991.

M. K. Liszewski, M. Kolev, G. Le-friec, M. Leung, P. G. Bertram et al., Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation, Immunity, vol.39, pp.1143-1157, 2013.
DOI : 10.1016/j.immuni.2013.10.018

URL : https://doi.org/10.1016/j.immuni.2013.10.018

J. Liu, T. Miwa, B. Hilliard, Y. Chen, J. D. Lambris et al., The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo, J. Exp. Med, vol.201, pp.567-577, 2005.

Z. Liu, Y. Jiang, Y. Li, J. Wang, L. Fan et al.,

, TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation, J. Immunol. Baltim. Md, pp.857-864, 1950191.

M. Locatelli, S. Buelli, A. Pezzotta, D. Corna, L. Perico et al., Shiga Toxin Promotes Podocyte Injury in Experimental Hemolytic Uremic Syndrome via Activation of the Alternative Pathway of Complement, J. Am. Soc. Nephrol, vol.25, p.1786, 2014.

K. M. Lochhead, E. D. Kharasch, and R. A. Zager, Anesthetic effects on the glycerol model of rhabdomyolysis-induced acute renal failure in rats, J. Am. Soc. Nephrol. JASN, vol.9, pp.305-309, 1998.

D. T. Lodowski, J. A. Pitcher, W. D. Capel, R. J. Lefkowitz, and J. J. Tesmer, Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma, Science, vol.300, pp.1256-1262, 2003.
DOI : 10.1126/science.1082348

M. A. Loeven, A. L. Rops, M. J. Lehtinen, T. H. Van-kuppevelt, M. R. Daha et al., Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro, J. Biol. Chem, vol.291, pp.4974-4981, 2016.
DOI : 10.1074/jbc.m115.702506

URL : http://www.jbc.org/content/291/10/4974.full.pdf

G. L. Logue, W. F. Rosse, and J. P. Adams, Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells, J. Clin. Invest, vol.52, pp.1129-1137, 1973.

C. Loirat, F. Fakhouri, G. Ariceta, N. Besbas, M. Bitzan et al., An international consensus approach to the management of atypical hemolytic uremic syndrome in children, Pediatr. Nephrol. Berl. Ger, vol.31, pp.15-39, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02149335

K. Loniewski, Y. Shi, J. Pestka, and N. Parameswaran, Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages, Mol. Immunol, vol.45, pp.2312-2322, 2008.
DOI : 10.1016/j.molimm.2007.11.012

L. L. Lovelace, C. L. Cooper, J. M. Sodetz, and L. Lebioda, , 2011.

, Chem, vol.286, pp.17585-17592

D. M. Lublin and J. P. Atkinson, Decay-accelerating factor: biochemistry, molecular biology, and function, Annu. Rev. Immunol, vol.7, pp.35-58, 1989.
DOI : 10.1146/annurev.immunol.7.1.35

M. Lynn, Y. N. Wong, J. L. Wheeler, R. J. Kao, C. A. Perdomo et al., , 2004.

, J. Pharmacol. Exp. Ther, vol.308, pp.175-181

M. Magnani, L. Rossi, L. Cucchiarini, V. Stocchi, and G. Fornaini, Effect of phenylhydrazine on red blood cell metabolism, Cell Biochem. Funct, vol.6, pp.175-182, 1988.
DOI : 10.1002/cbf.290060305

G. Maigne, S. Ferlicot, F. Galacteros, X. Belenfant, T. Ulinski et al., Glomerular lesions in patients with sickle cell disease, Medicine, vol.89, pp.18-27, 2010.

M. D. Maines and J. C. Veltman, Phenylhydrazine-mediated induction of haem oxygenase activity in rat liver and kidney and development of hyperbilirubinaemia. Inhibition by zincprotoporphyrin, Biochem. J, vol.217, pp.409-417, 1984.

G. Majno and G. E. Palade, Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study, J. Biophys. Biochem. Cytol, vol.11, pp.571-605, 1961.

T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, M. Noris et al., Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J. Clin. Invest, vol.111, pp.1181-1190, 2003.
DOI : 10.1172/jci16651

URL : http://www.jci.org/articles/view/16651/files/pdf

E. Marcenaro, R. Augugliaro, M. Falco, R. Castriconi, S. Parolini et al., CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity, Eur. J. Immunol, vol.33, pp.3367-3376, 2003.
DOI : 10.1002/eji.200324425

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.200324425

A. J. Marengo-rowe, Structure-function relations of human hemoglobins, Proc. Bayl. Univ. Med. Cent, vol.19, pp.239-245, 2006.

M. C. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni et al., Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J. Am. Soc. Nephrol. JASN, vol.25, pp.2053-2065, 2014.

M. Marinozzi, S. Chauvet, M. Le-quintrec, M. Mignotet, F. Petitprez et al., C5 nephritic factors drive the biological phenotype of C3 glomerulopathies, Kidney Int, vol.92, issue.5, pp.1232-1241, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01758552

M. M. Markiewski, R. A. Deangelis, F. Benencia, S. K. Ricklin-lichtsteiner, A. Koutoulaki et al., Modulation of the antitumor immune response by complement, 2008.

, Nat. Immunol, vol.9, pp.1225-1235

M. Martin and A. M. Blom, Complement in removal of the dead -balancing inflammation, Immunol. Rev, vol.274, pp.218-232, 2016.

P. Masaratana, G. O. Latunde-dada, N. Patel, R. J. Simpson, S. Vaulont et al., , 2012.

J. C. Mason, H. Yarwood, K. Sugars, B. P. Morgan, K. A. Davies et al., Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition, Blood, vol.94, pp.1673-1682, 1999.

J. C. Mason, E. A. Lidington, H. Yarwood, D. M. Lublin, and D. O. Haskard, , 2001.

J. C. Mason, E. A. Lidington, S. R. Ahmad, and D. O. Haskard, bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction, Am. J. Physiol. Cell Physiol, vol.282, pp.578-587, 2002.

J. Mathison, E. Wolfson, S. Steinemann, P. Tobias, and R. Ulevitch, Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages, J. Clin. Invest, vol.92, pp.2053-2059, 1993.

N. M. Matsui, A. Varki, and S. H. Embury, Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin, Blood, vol.100, pp.3790-3796, 2002.

N. Matsunaga, N. Tsuchimori, T. Matsumoto, and M. Ii, TAK-242 (Resatorvid), a SmallMolecule Inhibitor of Toll-Like Receptor (TLR), p.4, 2011.

. Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules, Mol. Pharmacol, vol.79, pp.34-41

K. W. Matthews, S. L. Mueller-ortiz, and R. A. Wetsel, Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol. Immunol, vol.40, pp.785-793, 2004.

T. N. Mayadas, R. C. Johnson, H. Rayburn, R. O. Hynes, and D. D. Wagner, Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice, Cell, vol.74, pp.541-554, 1993.

D. M. Mcdonald, G. Thurston, and P. Baluk, Endothelial gaps as sites for plasma leakage in inflammation, vol.6, pp.7-22, 1994.

R. P. Mcever, J. H. Beckstead, K. L. Moore, L. Marshall-carlson, and D. F. Bainton, GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies, J. Clin. Invest, vol.84, pp.92-99, 1989.

L. A. Mcnamara, N. Topaz, X. Wang, S. Hariri, L. Fox et al., High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine, MMWR Morb. Mortal. Wkly. Rep, vol.66, pp.734-737, 2017.

J. L. Mcrae, T. G. Duthy, K. M. Griggs, R. J. Ormsby, P. J. Cowan et al., Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, 2005.

, J. Immunol. Baltim. Md, vol.174, pp.6250-6256, 1950.

N. Medjeral-thomas and M. C. Pickering, The complement factor H-related proteins, Immunol. Rev, vol.274, pp.191-201, 2016.

S. Meher, T. S. Mishra, P. K. Sasmal, S. Rath, R. Sharma et al., Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis, J. Biomark, vol.2015, pp.1-13, 2015.

S. Meri, B. P. Morgan, A. Davies, R. H. Daniels, M. G. Olavesen et al.,

, 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers, Immunology, vol.18, pp.1-9

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina, , 2015.

, Complement System Part II: Role in Immunity. Front. Immunol, vol.6

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front. Immunol, vol.6, 2015.

L. Mery and F. Boulay, Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding, Eur. J. Haematol, vol.51, pp.282-287, 1993.

W. Mickols, M. F. Maestre, I. Tinoco, and S. H. Embury, Visualization of oriented hemoglobin S in individual erythrocytes by differential extinction of polarized light, Proc. Natl. Acad. Sci. U. S. A, vol.82, pp.6527-6531, 1985.

H. Min, B. Choi, Y. H. Jang, I. Cho, and S. J. Lee, , 2017.

X. Min, C. Liu, Y. Wei, N. Wang, G. Yuan et al., Expression and regulation of complement receptors by human natural killer cells, Immunobiology, vol.219, pp.671-679, 2014.

P. C. Minneci, Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin, J. Clin. Invest, vol.115, pp.3409-3417, 2005.

S. K. Moestrup, J. Gliemann, and G. Pallesen, , 1992.

C. Mold, J. D. Tamerius, and G. Phillips, Complement activation during painful crisis in sickle cell anemia, Clin. Immunol. Immunopathol, vol.76, pp.314-320, 1995.

T. Monsinjon, P. Gasque, P. Chan, A. Ischenko, J. J. Brady et al., , 2003.

, FASEB J, vol.17, pp.1003-1014

B. P. Morgan, Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem. J, vol.264, pp.1-14, 1989.

B. P. Morgan, D. Walters, M. Serna, and D. Bubeck, Terminal complexes of the complement system: new structural insights and their relevance to function, Immunol. Rev, vol.274, pp.141-151, 2016.

H. P. Morgan, C. Q. Schmidt, M. Guariento, B. S. Blaum, D. Gillespie et al., Structural basis for engagement by complement factor H of C3b on a self surface, Nat. Struct. Mol. Biol, vol.18, pp.463-470, 2011.

H. P. Morgan, H. D. Mertens, M. Guariento, C. Q. Schmidt, D. C. Soares et al., Structural Analysis of the C-Terminal Region (Modules 18-20) of Complement Regulator Factor H (FH), PLoS ONE, vol.7, 2012.

M. Morigi, M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli et al., Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis, J. Immunol, vol.187, pp.172-180, 2011.

C. M. Morris, J. M. Candy, J. A. Edwardson, C. A. Bloxham, and A. Smith, , 1993.

R. A. Nelson, An alternative mechanism for the properdin system, J. Exp. Med, vol.108, pp.515-535, 1958.

G. R. Nemerow, K. I. Yamamoto, and T. F. Lint, , 1979.

, J. Immunol. Baltim. Md, vol.123, pp.1245-1252, 1950.

F. Niculescu and H. Rus, Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells, Immunol. Res, vol.24, pp.191-199, 2001.

V. G. Nielsen, J. B. Cohen, S. N. Malayaman, M. Nowak, and K. Vosseller, Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report, Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb, vol.22, pp.443-447, 2011.

B. Nilsson, N. Ekdahl, and K. , The tick-over theory revisited: is C3 a contact-activated protein?, Immunobiology, vol.217, pp.1106-1110, 2012.

U. R. Nilsson and H. J. Mueller-eberhard, ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT, J. Exp. Med, vol.122, pp.277-298, 1965.

S. C. Nilsson, N. Kalchishkova, L. A. Trouw, V. Fremeaux-bacchi, B. O. Villoutreix et al.,

S. C. Nilsson, R. B. Sim, S. M. Lea, V. Fremeaux-bacchi, and A. M. Blom, Complement factor I in health and disease, Mol. Immunol, vol.48, pp.1611-1620, 2011.

N. Nishida, T. Walz, and T. A. Springer, Structural transitions of complement component C3 and its activation products, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.19737-19742, 2006.

M. Nonaka and A. Kimura, , 2006.

D. G. Noone, M. Riedl, F. G. Pluthero, M. L. Bowman, M. K. Liszewski et al., Von Willebrand factor regulates complement on endothelial cells. Kidney Int, 2016.

M. Noris and G. Remuzzi, Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015, Am. J. Kidney Dis, vol.66, pp.359-375, 2015.

C. A. Ogden, A. Decathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet et al., C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J. Exp. Med, vol.194, pp.781-795, 2001.

A. Ohbuchi, M. Kono, K. Kitagawa, M. Takenokuchi, S. Imoto et al., Quantitative analysis of hemin-induced neutrophil extracellular trap formation and effects of hydrogen peroxide on this phenomenon, Biochem. Biophys. Rep, vol.11, pp.147-153, 2017.

J. S. Olson, E. W. Foley, C. Rogge, A. Tsai, M. P. Doyle et al., No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic, Biol. Med, vol.36, pp.685-697, 2004.

M. G. Olsson, M. Allhorn, L. Bülow, S. R. Hansson, D. Ley et al., Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, 2012.

, Antioxid. Redox Signal, vol.17, pp.813-846

L. A. O'neill, D. Golenbock, and A. G. Bowie, The history of Toll-like receptors -redefining innate immunity, Nat. Rev. Immunol, vol.13, pp.453-460, 2013.

M. Oppermann, T. Manuelian, M. Józsi, E. Brandt, T. S. Jokiranta et al., , 2006.

R. J. Ormsby, T. S. Jokiranta, T. G. Duthy, K. M. Griggs, T. A. Sadlon et al.,

, Mol. Immunol, vol.43, pp.1624-1632

B. Osterud, M. S. Bajaj, and S. P. Bajaj, , 1995.

L. Ottonello, A. Corcione, G. Tortolina, I. Airoldi, E. Albesiano et al., rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues, J. Immunol. Baltim. Md, vol.162, pp.6510-6517, 1950.

A. Ozen, W. A. Comrie, R. C. Ardy, C. Domínguez-conde, B. Dalgic et al., CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis, vol.377, pp.52-61, 2017.

N. Packiriswamy and N. Parameswaran, G-protein-coupled receptor kinases in inflammation and disease, Genes Immun, vol.16, pp.367-377, 2015.

H. Païdassi, P. Tacnet-delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet et al., C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J. Immunol. Baltim. Md, vol.180, pp.2329-2338, 1950.

H. Païdassi, P. Tacnet-delorme, M. Verneret, C. Gaboriaud, G. Houen et al., Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J. Mol. Biol, vol.408, pp.277-290, 2011.

R. M. Palmer, A. G. Ferrige, and S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, vol.327, pp.524-526, 1987.

A. Pamplona, A. Ferreira, J. Balla, V. Jeney, G. Balla et al., Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria, Nat. Med, vol.13, pp.703-710, 2007.

M. K. Pangburn, Analysis of the natural polymeric forms of human properdin and their functions in complement activation, J. Immunol. Baltim. Md, vol.142, pp.202-207, 1950.

M. K. Pangburn and H. J. Müller-eberhard, Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I, Biochemistry (Mosc.), vol.22, pp.178-185, 1983.

M. K. Pangburn and H. J. Müller-eberhard, , 1986.

M. K. Pangburn and N. Rawal, Structure and function of complement C5 convertase enzymes, Biochem. Soc. Trans, vol.30, pp.1006-1010, 2002.

M. K. Pangburn, R. D. Schreiber, and H. J. Müller-eberhard, Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution, J. Exp. Med, vol.146, pp.257-270, 1977.

M. K. Pangburn, R. D. Schreiber, and H. J. Müller-eberhard, , 1981.

, J. Exp. Med, vol.154, pp.856-867

M. K. Pangburn, R. D. Schreiber, and H. J. Müller-eberhard, , 1983.

, Immunol. Baltim. Md, vol.131, pp.1930-1935, 1950.

J. C. Papadimitriou, L. E. Ramm, C. B. Drachenberg, B. F. Trump, and M. L. Shin, , 1991.

L. Pape, H. Hartmann, F. C. Bange, S. Suerbaum, E. Bueltmann et al., , 2015.

, Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement: Medicine (Baltimore) 94, e1000

V. Pardo, J. Strauss, H. Kramer, T. Ozawa, and R. M. Mcintosh, Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients, Am. J. Med, vol.59, pp.650-659, 1975.

B. S. Park, D. H. Song, H. M. Kim, B. Choi, H. Lee et al., The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex, Nature, vol.458, pp.1191-1195, 2009.

A. K. Parpart and J. C. Shull, Permeability of the erythrocyte for glycerol, J. Cell. Comp. Physiol, vol.6, pp.129-135, 1935.

R. F. Paulson, L. Shi, and D. Wu, Stress erythropoiesis: new signals and new stress progenitor cells, vol.18, pp.139-145, 2011.

R. Pawliuk, Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy, Science, vol.294, pp.2368-2371, 2001.

A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, , 2007.

I. C. Pechtl, D. Kavanagh, N. Mcintosh, C. L. Harris, and P. N. Barlow, Disease-associated Nterminal complement factor H mutations perturb cofactor and decay-accelerating activities, J. Biol. Chem, vol.286, pp.11082-11090, 2011.

D. V. Pedersen, L. Roumenina, R. K. Jensen, T. A. Gadeberg, C. Marinozzi et al., Functional and structural insight into properdin control of complement alternative pathway amplification, EMBO J, vol.36, pp.1084-1099, 2017.

E. I. Peerschke, W. Yin, S. E. Grigg, and B. Ghebrehiwet, Blood platelets activate the classical pathway of human complement, J. Thromb. Haemost. JTH, vol.4, pp.2035-2042, 2006.

Q. Peng, K. Li, H. Patel, S. H. Sacks, and W. Zhou, , 2006.

Q. Peng, K. Li, K. Anderson, C. A. Farrar, B. Lu et al., Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction, Blood, vol.111, pp.2452-2461, 2008.

M. C. Perianayagam, V. S. Balakrishnan, A. J. King, B. J. Pereira, and B. L. Jaber, , 2002.

S. J. Perkins, R. Nan, K. Li, S. Khan, and A. Miller, Complement factor H-ligand interactions: self-association, multivalency and dissociation constants, Immunobiology, vol.217, pp.281-297, 2012.

S. J. Perkins, K. W. Fung, and S. Khan, Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands, Front. Immunol, vol.5, p.126, 2014.

B. D. Persson, N. B. Schmitz, C. Santiago, G. Zocher, M. Larvie et al., Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens, PLoS Pathog, vol.6, p.1001122, 2010.

P. Petzelbauer, J. R. Bender, J. Wilson, and J. S. Pober, Immunol. Baltim. Md, vol.151, pp.5062-5072, 1950.

H. P. Pham and B. H. Shaz, Update on massive transfusion, Br. J. Anaesth, vol.111, pp.71-82, 2013.
DOI : 10.1093/bja/aet376

M. Phelan, S. P. Perrine, M. Brauer, and D. V. Faller, Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture, J. Clin. Invest, vol.96, pp.1145-1151, 1995.

M. Piazza, G. Damore, B. Costa, T. L. Gioannini, J. P. Weiss et al., , 2011.

M. C. Pickering, M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport, Systemic lupus erythematosus, complement deficiency, and apoptosis, Adv. Immunol, vol.76, pp.227-324, 2000.
DOI : 10.1016/s0065-2776(01)76021-x

M. C. Pickering, H. T. Cook, J. Warren, A. E. Bygrave, J. Moss et al., , 2002.

, Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H, Nat. Genet, vol.31, pp.424-428

F. B. Piel, A. P. Patil, R. E. Howes, O. A. Nyangiri, P. W. Gething et al., Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates, The Lancet, vol.381, pp.142-151, 2013.

F. B. Piel, S. I. Hay, S. Gupta, D. J. Weatherall, and T. N. Williams, Global Burden of Sickle Cell Anaemia in Children under Five, Modelling Based on Demographics, Excess Mortality, and Interventions, vol.10, 2010.

R. Pihl, L. Jensen, A. G. Hansen, I. B. Thøgersen, S. Andres et al., Analysis of Factor D Isoforms in Malpuech-Michels-Mingarelli-Carnevale, 2017.

, Immunol, vol.199, pp.2158-2170

L. Pillemer, L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd et al., The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science, vol.120, pp.279-285, 1954.

O. S. Platt, D. J. Brambilla, W. F. Rosse, P. F. Milner, O. Castro et al., , 1994.

, J. Med, vol.330, pp.1639-1644

J. S. Pober and W. C. Sessa, Evolving functions of endothelial cells in inflammation, Nat. Rev. Immunol, vol.7, pp.803-815, 2007.

E. R. Podack, Molecular composition of the tubular structure of the membrane attack complex of complement, J. Biol. Chem, vol.259, pp.8641-8647, 1984.

R. Polanowska-grabowska, K. Wallace, J. J. Field, L. Chen, M. A. Marshall et al., P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease, Arterioscler. Thromb. Vasc. Biol, vol.30, pp.2392-2399, 2010.

M. J. Polley and R. L. Nachman, Human platelet activation by C3a and C3a des-arg, J. Exp. Med, vol.158, pp.603-615, 1983.
DOI : 10.1084/jem.158.2.603

URL : http://jem.rupress.org/content/158/2/603.full.pdf

A. Poltorak, X. He, I. Smirnova, M. Y. Liu, C. Van-huffel et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998.

B. N. Porto, L. S. Alves, P. L. Fernandez, T. P. Dutra, R. T. Figueiredo et al., Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors, J. Biol. Chem, vol.282, pp.24430-24436, 2007.

K. D. Poss and S. Tonegawa, Heme oxygenase 1 is required for mammalian iron reutilization, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.10919-10924, 1997.

K. P. Preissner, E. R. Podack, and H. J. Müller-eberhard, SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules, Eur. J. Immunol, vol.19, pp.69-75, 1989.

K. T. Preissner, E. R. Podack, and H. J. Müller-eberhard, , 1985.

, J. Immunol. Baltim. Md, vol.135, pp.445-451, 1950.

N. Radhakrishnan, S. P. Yadav, A. Sachdeva, P. K. Pruthi, S. Sawhney et al., Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia, J. Pediatr. Hematol. Oncol, vol.33, pp.74-78, 2011.

C. R. Raetz and C. Whitfield, Lipopolysaccharide endotoxins, Annu. Rev. Biochem, vol.71, pp.635-700, 2002.

R. Rajagopalan, T. Nyaundi, V. P. Salvi, and N. Rawal, complement. Mol. Immunol, vol.47, pp.2505-2514, 2010.

G. J. Randolph, C. Jakubzick, and C. Qu, Antigen presentation by monocytes and monocytederived cells, Curr. Opin. Immunol, vol.20, pp.52-60, 2008.

. Ranvers, Über Pyrodin, Arb Ad Erst Med Klin Zu Berl ii, p.471, 1891.

S. G. Rasmussen, H. Choi, D. M. Rosenbaum, T. S. Kobilka, F. S. Thian et al., Crystal structure of the human beta2 adrenergic G-protein-coupled receptor, Nature, vol.450, pp.383-387, 2007.

J. Rayes, L. T. Roumenina, J. D. Dimitrov, Y. Repessé, M. Ing et al., The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status, Blood, vol.123, pp.121-125, 2014.

J. G. Raynes, S. Eagling, and K. P. Mcadam, Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6, Clin. Exp. Immunol, vol.83, pp.488-491, 1991.

T. Reinheckel, B. Nedelev, J. Prause, W. Augustin, H. U. Schulz et al., Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis. Free Radic, Biol. Med, vol.24, pp.393-400, 1998.

C. D. Reiter and M. T. Gladwin, An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy, Curr. Opin. Hematol, vol.10, pp.99-107, 2003.

C. D. Reiter, X. Wang, J. E. Tanus-santos, N. Hogg, R. O. Cannon et al.,

, Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease, Nat. Med, vol.8, pp.1383-1389

F. Rendu and B. Brohard-bohn, The platelet release reaction: granules' constituents, secretion and functions, Platelets, vol.12, pp.261-273, 2001.

J. Ripoche, J. A. Mitchell, A. Erdei, C. Madin, B. Moffatt et al.,

, J. Exp. Med, vol.168, pp.1917-1922

A. M. Risitano, R. Notaro, C. Pascariello, M. Sica, L. Del-vecchio et al., , 2012.

D. A. Rodeberg, R. E. Morris, and G. F. Babcock, Azurophilic granules of human neutrophils contain CD14, Infect. Immun, vol.65, pp.4747-4753, 1997.

E. Rodriguez, R. Nan, K. Li, J. Gor, and S. J. Perkins, A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J. Biol. Chem, vol.290, issue.4, pp.2334-2350, 2015.

D. M. Rosenbaum, S. G. Rasmussen, and B. K. Kobilka, The structure and function of Gprotein-coupled receptors, Nature, vol.459, pp.356-363, 2009.

G. D. Ross and V. V?tvicka, CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clin. Exp. Immunol, vol.92, pp.181-184, 1993.

G. D. Ross, J. D. Lambris, J. A. Cain, and S. L. Newman, , 1982.

, Immunol. Baltim. Md, vol.129, pp.2051-2060, 1950.

D. P. Rossignol, K. M. Wasan, E. Choo, E. Yau, N. Wong et al., , 2004.

, Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran

D. P. Rossignol, N. Wong, R. Noveck, L. , and M. , Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers, Innate Immun, vol.14, pp.383-394, 2008.

A. Röth, A. Huttmann, R. P. Rother, U. Duhrsen, and T. Philipp, , 2009.

R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, vol.293, p.1653, 2005.

R. P. Rother, S. A. Rollins, C. F. Mojcik, R. A. Brodsky, and L. Bell, , 2007.

, Nat. Biotechnol, vol.25, pp.1256-1264

L. T. Roumenina, K. T. Popov, S. V. Bureeva, M. Kojouharova, M. Gadjeva et al., Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim. Biophys. Acta, vol.1784, pp.1271-1276, 2008.

L. T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov et al., , vol.114, pp.2837-2845, 2009.

L. T. Roumenina, D. Sène, M. Radanova, J. Blouin, L. Halbwachs-mecarelli et al., Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance, J. Immunol. Baltim. Md, vol.187, pp.4369-4373, 1950.

L. T. Roumenina, M. Radanova, B. P. Atanasov, K. T. Popov, S. V. Kaveri et al., Heme interacts with c1q and inhibits the classical complement pathway, J. Biol. Chem, vol.286, pp.16459-16469, 2011.

L. T. Roumenina, C. Loirat, M. Dragon-durey, L. Halbwachs-mecarelli, C. Sautes-fridman et al., , 2011.

L. T. Roumenina, M. Frimat, E. C. Miller, F. Provot, M. Dragon-durey et al., , 2012.

L. T. Roumenina, J. Rayes, S. Lacroix-desmazes, and J. D. Dimitrov, Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016.

L. T. Roumenina, J. Rayes, M. Frimat, and V. Fremeaux-bacchi, Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016.

P. Roversi, S. Johnson, J. J. Caesar, F. Mclean, K. J. Leath et al., Structural basis for complement factor I control and its diseaseassociated sequence polymorphisms, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.12839-12844, 2011.

M. P. Ruiz-torres, F. Casiraghi, M. Galbusera, D. Macconi, S. Gastoldi et al., Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies, Thromb. Haemost, vol.93, issue.3, pp.443-452, 2005.

H. G. Rus, F. Niculescu, and M. L. Shin, Sublytic complement attack induces cell cycle in oligodendrocytes, J. Immunol. Baltim. Md, vol.156, pp.4892-4900, 1950.

H. G. Rus, F. I. Niculescu, and M. L. Shin, , 2001.

R. Rutkowski, T. Moniuszko, A. Stasiak-barmuta, B. Koszty?a-hojna, M. Alifier et al., CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma, Arch. Immunol. Ther. Exp. (Warsz.), vol.51, pp.421-428, 2003.

S. W. Ryter, L. E. Otterbein, D. Morse, and A. M. Choi, Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance, Mol. Cell. Biochem, pp.249-263, 2002.

S. Saadi, R. A. Holzknecht, C. P. Patte, D. M. Stern, and J. L. Platt, Complement-mediated regulation of tissue factor activity in endothelium, J. Exp. Med, vol.182, pp.1807-1814, 1995.

S. Sadallah, C. Eken, and J. A. Schifferli, Erythrocyte-derived ectosomes have immunosuppressive properties, J. Leukoc. Biol, vol.84, pp.1316-1325, 2008.

J. E. Sadler, Biochemistry and genetics of von Willebrand factor, Annu. Rev. Biochem, vol.67, pp.395-424, 1998.

G. Saggu, C. Cortes, H. N. Emch, G. Ramirez, R. G. Worth et al., , 2013.

A. La-sala, M. Gadina, and B. L. Kelsall, G(i)-and JNK, J. Immunol. Baltim. Md, vol.175, pp.2994-2999, 1950.

M. F. Sanner, Python: a programming language for software integration and development, J. Mol. Graph. Model, vol.17, pp.57-61, 1999.

S. L. Saraf, X. Zhang, T. Kanias, J. P. Lash, R. E. Molokie et al., Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia, Br. J. Haematol, vol.164, pp.729-739, 2014.

L. Sartz, A. I. Olin, A. Kristoffersson, A. Ståhl, M. E. Johansson et al., , 2012.

, J. Immunol. Baltim. Md, vol.188, pp.2030-2037, 1950.

M. Saruc, N. Ozden, Y. , and H. , How hemolysis causes acute pancreatitis, Med. Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.8, pp.51-52, 2002.

M. Saruç, H. Yuceyar, N. Turkel, O. Ozutemiz, I. Tuzcuoglu et al., An experimental model of hemolysis-induced acute pancreatitis. Braz, J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol, vol.36, pp.879-886, 2003.

M. Saruç, H. Yuceyar, N. Turkel, O. Ozutemiz, I. Tuzcuoglu et al., The role of heme in hemolysis-induced acute pancreatitis, Med. Sci. Monit. Int, 2007.

.. J. Med and . Exp, Clin. Res, vol.13, pp.67-72

A. Savva, R. , and T. , Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases. Front, 2013.

S. Sayah, A. C. Jauneau, C. Patte, M. C. Tonon, H. Vaudry et al., , 2003.

D. J. Schaer, P. W. Buehler, A. I. Alayash, J. D. Belcher, and G. M. Vercellotti, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, vol.121, pp.1276-1284, 2013.

D. J. Schaer, F. Vinchi, G. Ingoglia, E. Tolosano, and P. W. Buehler, Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development, Oxid. Physiol, vol.5, p.415, 2014.

. Schaid, . Nguyen, . Chen, . Abdulla, . Killeen et al., Complement Activation in a Murine Model of Sickle Cell Disease: Inhibition of VasoOcclusion By Blocking C5 Activation, Blood Journal, vol.128, p.158, 2016.

J. A. Schatz-jakobsen, L. Yatime, C. Larsen, S. V. Petersen, A. Klos et al., , 2014.

, Structural and functional characterization of human and murine C5a anaphylatoxins, Acta Crystallogr

, D Biol. Crystallogr, vol.70, pp.1704-1717

J. A. Schatz-jakobsen, Y. Zhang, K. Johnson, A. Neill, D. Sheridan et al., , 2016.

, Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway, J. Immunol. Baltim. Md, pp.337-344, 1950197.

C. Q. Schmidt, A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton et al., A new map of glycosaminoglycan and C3b binding sites on factor H, J. Immunol. Baltim. Md, vol.181, pp.2610-2619, 1950.

C. Q. Schmidt, J. D. Lambris, and D. Ricklin, Protection of host cells by complement regulators, Immunol. Rev, vol.274, pp.152-171, 2016.

M. Schmidt, B. Raghavan, V. Müller, T. Vogl, G. Fejer et al., , 2010.

J. B. Schnog, A. J. Duits, F. A. Muskiet, H. Cate, R. A. Rojer et al., Sickle cell disease; a general overview, Neth. J. Med, vol.62, pp.364-374, 2004.

E. C. Schramm, L. T. Roumenina, T. Rybkine, S. Chauvet, P. Vieira-martins et al., Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-2369, 2015.

I. U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. Discipio, Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells, J. Immunol, vol.169, pp.2102-2110, 2002.

A. J. Schroit, J. W. Madsen, and Y. Tanaka, In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes, J. Biol. Chem, vol.260, pp.5131-5138, 1985.

A. B. Schromm, E. Lien, P. Henneke, J. C. Chow, A. Yoshimura et al., , 2001.

R. R. Schumann, S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright et al., Structure and function of lipopolysaccharide binding protein, Science, vol.249, pp.1429-1431, 1990.

W. Schwaeble, H. P. Huemer, J. Möst, M. P. Dierich, M. Ströbel et al., Expression of properdin in human monocytes, Eur. J. Biochem. FEBS, vol.219, pp.759-764, 1994.

N. J. Scolding, B. P. Morgan, W. A. Houston, C. Linington, A. K. Campbell et al., , 1989.

C. H. Serezani, C. Lewis, S. Jancar, and M. Peters-golden, Leukotriene B4 amplifies NF-?B activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression, J. Clin. Invest, vol.121, pp.671-682, 2011.

G. R. Serjeant, The Natural History of Sickle Cell Disease. Cold Spring Harb, 2013.

S. Sethi and F. C. Fervenza, Membranoproliferative glomerulonephritis--a new look at an old entity, N. Engl. J. Med, vol.366, pp.1119-1131, 2012.

B. N. Setty, S. G. Betal, J. Zhang, and M. J. Stuart, Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia, J. Thromb. Haemost. JTH, vol.6, pp.2202-2209, 2008.

T. H. Sharp, A. J. Koster, and P. Gros, Heterogeneous MAC Initiator and Pore Structures in a Lipid Bilayer by Phase-Plate Cryo-electron Tomography, Cell Rep, vol.15, pp.1-8, 2016.

P. X. Shaw, L. Zhang, M. Zhang, H. Du, L. Zhao et al.,

, phospholipids. Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.13757-13762

T. Shibata, T. Berney, L. Reininger, Y. Chicheportiche, S. Ozaki et al., , 1990.

, Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms, Int. Immunol, vol.2, pp.1133-1141

R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome et al., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4, J. Exp. Med, vol.189, pp.1777-1782, 1999.

C. L. Shive, W. Jiang, D. D. Anthony, and M. M. Lederman, Soluble CD14 is a nonspecific marker of monocyte activation, AIDS, vol.29, pp.1263-1265, 2015.

S. J. Siciliano, T. E. Rollins, J. Demartino, Z. Konteatis, L. Malkowitz et al., Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.1214-1218, 1994.

P. J. Sims and T. Wiedmer, Induction of cellular procoagulant activity by the membrane attack complex of complement, Semin. Cell Biol, vol.6, pp.275-282, 1995.

P. J. Sims, E. M. Faioni, T. Wiedmer, and S. J. Shattil, , 1988.

, J. Biol. Chem, vol.263, pp.18205-18212

E. I. Sinauridze, D. A. Kireev, N. Y. Popenko, A. V. Pichugin, M. A. Panteleev et al., , 2007.

K. Singbartl, S. A. Green, and K. Ley, Blocking P-selectin protects from ischemia/reperfusioninduced acute renal failure, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.14, pp.48-54, 2000.

A. P. Singh, A. Junemann, A. Muthuraman, A. S. Jaggi, N. Singh et al., Animal models of acute renal failure, Pharmacol. Rep. PR, vol.64, pp.31-44, 2012.

E. W. Skjeflo, D. Christiansen, T. Espevik, E. W. Nielsen, and T. E. Mollnes, , 2014.

, J. Immunol. Baltim. Md, pp.2857-2864, 1950192.

A. Smith and W. T. Morgan, Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein, Biochem. J, vol.182, pp.47-54, 1979.

K. Smith-jackson, Y. Yang, H. Denton, I. Pappworth, D. Kavanagh et al., , 2017.

L. Soane, H. Rus, F. Niculescu, and M. L. Shin, Immunol. Baltim. Md, vol.163, pp.6132-6138, 1950.

M. P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat. Med, vol.4, pp.1073-1077, 1998.

P. I. Song, T. A. Abraham, Y. Park, A. S. Zivony, B. Harten et al., The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells, Invest. Ophthalmol. Vis. Sci, vol.42, pp.2867-2877, 2001.

P. I. Song, N. Neparidze, C. A. Armstrong, J. C. Ansel, Y. Park et al., Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4, J. Invest. Dermatol, vol.119, pp.424-432, 2002.

E. M. Sparkenbaugh, P. Chantrathammachart, S. Wang, W. Jonas, D. Kirchhofer et al., Excess of heme induces tissue factordependent activation of coagulation in mice, Haematologica, vol.100, pp.308-314, 2015.

J. L. Spivak, Polycythemia vera: myths, mechanisms, and management, Blood, vol.100, pp.4272-4290, 2002.

T. A. Springer, D. , and M. L. , Integrin inside-out signaling and the immunological synapse, 2012.

, Curr. Opin. Cell Biol, vol.24, pp.107-115

T. Sprong, A. W. Moller, A. Bjerre, E. Wedege, P. Kierulf et al., Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide, Infect. Immun, vol.72, pp.3344-3349, 2004.

M. G. Strainic, J. Liu, D. Huang, F. An, P. N. Lalli et al., Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells, Immunity, vol.28, pp.425-435, 2008.

J. Strauss, V. Pardo, M. N. Koss, W. Griswold, and R. M. Mcintosh, J. Med, vol.58, pp.382-387, 1975.

J. J. Strouse, L. C. Jordan, S. Lanzkron, and J. F. Casella, The excess burden of stroke in hospitalized adults with sickle cell disease, Am. J. Hematol, vol.84, pp.548-552, 2009.

Z. Sun, A. Almogren, P. B. Furtado, B. Chowdhury, M. A. Kerr et al., Semi, 2005.
URL : https://hal.archives-ouvertes.fr/in2p3-00435397

N. Sundaram, M. Bennett, J. Wilhelm, M. Kim, G. Atweh et al., , 2011.

, Biomarkers for early detection of sickle nephropathy, Am. J. Hematol, vol.86, pp.559-566

R. A. Swerlick, J. R. Eckman, A. Kumar, M. Jeitler, and T. M. Wick, , pp.1891-1899, 199382.

D. Sylvestre, R. Clynes, M. Ma, H. Warren, M. C. Carroll et al., Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice, J. Exp. Med, vol.184, pp.2385-2392, 1996.

G. Szakonyi, J. M. Guthridge, D. Li, K. Young, V. M. Holers et al., Structure of complement receptor 2 in complex with its C3d ligand, Science, vol.292, pp.1725-1728, 2001.

T. Takabayashi, E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello et al.,

, A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, J. Immunol. Baltim. Md, vol.156, pp.3455-3460, 1950.

K. Takashima, N. Matsunaga, M. Yoshimatsu, K. Hazeki, T. Kaisho et al., Pharmacol, vol.157, pp.1250-1262, 2009.

J. R. Tame and B. Vallone, The structures of deoxy human haemoglobin and the mutant Hb Tyralpha42His at 120 K, Acta Crystallogr. D Biol. Crystallogr, vol.56, pp.805-811, 2000.

F. Tedesco, M. Pausa, E. Nardon, M. Introna, A. Mantovani et al., The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity, J. Exp. Med, vol.185, pp.1619-1627, 1997.

A. Teghanemt, D. Zhang, E. N. Levis, J. P. Weiss, and T. L. Gioannini, Molecular basis of reduced potency of underacylated endotoxins, J. Immunol. Baltim. Md, vol.175, pp.4669-4676, 1950.

M. J. Telen, T. Wun, T. L. Mccavit, L. M. De-castro, L. Krishnamurti et al., Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use, Blood, vol.125, pp.2656-2664, 2015.

R. Terrasse, P. Tacnet-delorme, C. Moriscot, J. Pérard, G. Schoehn et al., Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J. Biol. Chem, vol.287, pp.42620-42633, 2012.

S. T. Test and V. S. Woolworth, , 1994.

R. A. Thomas, A. Czopek, C. O. Bellamy, S. J. Mcnally, D. C. Kluth et al., Hemin Preconditioning Upregulates Heme Oxygenase-1 in Deceased Donor Renal Transplant Recipients: A Randomized, Controlled, Phase IIB Trial, Transplantation, vol.100, pp.176-183, 2016.

F. Vinchi, L. De-franceschi, A. Ghigo, T. Townes, J. Cimino et al., Hemopexin Therapy Improves Cardiovascular Function by Preventing HemeInduced Endothelial Toxicity in Mouse Models of Hemolytic Diseases, Circulation, vol.127, pp.1317-1329, 2013.

F. Vinchi, M. Costa-da-silva, G. Ingoglia, S. Petrillo, N. Brinkman et al., , vol.12, pp.1317-1329, 2016.

S. Viriyakosol, P. S. Tobias, R. L. Kitchens, and T. N. Kirkland, MD-2 binds to bacterial lipopolysaccharide, J. Biol. Chem, vol.276, pp.38044-38051, 2001.

W. M. Vogel, R. C. Dennis, G. Cassidy, C. S. Apstein, and C. R. Valeri, Coronary constrictor effect of stroma-free hemoglobin solutions, Am. J. Physiol, vol.251, pp.413-420, 1986.

L. Vogt, N. Schmitz, M. O. Kurrer, M. Bauer, H. I. Hinton et al., VSIG4, a B7 family-related protein, is a negative regulator of T cell activation, J. Clin. Invest, vol.116, pp.2817-2826, 2006.

W. Vogt, G. Schmidt, B. Von-buttlar, and L. Dieminger, A new function of the activated third component of complement: binding to C5, an essential step for C5 activation, Immunology, vol.34, pp.29-40, 1978.

F. A. Wagener, E. Feldman, T. De-witte, A. , and N. G. , Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.216, pp.456-463, 1997.

M. Wagner, P. Cadetg, R. Ruf, L. Mazzucchelli, P. Ferrari et al., Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts, Kidney Int, vol.63, pp.1564-1573, 2003.

R. Wallis, D. A. Mitchell, R. Schmid, W. J. Schwaeble, and A. H. Keeble, Paths reunited: Initiation of the classical and lectin pathways of complement activation, Immunobiology, vol.215, pp.1-11, 2010.

W. C. Wang, The pathophysiology, prevention, and treatment of stroke in sickle cell disease, 2007.

, Curr. Opin. Hematol, vol.14, pp.191-197

R. H. Wang, G. Phillips, M. E. Medof, and C. Mold, , 1993.

, J. Clin. Invest, vol.92, pp.1326-1335

Y. Wang, S. Sun, Q. Liu, Y. Yu, J. Guo et al., Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression, Cancer Discov, vol.6, pp.1022-1035, 2016.

Z. Wang, L. R. Filgueiras, S. Wang, A. P. Serezani, M. Peters-golden et al.,

, Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation, J. Immunol. Baltim. Md, pp.2349-2356, 1950192.

H. B. Warren, P. Pantazis, and P. F. Davies, , 1987.

J. M. Weiler, M. R. Daha, K. F. Austen, and D. T. Fearon, , 1976.

D. Weismann, K. Hartvigsen, N. Lauer, K. L. Bennett, H. P. Scholl et al., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011.

K. Whaley, R. , and S. , Modulation of the alternative complement pathways by beta 1 H globulin, J. Exp. Med, vol.144, pp.1147-1163, 1976.

S. E. Wickham, E. M. Hotze, A. J. Farrand, G. Polekhina, T. L. Nero et al., , 2011.

, Biol. Chem, vol.286, pp.20952-20962

J. P. Wiebe and C. J. Dinsdale, Inhibition of cell proliferation by glycerol, Life Sci, vol.48, pp.1511-1517, 1991.

T. Wiedmer, C. T. Esmon, and P. J. Sims, , 1986.

T. Wiedmer, B. Ando, and P. J. Sims, Biol. Chem, vol.262, pp.13674-13681, 1987.

C. Wiesmann, K. J. Katschke, J. Yin, K. Y. Helmy, M. Steffek et al., Structure of C3b in complex with CRIg gives insights into regulation of complement activation, Nature, vol.444, pp.217-220, 2006.

M. S. Winters, D. S. Spellman, and J. D. Lambris, , 2005.

U. Wirthmueller, B. Dewald, M. Thelen, M. K. Schäfer, C. Stover et al., Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J. Immunol. Baltim. Md, vol.158, pp.4444-4451, 1950.

B. C. Wishner, K. B. Ward, E. E. Lattman, and W. E. Love, Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution, J. Mol. Biol, vol.98, pp.179-194, 1975.

J. Wojta, C. Kaun, G. Zorn, M. Ghannadan, A. W. Hauswirth et al., C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils, Blood, vol.100, pp.517-523, 2002.

H. Wolinsky, , 1980.

E. K. Wong, T. H. Goodship, and D. Kavanagh, Complement therapy in atypical haemolytic uraemic syndrome (aHUS), Mol. Immunol, vol.56, pp.199-212, 2013.

W. W. Wong, J. M. Cahill, M. D. Rosen, C. A. Kennedy, E. T. Bonaccio et al., , 1989.

D. Wouters and S. Zeerleder, Complement inhibitors to treat IgM-mediated autoimmune hemolysis, Haematologica, vol.100, pp.1388-1395, 2015.

S. D. Wright, R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, vol.249, pp.1431-1433, 1990.

F. Wu, Q. Zou, X. Ding, D. Shi, X. Zhu et al., , 2016.

J. Wu, Y. Wu, D. Ricklin, B. J. Janssen, J. D. Lambris et al., Structure of C3b-factor H and implications for host protection by complement regulators, Nat. Immunol, vol.10, pp.728-733, 2009.

M. C. Wu, F. H. Brennan, J. P. Lynch, S. Mantovani, S. Phipps et al., The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.9439-9444, 2013.

T. A. Wynn, A. Chawla, and J. W. Pollard, Macrophage biology in development, homeostasis and disease, Nature, vol.496, pp.445-455, 2013.

X. Xue, J. Wu, D. Ricklin, F. Forneris, P. Di-crescenzio et al., Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses, Nat. Struct. Mol. Biol, vol.24, pp.643-651, 2017.

J. Yang, L. Zhang, C. Yu, X. Yang, W. et al., Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases, Biomark. Res, vol.2, p.1, 2014.

W. Yin, B. Ghebrehiwet, and E. I. Peerschke, Expression of complement components and inhibitors on platelet microparticles, Platelets, vol.19, pp.225-233, 2008.

W. Yin, B. Ghebrehiwet, B. Weksler, and E. I. Peerschke, , 2008.

H. Yu, Y. Yanagisawa, M. A. Forbes, E. H. Cooper, R. A. Crockson et al., Alpha-1-microglobulin: an indicator protein for renal tubular function, J. Clin. Pathol, vol.36, pp.253-259, 1983.

A. Zanella and W. Barcellini, Treatment of autoimmune hemolytic anemias, Haematologica, vol.99, pp.1547-1554, 2014.

I. Zanoni, R. Ostuni, L. R. Marek, S. Barresi, R. Barbalat et al.,

, CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor, vol.4, pp.868-880

D. Zecher, A. Cumpelik, and J. A. Schifferli, Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement, Arterioscler. Thromb. Vasc. Biol, vol.34, pp.313-320, 2014.

B. M. Zeigler, J. Vajdos, W. Qin, L. Loverro, and K. Niss, A mouse model for an erythropoietin-deficiency anemia, Dis. Model. Mech, vol.3, pp.763-772, 2010.

R. Zennadi, A. Chien, K. Xu, M. Batchvarova, and M. J. Telen, Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium, Blood, vol.112, pp.3474-3483, 2008.

Y. Zhao, H. Xu, W. Yu, and B. Xie, Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol. Med. Rep, vol.10, pp.45-52, 2014.

L. Ziegler-heitbrock and T. P. Hofer, , 2013.

C. G. Zou, N. S. Agar, and G. L. Jones, Haemolysis of human and sheep red blood cells in glycerol media: the effect of pH and the role of band 3, Comp. Biochem. Physiol. A. Mol. Integr. Physiol, vol.127, pp.347-353, 2000.

J. Zuber, F. Fakhouri, L. T. Roumenina, C. Loirat, V. Frémeaux-bacchi et al., Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat. Rev. Nephrol, vol.8, pp.643-657

D. Ricklin, G. Hajishengallis, K. Yang, and J. D. Lambris, Complement: a key system for immune surveillance and homeostasis, Nat Immunol, vol.11, pp.785-97, 2010.

M. Kolev, L. Friec, G. Kemper, and C. , Complement -tapping into new sites and effector systems, Nat Rev Immunol, vol.14, pp.811-831, 2014.

N. S. Merle, R. Noe, L. Halbwachs-mecare, V. Fremeaux-bacchi, and L. T. Roumenina, Complement system part II: role in immunity, Front Immunol, vol.6, p.257, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01216398

P. J. Lachmann and L. Halbwachs, The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin Exp Immunol, vol.21, pp.109-123, 1975.

M. K. Pangburn, R. D. Schreiber, and H. J. Müller-eberhard, Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3, J Exp Med, vol.154, pp.856-67, 1981.

B. Nilsson, N. Ekdahl, and K. , The tick-over theory revisited: is C3 a contact-activated protein?, Immunobiology, vol.217, 2012.

D. E. Isenman, D. I. Kells, N. R. Cooper, H. J. Müller-eberhard, and M. K. Pangburn, Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry, vol.20, pp.4458-67, 1981.

K. Li, J. Gor, and S. J. Perkins, Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem J, vol.431, pp.63-72, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00517253

N. Nishida, T. Walz, and T. A. Springer, Structural transitions of complement component C3 and its activation products, Proc Natl Acad Sci, vol.103, pp.19737-19779, 2006.

E. Rodriguez, R. Nan, K. Li, J. Gor, and S. J. Perkins, A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J Biol Chem, vol.290, issue.4, pp.2334-50, 2014.

M. S. Winters, D. S. Spellman, and J. D. Lambris, Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry, J Immunol, issue.174, pp.3469-74, 2005.

A. Sahu, T. R. Kozel, and M. K. Pangburn, Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation, Biochem J, pp.429-465, 1994.

S. K. Law and A. W. Dodds, The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci, vol.6, pp.263-74, 1997.

A. P. Manderson, M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish, Continual low-level activation of the classical complement pathway, J Exp Med, vol.194, pp.747-56, 2001.

M. D. Galvan, M. C. Greenlee-wacker, and S. S. Bohlson, C1q and phagocytosis: the perfect complement to a good meal, J Leukoc Biol, vol.92, pp.489-97, 2012.

I. Verbovetski, H. Bychkov, U. Trahtemberg, I. Shapira, M. Hareuveni et al., Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7, J Exp Med, vol.196, pp.1553-61, 2002.

L. Baudino, A. Sardini, M. M. Ruseva, L. Fossati-jimack, H. T. Cook et al., C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens, Proc Natl Acad Sci U S A, vol.111, pp.1503-1511, 2014.

E. V. Clarke, B. M. Weist, C. M. Walsh, and A. J. Tenner, Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation, J Leukoc Biol, vol.97, pp.147-60, 2015.

A. J. Nauta, G. Castellano, W. Xu, A. M. Woltman, M. C. Borrias et al., Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells, J Immunol, issue.173, pp.3044-50, 2004.

M. J. Walport and . Complement, Second of two parts, N Engl J Med, vol.344, pp.1140-1144, 2001.

M. Harboe and T. E. Mollnes, The alternative complement pathway revisited, J Cell Mol Med, vol.12, issue.4, pp.1074-84, 2008.

P. J. Lachmann, The amplification loop of the complement pathways, Adv Immunol, vol.104, pp.115-164, 2009.

R. Ghai, P. Waters, L. T. Roumenina, M. Gadjeva, M. S. Kojouharova et al., C1q and its growing family, Immunobiology, vol.212, pp.253-66, 2007.

L. T. Roumenina, A. A. Kantardjiev, B. P. Atanasov, P. Waters, M. Gadjeva et al., Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q, Biochemistry, vol.44, pp.14097-109, 2005.

U. Kishore, R. Ghai, T. J. Greenhough, A. K. Shrive, D. M. Bonifati et al., Structural and functional anatomy of the globular domain of complement protein C1q, Immunol Lett, vol.95, pp.113-141, 2004.

M. G. Gadjeva, M. M. Rouseva, A. S. Zlatarova, K. Reid, U. Kishore et al., Interaction of human C1q with IgG and IgM: revisited, Biochemistry, vol.47, pp.13093-102, 2008.

M. S. Kojouharova, M. G. Gadjeva, I. G. Tsacheva, A. Zlatarova, L. T. Roumenina et al., Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction, J Immunol, issue.172, pp.4351-4359, 2004.

L. T. Roumenina, M. M. Ruseva, A. Zlatarova, R. Ghai, M. Kolev et al., Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains, Biochemistry, vol.45, pp.4093-104, 2006.

A. S. Zlatarova, M. Rouseva, L. T. Roumenina, M. Gadjeva, M. Kolev et al., Existence of different but overlapping IgG-and IgM-binding sites on the globular domain of human C1q, Biochemistry, vol.45, pp.9979-88, 2006.

L. T. Roumenina, K. T. Popov, S. V. Bureeva, M. Kojouharova, M. Gadjeva et al., Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim Biophys Acta, vol.1784, pp.1271-1277, 2008.

S. Albertí, G. Marqués, S. Hernández-allés, X. Rubires, J. M. Tomás et al., Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36, Infect Immun, vol.64, pp.4719-4744, 1996.

C. Gaboriaud, P. Frachet, N. M. Thielens, and G. J. Arlaud, The human c1q globular domain: structure and recognition of non-immune self ligands, Front Immunol, vol.2, p.92, 2011.

A. J. Nauta, L. A. Trouw, M. R. Daha, O. Tijsma, R. Nieuwland et al., Direct binding of C1q to apoptotic cells and cell blebs induces complement activation, Eur J Immunol, vol.32, pp.1726-1762, 2002.

H. Païdassi, P. Tacnet-delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet et al., C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J Immunol, issue.180, pp.2329-2367, 2008.

H. Païdassi, P. Tacnet-delorme, M. Verneret, C. Gaboriaud, G. Houen et al., Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J Mol Biol, vol.408, pp.277-90, 2011.

H. Païdassi, P. Tacnet-delorme, T. Lunardi, G. J. Arlaud, N. M. Thielens et al., The lectin-like activity of human C1q and its implication in DNA and apoptotic cell recognition, FEBS Lett, vol.582, pp.3111-3117, 2008.

B. Tissot, R. Daniel, and C. Place, Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy, Eur J Biochem, vol.270, pp.4714-4734, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01967657

R. Terrasse, P. Tacnet-delorme, C. Moriscot, J. Pérard, G. Schoehn et al., Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J Biol Chem, vol.287, pp.42620-42653, 2012.

M. Martin, J. Leffler, and A. M. Blom, Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells, J Biol Chem, vol.287, pp.33733-33777, 2012.

C. A. Ogden, A. Decathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet et al., C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J Exp Med, vol.194, pp.781-95, 2001.

A. Steinø, C. S. Jørgensen, I. Laursen, and G. Houen, Interaction of C1q with the receptor calreticulin requires a conformational change in C1q, Frontiers in Immunology | www.frontiersin.org 41, vol.59, pp.485-95, 2004.

M. Verneret, P. Tacnet-delorme, R. Osman, R. Awad, A. Grichine et al., Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis, J Innate Immun, vol.6, pp.426-460, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01096597

M. Matsushita, Y. Endo, S. Taira, Y. Sato, T. Fujita et al., A novel human serum lectin with collagen-and fibrinogen-like domains that functions as an opsonin, J Biol Chem, vol.271, pp.2448-54, 1996.

I. Bally, V. Rossi, T. Lunardi, N. M. Thielens, C. Gaboriaud et al., Identification of the C1q-binding sites of human C1r and C1s: a refined three-dimensional model of the C1 complex of complement, J Biol Chem, vol.284, pp.19340-19348, 2009.

S. Brier, D. Pflieger, L. Mignon, M. Bally, I. Gaboriaud et al., Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex, J Biol Chem, vol.285, pp.32251-63, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01967560

F. Teillet, B. Dublet, J. Andrieu, C. Gaboriaud, G. J. Arlaud et al., The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBLassociated serine proteases, J Immunol, issue.174, pp.2870-2877, 2005.

S. Thiel, T. Vorup-jensen, C. M. Stover, W. Schwaeble, S. B. Laursen et al., A second serine protease associated with mannan-binding lectin that activates complement, Nature, vol.386, pp.506-516, 1997.

C. Gaboriaud, N. M. Thielens, L. A. Gregory, V. Rossi, J. C. Fontecilla-camps et al., Structure and activation of the C1 complex of complement: unraveling the puzzle, Trends Immunol, vol.25, pp.368-73, 2004.

C. A. Diebolder, F. J. Beurskens, R. N. De-jong, R. I. Koning, K. Strumane et al., Complement is activated by IgG hexamers assembled at the cell surface, Science, vol.343, pp.1260-1263, 2014.

M. S. Cragg, S. M. Morgan, H. Chan, B. P. Morgan, A. V. Filatov et al., Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts, Blood, vol.101, pp.1045-52, 2003.

N. C. Hughes-jones, B. D. Gorick, J. C. Howard, and A. Feinstein, Antibody density on rat red cells determines the rate of activation of the complement component C1

, Eur J Immunol, vol.15, pp.976-80, 1985.

J. Preiner, N. Kodera, J. Tang, A. Ebner, M. Brameshuber et al., IgGs are made for walking on bacterial and viral surfaces, Nat Commun, vol.5, p.4394, 2014.

C. Gaboriaud, W. L. Ling, N. M. Thielens, I. Bally, and V. Rossi, Deciphering the fine details of c1 assembly and activation mechanisms: "mission impossible, Front Immunol, vol.5, p.565, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01097216

I. Bally, S. Ancelet, C. Moriscot, F. Gonnet, A. Mantovani et al., Expression of recombinant human complement C1q allows identification of the C1r/ C1s-binding sites, Proc Natl Acad Sci U S A, vol.110, pp.8650-8655, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01179709

L. T. Roumenina, M. Radanova, B. P. Atanasov, K. T. Popov, S. V. Kaveri et al., Heme interacts with c1q and inhibits the classical complement pathway, J Biol Chem, vol.286, pp.16459-69, 2011.

G. J. Arlaud, C. Gaboriaud, N. M. Thielens, V. Rossi, B. Bersch et al., Structural biology of C1: dissection of a complex molecular machinery, Immunol Rev, vol.180, pp.136-181, 2001.

G. J. Arlaud, C. Gaboriaud, G. Garnier, A. Circolo, N. M. Thielens et al., Structure, function and molecular genetics of human and murine C1r, Immunobiology, vol.205, pp.365-82, 2002.

G. J. Arlaud, C. Gaboriaud, N. M. Thielens, M. Budayova-spano, V. Rossi et al., Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity, Mol Immunol, vol.39, pp.383-94, 2002.

M. Budayova-spano, W. Grabarse, N. M. Thielens, H. Hillen, M. Lacroix et al., Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism, Structure, issue.10, pp.1509-1528, 2002.

M. Budayova-spano, M. Lacroix, N. M. Thielens, G. J. Arlaud, J. C. Fontecilla-camps et al., The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex, EMBO J, vol.21, pp.231-240, 2002.

L. A. Gregory, N. M. Thielens, G. J. Arlaud, J. C. Fontecilla-camps, and C. Gaboriaud, X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement, J Biol Chem, vol.278, pp.32157-64, 2003.

U. V. Girija, A. R. Gingras, J. E. Marshall, R. Panchal, M. A. Sheikh et al., Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation, Proc Natl Acad Sci U S A, vol.110, 2013.

R. J. Ziccardi, Activation of the early components of the classical complement pathway under physiologic conditions, J Immunol, issue.126, pp.1769-73, 1981.

T. R. Kjaer, S. Thiel, and G. R. Andersen, Toward a structure-based comprehension of the lectin pathway of complement, Mol Immunol, vol.56, pp.413-435, 2013.

M. Matsushita, Y. Endo, and T. Fujita, Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication, Arch Immunol Ther Exp (Warsz), vol.61, pp.273-83, 2013.

P. D. Frederiksen, S. Thiel, C. B. Larsen, and J. C. Jensenius, M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement

, Scand J Immunol, vol.62, pp.462-73, 2005.

A. Krarup, S. Thiel, A. Hansen, T. Fujita, and J. C. Jensenius, L-ficolin is a pattern recognition molecule specific for acetyl groups, J Biol Chem, vol.279, pp.47513-47522, 2004.

D. Héja, A. Kocsis, J. Dobó, K. Szilágyi, R. Szász et al., Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2, Proc Natl Acad Sci U S A, vol.109, pp.10498-503, 2012.

M. R. Dahl, S. Thiel, M. Matsushita, T. Fujita, A. C. Willis et al., MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway, Immunity, vol.15, pp.161-164, 2001.

C. Gaboriaud, R. K. Gupta, L. Martin, M. Lacroix, L. Serre et al., The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin, PLoS One, vol.8, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00868926

D. Iwaki, K. Kanno, M. Takahashi, Y. Endo, N. J. Lynch et al., Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway, J Immunol, issue.177, pp.8626-8658, 2006.

M. Megyeri, V. Harmat, B. Major, Á. Végh, J. Balczer et al., Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway, J Biol Chem, vol.288, pp.8922-8956, 2013.

M. Takahashi, D. Iwaki, K. Kanno, Y. Ishida, J. Xiong et al., Mannosebinding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway, J Immunol, issue.180, pp.6132-6140, 2008.

T. Yongqing, N. Drentin, R. C. Duncan, L. C. Wijeyewickrema, and R. N. Pike, Mannosebinding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?, Biochim Biophys Acta, vol.1824, pp.253-62, 2012.

P. Gál, V. Harmat, A. Kocsis, T. Bián, L. Barna et al., A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations, J Biol Chem, vol.280, pp.33435-33479, 2005.

S. E. Degn, T. R. Kjaer, R. T. Kidmose, L. Jensen, A. G. Hansen et al., Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, Proc Natl Acad Sci U S A, vol.111, pp.13445-50, 2014.

R. T. Kidmose, N. S. Laursen, J. Dobó, T. R. Kjaer, S. Sirotkina et al., Structural basis for activation of the complement system by component C4 cleavage, Proc Natl Acad Sci U S A, vol.109, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02095670

L. Beinrohr, J. Dobó, P. Závodszky, P. Gál, and . C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation, Trends Mol Med, vol.14, pp.511-532, 2008.

A. E. Davis, F. Lu, and P. Mejia, C1 inhibitor, a multi-functional serine protease inhibitor, Thromb Haemost, vol.104, pp.886-93, 2010.

, A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement, Frontiers in Immunology | www.frontiersin.org 80. Ziccardi RJ, pp.2505-2513, 1982.

H. Longhurst and M. Cicardi, Hereditary angio-oedema, Lancet, vol.379, pp.474-81, 2012.

D. K. Galanakis and B. Ghebrehiwet, A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen, J Clin Invest, vol.93, pp.303-313, 1994.

L. Roumenina, S. Bureeva, A. Kantardjiev, D. Karlinsky, J. E. Andia-pravdivy et al., Complement C1q-target proteins recognition is inhibited by electric moment effectors, J Mol Recognit, vol.20, pp.405-420, 2007.

V. Ferreira, C. Valck, G. Sánchez, A. Gingras, S. Tzima et al., The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi, J Immunol, issue.172, pp.3042-50, 2004.

S. Yadav, S. Gupta, C. Selvaraj, P. K. Doharey, A. Verma et al., In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q, PLoS One, vol.9, 2014.

S. E. Degn, A. G. Hansen, R. Steffensen, C. Jacobsen, J. C. Jensenius et al., MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation, J Immunol, issue.183, pp.7371-7379, 2009.

K. Paréj, J. Dobó, P. Závodszky, and P. Gál, The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while ?2-macroglobulin is not, Mol Immunol, vol.54, pp.415-437, 2013.

J. S. Presanis, K. Hajela, G. Ambrus, P. Gál, and R. B. Sim, Differential substrate and inhibitor profiles for human MASP-1 and MASP-2, Mol Immunol, vol.40, pp.921-930, 2004.

O. A. Hamad, P. H. Nilsson, D. Wouters, J. D. Lambris, K. N. Ekdahl et al., Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1, J Immunol, issue.184, pp.2686-92, 2010.

G. Saggu, C. Cortes, H. N. Emch, G. Ramirez, R. G. Worth et al., Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O), J Immunol, vol.190, pp.6457-67, 2013.

D. T. Fearon and K. F. Austen, Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase, J Exp Med, vol.142, pp.856-63, 1975.

D. E. Hourcade, The role of properdin in the assembly of the alternative pathway C3 convertases of complement, J Biol Chem, vol.281, pp.2128-2160, 2006.

C. Kemper, J. P. Atkinson, and D. E. Hourcade, Properdin: emerging roles of a pattern-recognition molecule, Annu Rev Immunol, vol.28, pp.131-55, 2010.

A. Zaferani, R. R. Vivès, P. Van-der-pol, J. J. Hakvoort, G. J. Navis et al., Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease, J Biol Chem, vol.286, pp.5359-67, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00638479

L. Camous, L. Roumenina, S. Bigot, S. Brachemi, V. Frémeaux-bacchi et al., Complement alternative pathway acts as a positive feedback amplification of neutrophil activation, Blood, vol.117, pp.1340-1349, 2011.

J. O'flynn, K. O. Dixon, F. Krol, M. C. Daha, M. R. Van-kooten et al., Myeloperoxidase directs properdin-mediated complement activation, J Innate Immun, vol.6, pp.417-442, 2014.

M. S. Goligorsky, D. Patschan, and M. Kuo, Weibel-Palade bodies -sentinels of acute stress, Nat Rev Nephrol, vol.5, pp.423-429, 2009.

I. Del-conde, Platelet activation leads to activation and propagation of the complement system, J Exp Med, vol.201, pp.871-880, 2005.

M. Morigi, M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli et al., Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis, J Immunol, vol.187, 2011.

K. J. Evans, D. S. Hansen, N. Van-rooijen, L. A. Buckingham, and L. Schofield, Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes, Blood, vol.107, pp.1192-1201, 2006.

A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J Immunol, issue.179, pp.5543-52, 2007.

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-92, 2013.

J. D. Belcher, C. Chen, J. Nguyen, L. Milbauer, F. Abdulla et al., Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-90, 2014.

F. Forneris, D. Ricklin, J. Wu, A. Tzekou, R. S. Wallace et al., Structures of C3b in complex with factors B and D give insight into complement convertase formation, Science, vol.330, pp.1816-1836, 2010.

B. Janssen, L. Gomes, R. I. Koning, D. I. Svergun, A. J. Koster et al., Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex, EMBO J, vol.28, pp.2469-78, 2009.

E. Torreira, A. Tortajada, T. Montes, R. De-córdoba, S. Llorca et al., Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase, J Immunol, issue.183, pp.7347-51, 2009.

Y. Yamauchi, J. W. Stevens, K. J. Macon, and J. E. Volanakis, Recombinant and native zymogen forms of human complement factor D, J Immunol, issue.152, pp.3645-53, 1994.

D. Iwaki, K. Kanno, M. Takahashi, Y. Endo, M. Matsushita et al., The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway, J Immunol, issue.187, pp.3751-3759, 2011.

M. Takahashi, Y. Ishida, D. Iwaki, K. Kanno, T. Suzuki et al., Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D, J Exp Med, vol.207, pp.29-37, 2010.

M. M. Ruseva, M. Takahashi, T. Fujita, and M. C. Pickering, C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo, Clin Exp Immunol, vol.176, pp.84-92, 2014.

S. E. Degn, L. Jensen, A. G. Hansen, D. Duman, M. Tekin et al., Mannanbinding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function, J Immunol, issue.189, pp.3957-69, 2012.

F. J. Milder, L. Gomes, A. Schouten, B. Janssen, E. G. Huizinga et al., Factor B structure provides insights into activation of the central protease of the complement system, Nat Struct Mol Biol, vol.14, pp.224-232, 2007.

S. Rooijakkers, J. Wu, M. Ruyken, R. Van-domselaar, K. L. Planken et al., Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-728, 2009.

F. Bexborn, P. O. Andersson, H. Chen, B. Nilsson, and K. N. Ekdahl, The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb), Mol Immunol, vol.45, pp.2370-2379, 2008.

V. Krishnan, Y. Xu, K. Macon, J. E. Volanakis, and S. Narayana, The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation, Acta Crystallogr D Biol Crystallogr, vol.65, pp.266-74, 2009.

M. Smith and M. Kerr, Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency, Immunol, vol.56, pp.561-70, 1985.

A. Aplan, Bradykinin and the pathogenesis of hereditary angioedema, World Allergy Organ J, vol.4, issue.4, pp.73-78, 2011.

P. Gros, F. J. Milder, and B. Janssen, Complement driven by conformational changes, Nat Rev Immunol, vol.8, pp.48-58, 2008.

M. K. Pangburn and H. J. Müller-eberhard, The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase, Biochem J, vol.235, pp.723-753, 1986.

L. Kouser, M. Abdul-aziz, A. Nayak, C. M. Stover, R. B. Sim et al., Properdin and factor h: opposing players on the alternative complement pathway "see-saw, Front Immunol, vol.4, p.93, 2013.

W. Schwaeble, W. G. Dippold, M. K. Schäfer, H. Pohla, J. D. Luttig et al., Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells, J Immunol, issue.151, pp.2521-2529, 1993.

W. Schwaeble, H. P. Huemer, J. Möst, M. P. Dierich, M. Ströbel et al., Expression of properdin in human monocytes, Eur J Biochem, vol.219, pp.759-64, 1994.

U. Wirthmueller, B. Dewald, M. Thelen, M. K. Schäfer, C. Stover et al., Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J Immunol, issue.158, pp.4444-51, 1997.

C. M. Stover, J. C. Luckett, B. Echtenacher, A. Dupont, S. E. Figgitt et al., Properdin plays a protective role in polymicrobial septic peritonitis, J Immunol, issue.180, pp.3313-3321, 2008.

Z. Sun, A. Almogren, P. B. Furtado, B. Chowdhury, M. A. Kerr et al., Semiextended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering, J Mol Biol, vol.353, pp.155-73, 2005.

M. K. Pangburn, Analysis of the natural polymeric forms of human properdin and their functions in complement activation, J Immunol, issue.142, pp.202-209, 1989.

C. Cortes, J. A. Ohtola, G. Saggu, and V. P. Ferreira, Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement, Front Immunol, vol.3, p.412, 2012.

V. P. Ferreira, C. Cortes, and M. K. Pangburn, Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement, Immunobiology, vol.215, pp.932-972, 2010.

M. Alcorlo, A. Tortajada, R. De-córdoba, S. Llorca, and O. , Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin, Proc Natl Acad Sci U S A, vol.110, pp.13504-13513, 2013.

T. Kajander, M. J. Lehtinen, S. Hyvärinen, A. Bhattacharjee, E. Leung et al., Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement, Proc Natl Acad Sci U S A, vol.108, pp.2897-902, 2011.

H. P. Morgan, C. Q. Schmidt, M. Guariento, B. S. Blaum, D. Gillespie et al., Structural basis for engagement by complement factor H of C3b on a self surface, Nat Struct Mol Biol, vol.18, 2011.

J. Wu, Y. Wu, D. Ricklin, B. Janssen, J. D. Lambris et al., Structure of C3b-factor H and implications for host protection by complement regulators, Nat Immunol, vol.10, pp.728-761, 2009.

J. D. Lambris, Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack et al., Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J Immunol, issue.156, pp.4821-4853, 1996.

P. Roversi, S. Johnson, J. Caesar, F. Mclean, K. J. Leath et al., Structural basis for complement factor I control and its disease-associated sequence polymorphisms, Proc Natl Acad Sci U S A, vol.108, pp.12839-12883, 2011.

A. E. Davis, R. A. Harrison, and P. J. Lachmann, Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g, J Immunol, issue.132, pp.1960-1966, 1984.

P. W. Andrews, B. B. Knowles, M. Parkar, B. Pym, K. Stanley et al., A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1, Ann Hum Genet, vol.49, pp.31-40, 1985.

M. K. Liszewski, M. K. Leung, and J. P. Atkinson, Membrane cofactor protein: importance of N-and O-glycosylation for complement regulatory function, J Immunol, issue.161, pp.3711-3719, 1998.

M. L. Barilla-labarca, M. K. Liszewski, J. D. Lambris, D. Hourcade, and J. P. Atkinson, Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells, J Immunol, issue.168, pp.6298-304, 2002.

M. K. Liszewski, T. W. Post, and J. P. Atkinson, Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster, Annu Rev Immunol, vol.9, pp.431-55, 1991.

B. D. Persson, N. B. Schmitz, C. Santiago, G. Zocher, M. Larvie et al., Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens, PLoS Pathog, vol.6, 2010.

M. K. Liszewski, M. Leung, W. Cui, V. B. Subramanian, J. Parkinson et al., Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46), J Biol Chem, vol.275, pp.37692-701, 2000.

E. C. Schramm, L. T. Roumenina, T. Rybkine, S. Chauvet, P. Vieira-martins et al., Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-69, 2015.

L. B. Klickstein, T. J. Bartow, V. Miletic, L. D. Rabson, J. A. Smith et al., Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis, J Exp Med, vol.168, pp.1699-717, 1988.

W. W. Wong, J. M. Cahill, M. D. Rosen, C. A. Kennedy, E. T. Bonaccio et al., Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele, J Exp Med, vol.169, pp.847-63, 1989.

M. Krych, R. Hauhart, and J. P. Atkinson, Structure-function analysis of the active sites of complement receptor type 1, J Biol Chem, vol.273, pp.8623-8632, 1998.

B. O. Smith, R. L. Mallin, M. Krych-goldberg, X. Wang, R. E. Hauhart et al., Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor, Cell, vol.108, pp.769-80, 2002.

A. E. Oran and D. E. Isenman, Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35), J Biol Chem, vol.274, pp.5120-5150, 1999.

A. M. Blom, J. Webb, B. O. Villoutreix, and B. Dahlbäck, A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function, J Biol Chem, vol.274, pp.19237-19282, 1999.

A. M. Blom, L. Kask, and B. Dahlbäck, Structural requirements for the complement regulatory activities of C4BP, J Biol Chem, vol.276, pp.27136-27180, 2001.

A. M. Blom, B. O. Villoutreix, and B. Dahlbäck, Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function, J Biol Chem, vol.278, pp.43437-43479, 2003.

N. Rawal, R. Rajagopalan, and V. P. Salvi, Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP), Mol Immunol, vol.46, pp.2902-2912, 2009.

T. Hofmeyer, S. Schmelz, M. T. Degiacomi, D. Peraro, M. Daneschdar et al., Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein, J Mol Biol, vol.425, pp.1302-1319, 2013.

L. Kask, A. Hillarp, B. Ramesh, B. Dahlbäck, and A. M. Blom, Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein, Biochemistry, vol.41, pp.9349-57, 2002.

R. J. Ziccardi, B. Dahlback, and H. J. Müller-eberhard, Characterization of the interaction of human C4b-binding protein with physiological ligands, J Biol Chem, vol.259, pp.13674-13683, 1984.

B. Dahlbäck, C. A. Smith, and H. J. Müller-eberhard, Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b, Proc Natl Acad Sci U S A, vol.80, pp.3461-3466, 1983.

M. Delvaeye, M. Noris, D. Vriese, A. Esmon, C. T. Esmon et al., Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.345-57, 2009.

J. Rayes, L. T. Roumenina, J. D. Dimitrov, Y. Repessé, M. Ing et al., The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status, Blood, vol.123, pp.121-126, 2014.

S. Feng, X. Liang, M. H. Kroll, and D. W. Chung, Afshar-Kharghan V. Von Willebrand Factor is a cofactor in complement regulation, Blood, vol.125, issue.6, pp.1034-1041, 2014.

M. Krych-goldberg, R. E. Hauhart, V. B. Subramanian, B. M. Yurcisin, D. L. Crimmins et al., Decay accelerating activity of complement receptor Frontiers in Immunology | www.frontiersin.org type 1 (CD35). Two active sites are required for dissociating C5 convertases, J Biol Chem, vol.274, pp.31160-31168, 1999.

A. Nicholson-weller and C. E. Wang, Structure and function of decay accelerating factor CD55, J Lab Clin Med, vol.123, pp.485-91, 1994.

D. E. Hourcade, L. Mitchell, L. A. Kuttner-kondo, J. P. Atkinson, and M. E. Medof, Decayaccelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb, J Biol Chem, vol.277, pp.1107-1119, 2002.

C. L. Harris, R. Abbott, R. A. Smith, B. P. Morgan, and S. M. Lea, Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55), J Biol Chem, vol.280, pp.2569-78, 2005.

C. L. Harris, D. M. Pettigrew, S. M. Lea, and B. P. Morgan, Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay, J Immunol, vol.178, pp.352-361, 2007.

R. J. Hasan, E. Pawelczyk, P. T. Urvil, M. S. Venkatarajan, P. Goluszko et al., Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation, Infect Immun, vol.70, pp.4485-93, 2002.

M. D. Kazatchkine, D. T. Fearon, and K. F. Austen, Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b, J Immunol, issue.122, pp.75-81, 1979.

J. M. Weiler, M. R. Daha, K. F. Austen, and D. T. Fearon, Control of the amplification convertase of complement by the plasma protein beta1H, Proc Natl Acad Sci U S A, vol.73, pp.3268-72, 1976.

K. Whaley and S. Ruddy, Modulation of the alternative complement pathways by beta 1 H globulin, J Exp Med, vol.144, pp.1147-63, 1976.

S. J. Perkins, R. Nan, K. Li, S. Khan, and A. Miller, Complement factor H-ligand interactions: self-association, multivalency and dissociation constants, Immunobiology, vol.217, pp.281-97, 2012.

P. F. Zipfel and C. Skerka, FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function, Immunol Today, vol.20, 1999.

J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen et al., Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H, J Immunol, issue.169, pp.6935-6979, 2002.

T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri, Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J Biol Chem, vol.275, pp.27657-62, 2000.

H. P. Morgan, H. Mertens, M. Guariento, C. Q. Schmidt, D. C. Soares et al., Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH), PLoS One, vol.7, issue.2, p.32187, 2012.

A. Bhattacharjee, M. J. Lehtinen, T. Kajander, A. Goldman, and T. S. Jokiranta, Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d, Mol Immunol, vol.47, pp.1686-91, 2010.

B. S. Blaum, J. P. Hannan, A. P. Herbert, D. Kavanagh, D. Uhrín et al., Structural basis for sialic acid-mediated self-recognition by complement factor H, Nat Chem Biol, vol.11, issue.1, pp.77-82, 2014.

V. P. Ferreira, A. P. Herbert, C. Cortés, K. A. Mckee, B. S. Blaum et al., The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, issue.182, pp.7009-7027, 2009.

T. S. Jokiranta, V. Jaakola, M. J. Lehtinen, M. Pärepalo, S. Meri et al., Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome, EMBO J, vol.25, pp.1784-94, 2006.

M. J. Lehtinen, A. L. Rops, D. E. Isenman, J. Van-der-vlag, and T. S. Jokiranta, Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome, J Biol Chem, vol.284, pp.15650-15658, 2009.

A. I. Okemefuna, K. Li, R. Nan, R. J. Ormsby, T. Sadlon et al., Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation, J Mol Biol, vol.391, pp.119-154, 2009.

M. Oppermann, T. Manuelian, M. Józsi, E. Brandt, T. S. Jokiranta et al., The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein, Clin Exp Immunol, vol.144, pp.342-52, 2006.

B. E. Prosser, S. Johnson, P. Roversi, A. P. Herbert, B. S. Blaum et al., Structural basis for complement factor H linked age-related macular degeneration, J Exp Med, vol.204, pp.2277-83, 2007.

C. Q. Schmidt, A. P. Herbert, H. Mertens, M. Guariento, D. C. Soares et al., The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module, J Mol Biol, vol.395, pp.105-127, 2010.

E. Makou, H. Mertens, M. Maciejewski, D. C. Soares, I. Matis et al., Solution structure of CCP modules 10-12 illuminates functional architecture of the complement regulator, factor H, J Mol Biol, vol.424, pp.295-312, 2012.

C. Q. Schmidt, A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton et al., A new map of glycosaminoglycan and C3b binding sites on factor H, J Immunol, issue.181, pp.2610-2619, 2008.

A. K. Sharma and M. K. Pangburn, Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis, Proc Natl Acad Sci U S A, vol.93, pp.10996-1001, 1996.

T. K. Blackmore, J. Hellwage, T. A. Sadlon, N. Higgs, P. F. Zipfel et al., Identification of the second heparin-binding domain in human complement factor H, J Immunol, issue.160, pp.3342-3350, 1998.

S. J. Clark, P. N. Bishop, and A. J. Day, The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation, Inflammation, vol.4, p.412, 2013.

A. P. Herbert, J. A. Deakin, C. Q. Schmidt, B. S. Blaum, C. Egan et al., Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism, J Biol Chem, vol.282, pp.18960-18968, 2007.

R. J. Ormsby, T. S. Jokiranta, T. G. Duthy, K. M. Griggs, T. A. Sadlon et al., Localization of the third heparin-binding site in the human complement regulator factor H1, Mol Immunol, vol.43, pp.1624-1656, 2006.

S. J. Perkins, K. W. Fung, and S. Khan, Molecular interactions between complement factor H and its heparin and heparan sulfate ligands, Front Immunol, vol.5, p.126, 2014.

A. Zaferani, R. R. Vivès, P. Van-der-pol, G. J. Navis, M. R. Daha et al., Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate, J Biol Chem, vol.287, pp.31471-81, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00847974

L. T. Roumenina, R. Roquigny, C. Blanc, N. Poulain, S. Ngo et al., Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS), Methods Mol Biol, vol.1100, pp.237-284, 2014.

S. J. Clark, L. A. Ridge, A. P. Herbert, S. Hakobyan, B. Mulloy et al., Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions, J Immunol, pp.2049-57, 0190.

A. Langford-smith, A. J. Day, P. N. Bishop, and S. J. Clark, Complementing the sugar code: role of GAGs and sialic acid in complement regulation, Mol Innate Immun, vol.6, p.25, 2015.

A. O. Edwards, R. Ritter, K. J. Abel, A. Manning, C. Panhuysen et al., Complement factor H polymorphism and age-related macular degeneration, Science, vol.308, pp.421-425, 2005.

G. S. Hageman, D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber et al., A common haplotype in the complement regulatory gene factor H (HF1/ CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, vol.102, pp.7227-7259, 2005.

J. L. Haines, M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson et al., Complement factor H variant increases the risk of age-related macular degeneration, Science, vol.308, pp.419-440, 2005.

R. J. Klein, C. Zeiss, E. Y. Chew, J. Tsai, R. S. Sackler et al., Complement factor H polymorphism in age-related macular degeneration, Science, vol.308, pp.385-394, 2005.

P. X. Shaw, L. Zhang, M. Zhang, H. Du, L. Zhao et al., Complement factor H genotypes impact risk of age-related macular degeneration by interaction Frontiers in Immunology | www.frontiersin.org with oxidized phospholipids, Proc Natl Acad Sci U S A, vol.109, pp.13757-62, 2012.

D. Weismann and C. J. Binder, The innate immune response to products of phospholipid peroxidation, Biochim Biophys Acta, vol.1818, pp.2465-75, 2012.

D. Weismann, K. Hartvigsen, N. Lauer, K. L. Bennett, H. Scholl et al., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011.

A. I. Okemefuna, R. Nan, A. Miller, J. Gor, and S. J. Perkins, Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations, J Biol Chem, vol.285, pp.1053-65, 2010.

C. Skerka, Q. Chen, V. Fremeaux-bacchi, and L. T. Roumenina, Complement factor H related proteins (CFHRs), Mol Immunol, vol.56, 2013.

J. E. Goicoechea-de, J. Caesar, T. H. Malik, M. Patel, M. Colledge et al., Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, vol.110, pp.4685-90, 2013.

A. Tortajada, H. Yébenes, C. Abarrategui-garrido, J. Anter, J. M. García-fernández et al., C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J Clin Invest, vol.123, pp.2434-2480, 2013.

L. G. Fritsche, N. Lauer, A. Hartmann, S. Stippa, C. N. Keilhauer et al., An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD), Hum Mol Genet, vol.19, pp.4694-704, 2010.

S. Heinen, A. Hartmann, N. Lauer, U. Wiehl, H. Dahse et al., Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation, Blood, vol.114, pp.2439-2486, 2009.

D. Bubeck, The making of a macromolecular machine: assembly of the membrane attack complex, Biochemistry, vol.53, pp.1908-1923, 2014.

T. Kinoshita, Y. Takata, H. Kozono, J. Takeda, K. S. Hong et al., C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, issue.141, pp.3895-901, 1988.

Y. U. Kim, M. C. Carroll, D. E. Isenman, M. Nonaka, P. Pramoonjago et al., Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation, J Biol Chem, vol.267, pp.4171-4177, 1992.

E. Barrio, L. C. Antón, G. Marqués, A. Sánchez, and F. Vivanco, Formation of covalently linked C3-C3 dimers on IgG immune aggregates, Eur J Immunol, vol.21, pp.343-352, 1991.

N. S. Laursen, K. R. Andersen, I. Braren, E. Spillner, L. Sottrup-jensen et al., Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex, EMBO J, vol.30, pp.606-622, 2011.

S. Mortensen, R. T. Kidmose, S. V. Petersen, Á. Szilágyi, Z. Prohászka et al., Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement, J Immunol, vol.194, pp.5488-96, 2015.

M. K. Pangburn and N. Rawal, Structure and function of complement C5 convertase enzymes, Biochem Soc Trans, vol.30, pp.1006-1016, 2002.

N. Rawal and M. K. Pangburn, Formation of high affinity C5 convertase of the classical pathway of complement, J Biol Chem, vol.278, pp.38476-83, 2003.

E. Fischer and M. D. Kazatchkine, Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement, J Immunol, issue.130, pp.2821-2825, 1983.

R. G. Medicus, R. D. Schreiber, O. Götze, and H. J. Müller-eberhard, A molecular concept of the properdin pathway, Proc Natl Acad Sci U S A, vol.73, pp.612-618, 1976.

M. Huber-lang, J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff et al., Generation of C5a in the absence of C3: a new complement activation pathway, Nat Med, vol.12, pp.682-689, 2006.

U. Amara, M. A. Flierl, D. Rittirsch, A. Klos, H. Chen et al., Molecular intercommunication between the complement and coagulation systems, J Immunol, issue.185, pp.5628-5664, 2010.

M. Huber-lang, E. M. Younkin, J. V. Sarma, N. Riedemann, S. R. Mcguire et al., Generation of C5a by phagocytic cells, Am J Pathol, vol.161, issue.10, pp.64461-64467, 2002.

M. J. Krisinger, V. Goebeler, Z. Lu, S. C. Meixner, T. Myles et al., Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway, Blood, vol.120, pp.1717-1742, 2012.

U. Amara, D. Rittirsch, M. Flierl, U. Bruckner, A. Klos et al., Interaction between the coagulation and complement system, Adv Exp Med Biol, vol.632, pp.71-80, 2008.

D. Barthel, S. Schindler, and P. F. Zipfel, Plasminogen is a complement inhibitor, J Biol Chem, vol.287, pp.18831-18873, 2012.

J. H. Foley, E. A. Peterson, V. Lei, L. W. Wan, M. J. Krisinger et al., Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses, J Thromb Haemost, vol.13, issue.4, pp.610-618, 2014.

M. A. Hadders, D. Bubeck, P. Roversi, S. Hakobyan, F. Forneris et al., Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9, Cell Rep, vol.1, pp.200-207, 2012.

K. T. Preissner, E. R. Podack, and H. J. Müller-eberhard, The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7, J Immunol, issue.135, pp.445-51, 1985.

M. A. Hadders, D. X. Beringer, and P. Gros, Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense, Science, vol.317, pp.1552-1556, 2007.

S. Bhakdi and J. Tranum-jensen, Complement lysis: a hole is a hole, Immunol Today, vol.12, p.90007, 1991.

D. S. Cole and B. P. Morgan, Beyond lysis: how complement influences cell fate, Clin Sci, vol.1979, issue.104, pp.455-66, 2003.

C. L. Koski, L. E. Ramm, C. H. Hammer, M. M. Mayer, and M. L. Shin, Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics, Proc Natl Acad Sci U S A, vol.80, pp.3816-3836, 1983.

S. Bhakdi, G. Kuller, M. Muhly, S. Fromm, G. Seibert et al., Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect Immun, vol.55, pp.206-216, 1987.

L. A. Lewis and S. Ram, Meningococcal disease and the complement system, Virulence, vol.5, pp.98-126, 2014.

B. P. Morgan, Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem J, vol.264, pp.1-14, 1989.

D. G. Campbell, J. Gagnon, K. B. Reid, and A. F. Williams, Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region, Biochem J, vol.195, pp.15-30, 1981.

B. P. Morgan and A. K. Campbell, The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium, Biochem J, vol.231, pp.205-213, 1985.

G. R. Nemerow, K. I. Yamamoto, and T. F. Lint, Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence, J Immunol, issue.123, pp.1245-52, 1979.

N. H. Choi, T. Mazda, and M. Tomita, A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes, Mol Immunol, vol.26, pp.90139-90148, 1989.

K. P. Preissner, E. R. Podack, and H. J. Müller-eberhard, SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules, Eur J Immunol, vol.19, pp.69-75, 1989.

J. Tschopp, A. Chonn, S. Hertig, and L. E. French, Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9, J Immunol, issue.151, pp.2159-65, 1993.

C. M. Fletcher, R. A. Harrison, P. J. Lachmann, and D. Neuhaus, Structure of a soluble, glycosylated form of the human complement regulatory protein CD59, Structure, vol.1993, issue.2, pp.185-99, 1994.

K. J. Leath, S. Johnson, P. Roversi, T. R. Hughes, R. Smith et al., High-resolution structures of bacterially expressed soluble human CD59, Acta Crystallogr Sect F Struct Biol Cryst Commun, vol.63, pp.648-52, 2007.

I. Farkas, L. Baranyi, Y. Ishikawa, N. Okada, C. Bohata et al., CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by Frontiers in Immunology | www.frontiersin.org homologous C5b-8 as well as C5b-9, J Physiol, vol.539, pp.537-582, 2002.

S. Meri, B. P. Morgan, A. Davies, R. H. Daniels, M. G. Olavesen et al., Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers, Immunology, vol.71, pp.1-9, 1990.

Y. Huang, F. Qiao, R. Abagyan, S. Hazard, and S. Tomlinson, Defining the CD59-C9 binding interaction, J Biol Chem, vol.281, pp.27398-404, 2006.

L. L. Lovelace, C. L. Cooper, J. M. Sodetz, and L. Lebioda, Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement, J Biol Chem, vol.286, pp.17585-92, 2011.

S. E. Wickham, E. M. Hotze, A. J. Farrand, G. Polekhina, T. L. Nero et al., Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9, J Biol Chem, vol.286, pp.20952-62, 2011.

F. Bossi, F. Fischetti, V. Pellis, R. Bulla, E. Ferrero et al., Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex, J Immunol, issue.173, pp.6921-6928, 2004.

B. P. Morgan, J. R. Dankert, and A. F. Esser, Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis, J Immunol, issue.138, pp.246-53, 1987.

O. Moskovich and Z. Fishelson, Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex, J Biol Chem, vol.282, pp.29977-86, 2007.

N. J. Scolding, B. P. Morgan, W. A. Houston, C. Linington, A. K. Campbell et al., Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement, Nature, vol.339, pp.620-622, 1989.

A. Klos, A. J. Tenner, K. Johswich, R. R. Ager, E. S. Reis et al., The role of the anaphylatoxins in health and disease, Mol Immunol, vol.46, pp.2753-66, 2009.

R. R. Aksamit, W. Falk, and E. J. Leonard, Chemotaxis by mouse macrophage cell lines, J Immunol, issue.126, pp.2194-2203, 1981.

Y. Murakami, T. Imamichi, and S. Nagasawa, Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages, Immunology, vol.79, pp.633-641, 1993.

J. Elsner, M. Oppermann, W. Czech, G. Dobos, E. Schöpf et al., C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils, Eur J Immunol, vol.24, pp.518-540, 1994.

M. U. Ehrengruber, T. Geiser, and D. A. Deranleau, Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst, FEBS Lett, vol.346, pp.181-185, 1994.

J. Elsner, M. Oppermann, W. Czech, and A. Kapp, C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins, Blood, vol.83, pp.3324-3355, 1994.

L. G. Coulthard and T. M. Woodruff, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J Immunol, pp.3542-3550, 0194.

T. Kretzschmar, A. Jeromin, C. Gietz, W. Bautsch, A. Klos et al., Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a, Eur J Immunol, vol.23, pp.558-61, 1993.

M. A. Lett-brown and E. J. Leonard, Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J Immunol, issue.118, pp.815-823, 1977.

S. G. El-lati, C. A. Dahinden, and M. K. Church, Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells, J Invest Dermatol, vol.102, pp.803-809, 1994.

S. Nataf, N. Davoust, R. S. Ames, and S. R. Barnum, Human T cells express the C5a receptor and are chemoattracted to C5a, J Immunol, issue.162, pp.4018-4041, 1999.

M. M. Markiewski, R. A. Deangelis, F. Benencia, S. K. Ricklin-lichtsteiner, A. Koutoulaki et al., Modulation of the antitumor immune response by complement, Nat Immunol, vol.9, pp.1225-1260, 2008.

T. Tsuruta, T. Yamamoto, S. Matsubara, S. Nagasawa, S. Tanase et al., Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis, Am J Pathol, vol.142, pp.1848-57, 1993.

Y. Zhao, H. Xu, W. Yu, and B. Xie, Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol Med Rep, vol.10, pp.45-52, 2014.

S. R. Barnum, C4a: an anaphylatoxin in name only, J Innate Immun, 2015.

X. Zhang, W. Boyar, M. J. Toth, L. Wennogle, and N. C. Gonnella, Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy, Proteins, vol.28, pp.261-268, 1997.

K. W. Matthews, S. L. Mueller-ortiz, and R. A. Wetsel, Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol Immunol, vol.40, pp.785-93, 2004.

S. L. Mueller-ortiz, D. Wang, J. E. Morales, L. Li, J. Chang et al., Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock, J Immunol, issue.182, pp.6533-6542, 2009.

G. Bajic, L. Yatime, A. Klos, and G. R. Andersen, Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg, Protein Sci, vol.22, pp.204-216, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02095673

W. J. Cook, N. Galakatos, W. C. Boyar, R. L. Walter, and S. E. Ealick, Structure of human desArg-C5a, Acta Crystallogr D Biol Crystallogr, vol.66, pp.190-197, 2010.

S. Sayah, A. C. Jauneau, C. Patte, M. C. Tonon, H. Vaudry et al., Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes, Brain Res Mol Brain Res, vol.112, pp.46-55, 2003.

J. A. Schatz-jakobsen, L. Yatime, C. Larsen, S. V. Petersen, A. Klos et al., Structural and functional characterization of human and murine C5a anaphylatoxins, Acta Crystallogr D Biol Crystallogr, vol.70, pp.1704-1721, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02096131

J. Gao, H. Choe, D. Bota, P. L. Wright, C. Gerard et al., Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin, J Biol Chem, vol.278, pp.37902-37910, 2013.

R. T. Venkatesha, B. Thangam, E. Zaidi, A. K. Ali, and H. , Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, vol.42, pp.581-588, 2005.

L. Mery and F. Boulay, Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding, Eur J Haematol, vol.51, pp.282-289, 1993.

S. J. Siciliano, T. E. Rollins, J. Demartino, Z. Konteatis, L. Malkowitz et al., Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors, Proc Natl Acad Sci U S A, vol.91, pp.1214-1222, 1994.

M. S. Huber-lang, J. V. Sarma, S. R. Mcguire, K. T. Lu, V. A. Padgaonkar et al., Structure-function relationships of human C5a and C5aR, J Immunol, issue.170, pp.6115-6139, 2003.

B. O. Gerber, E. C. Meng, V. Dotsch, T. J. Baranski, and H. R. Bourne, An activation switch in the ligand binding pocket of the C5a receptor, J Biol Chem, vol.276, pp.3394-400, 2001.

M. L. Matsumoto, K. Narzinski, P. D. Kiser, G. V. Nikiforovich, and T. J. Baranski, A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues, J Biol Chem, vol.282, pp.3105-3126, 2007.

J. M. Klco, C. B. Wiegand, K. Narzinski, and T. J. Baranski, Essential role for the second extracellular loop in C5a receptor activation, Nat Struct Mol Biol, vol.12, pp.320-326, 2005.

M. C. Perianayagam, V. S. Balakrishnan, A. J. King, B. Pereira, and B. L. Jaber, C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway, Kidney Int, vol.61, pp.456-63, 2002.

A. La-sala, M. Gadina, and B. L. Kelsall, G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK, J Immunol, issue.175, pp.2994-3003, 2005.

H. Jiang, Y. Kuang, Y. Wu, W. Xie, M. I. Simon et al., Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci U S A, vol.94, pp.7971-7976, 1997.

, Frontiers in Immunology | www.frontiersin.org

T. J. Mullmann, M. I. Siegel, R. W. Egan, and M. M. Billah, Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides, J Immunol, issue.144, pp.1901-1909, 1990.

A. M. Buhl, N. Avdi, G. S. Worthen, and G. L. Johnson, Mapping of the C5a receptor signal transduction network in human neutrophils, Proc Natl Acad Sci U S A, vol.91, pp.9190-9194, 1994.

D. K. Lee, S. R. George, R. Cheng, T. Nguyen, Y. Liu et al., Identification of four novel human G protein-coupled receptors expressed in the brain, Brain Res Mol Brain Res, vol.86, pp.13-22, 2001.

S. Okinaga, D. Slattery, A. Humbles, Z. Zsengeller, O. Morteau et al., Biochemistry, vol.42, pp.9406-9421, 2003.

S. A. Cain and P. N. Monk, The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74), J Biol Chem, vol.277, pp.7165-7174, 2002.

R. Wang, B. Lu, C. Gerard, and N. P. Gerard, Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis, J Immunol, pp.4001-4010, 0191.

P. Poursharifi, M. Lapointe, D. Pétrin, D. Devost, D. Gauvreau et al., C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology, Cell Signal, vol.25, pp.910-918, 2013.

W. Hsu, Y. Lin, C. Hsieh, S. Chen, and N. , C5L2 is required for C5a-triggered receptor internalization and ERK signaling, Cell Signal, vol.26, pp.1409-1428, 2014.

K. A. Defea, J. Zalevsky, M. S. Thoma, O. Déry, R. D. Mullins et al., beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2, J Cell Biol, vol.148, pp.1267-81, 2000.

S. M. Dewire, S. Ahn, and R. J. Lefkowitz, Shenoy SK. ?-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007.

M. Van-lookeren-campagne, C. Wiesmann, and E. J. Brown, Macrophage complement receptors and pathogen clearance, Cell Microbiol, vol.9, pp.2095-102, 2007.

J. Q. He, C. Wiesmann, and M. Van-lookeren-campagne, A role of macrophage complement receptor CRIg in immune clearance and inflammation, Mol Immunol, vol.45, pp.4041-4048, 2008.

L. Vogt, N. Schmitz, M. O. Kurrer, M. Bauer, H. I. Hinton et al., VSIG4, a B7 family-related protein, is a negative regulator of T cell activation, J Clin Invest, vol.116, pp.2817-2843, 2006.

A. K. Matsumoto, D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn et al., Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes, J Exp Med, vol.178, pp.1407-1424, 1993.

P. W. Dempsey, M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon, C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-50, 1996.

M. C. Carroll and D. E. Isenman, Regulation of humoral immunity by complement, Immunity, vol.37, pp.199-207, 2012.

K. R. Kalli, J. M. Ahearn, and D. T. Fearon, Interaction of iC3b with recombinant isotypic and chimeric forms of CR2, J Immunol, issue.147, pp.590-594, 1991.

G. Szakonyi, J. M. Guthridge, D. Li, K. Young, V. M. Holers et al., Structure of complement receptor 2 in complex with its C3d ligand, Science, vol.292, pp.1725-1733, 2001.

J. P. Hannan, K. A. Young, J. M. Guthridge, R. Asokan, G. Szakonyi et al., Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d, J Mol Biol, vol.346, pp.845-58, 2005.

D. E. Isenman, E. Leung, J. D. Mackay, S. Bagby, and J. Van-den-elsen, Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure, J Immunol, issue.184, pp.1946-55, 2010.

T. A. Springer and M. L. Dustin, Integrin inside-out signaling and the immunological synapse, Curr Opin Cell Biol, vol.24, pp.107-122, 2012.

D. M. Underhill and A. Ozinsky, Phagocytosis of microbes: complexity in action, Annu Rev Immunol, vol.20, pp.825-52, 2002.

G. Bajic, L. Yatime, R. B. Sim, T. Vorup-jensen, and G. R. Andersen, Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3, Proc Natl Acad Sci U S A, vol.110, pp.16426-16457, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02095685

X. Chen, Y. Yu, L. Mi, T. Walz, and T. A. Springer, Molecular basis for complement recognition by integrin ?X?2, Proc Natl Acad Sci U S A, vol.109, pp.4586-91, 2012.

M. S. Diamond, J. Garcia-aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer, The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands, J Cell Biol, vol.120, pp.1031-1074, 1993.

M. Alcorlo, R. Martínez-barricarte, F. J. Fernández, C. Rodríguez-gallego, A. Round et al., Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy, Proc Natl Acad Sci U S A, vol.108, 2011.

M. Sen, Y. K. Springer, and T. A. , An internal ligand-bound, metastable state of a leukocyte integrin, ?X?2, J Cell Biol, vol.203, pp.629-671, 2013.

N. N. Gorgani, J. Q. He, K. J. Katschke, K. Y. Helmy, H. Xi et al., Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages, J Immunol, issue.181, pp.7902-7910, 2008.

K. Y. Helmy, K. J. Katschke, N. N. Gorgani, N. M. Kljavin, J. M. Elliott et al., CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens, Cell, vol.124, pp.915-942, 2006.

C. Wiesmann, K. J. Katschke, J. Yin, K. Y. Helmy, M. Steffek et al., Structure of C3b in complex with CRIg gives insights into regulation of complement activation, Nature, vol.444, pp.217-237, 2006.

M. Malina, L. T. Roumenina, T. Seeman, L. Quintrec, M. Dragon-durey et al., Genetics of hemolytic uremic syndromes, vol.1983, pp.105-119, 2012.

M. Noris and G. Remuzzi, Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.1676-87, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01793663

L. T. Roumenina, C. Loirat, M. Dragon-durey, L. Halbwachs-mecarelli, C. Sautesfridman et al., Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011.

T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, M. Noris et al., Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J Clin Invest, vol.111, pp.1181-90, 2003.

P. Sánchez-corral, D. Pérez-caballero, O. Huarte, A. M. Simckes, E. Goicoechea et al., Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome, Am J Hum Genet, vol.71, pp.1285-95, 2002.

P. Sánchez-corral, C. González-rubio, R. De-córdoba, S. López-trascasa, and M. , Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H, Mol Immunol, vol.41, pp.81-85, 2004.

V. Frémeaux-bacchi, E. C. Miller, M. K. Liszewski, L. Strain, J. Blouin et al., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-52, 2008.

L. T. Roumenina, M. Frimat, E. C. Miller, F. Provot, M. Dragon-durey et al., A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-91, 2012.

M. C. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni et al., Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-65, 2014.

J. E. Goicoechea-de, C. L. Harris, J. Esparza-gordillo, L. Carreras, E. A. Arranz et al., Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc Natl Acad Sci U S A, vol.104, pp.240-245, 2007.

L. T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov et al., Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, pp.2837-2882, 2009.

D. Ricklin and J. D. Lambris, Complement in immune and inflammatory disorders: therapeutic interventions, J Immunol, pp.3839-3886, 0190.

, Frontiers in Immunology | www.frontiersin.org

L. T. Roumenina, J. Zuber, and V. Frémeaux-bacchi, Physiological and therapeutic complement regulators in kidney transplantation, Curr Opin Organ Transplant, vol.18, pp.421-430, 2013.

R. P. Rother, S. A. Rollins, C. F. Mojcik, R. A. Brodsky, and L. Bell, Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria, Nat Biotechnol, vol.25, pp.1256-64, 2007.

P. Hillmen, N. S. Young, J. Schubert, R. A. Brodsky, G. Socié et al., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, pp.1233-1276, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00599451

C. M. Legendre, C. Licht, and C. Loirat, Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013.

J. Zuber, F. Fakhouri, L. T. Roumenina, and C. Loirat, Frémeaux-Bacchi V; French Study Group for aHUS/C3G . Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-57, 2012.

D. Morikis, N. Assa-munt, A. Sahu, and J. D. Lambris, Solution structure of compstatin, a potent complement inhibitor, Protein Sci, vol.7, pp.619-646, 1998.

D. Ricklin and J. D. Lambris, Compstatin: a complement inhibitor on its way to clinical application, Adv Exp Med Biol, vol.632, pp.273-92, 2008.

B. Janssen, E. F. Halff, J. D. Lambris, and P. Gros, Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition, J Biol Chem, vol.282, pp.29241-29248, 2007.

B. Nilsson, R. Larsson, J. Hong, G. Elgue, K. N. Ekdahl et al., Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation, Blood, vol.92, pp.1661-1668, 1998.

R. Silasi-mansat, H. Zhu, N. I. Popescu, G. Peer, G. Sfyroera et al., Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis, Blood, vol.116, pp.1002-1012, 2010.

A. M. Risitano, D. Ricklin, Y. Huang, E. S. Reis, H. Chen et al., Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood, vol.123, pp.2094-101, 2014.

M. Hebecker, M. Alba-domínguez, L. T. Roumenina, S. Reuter, S. Hyvärinen et al., An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H, J Immunol, pp.912-933, 0191.

C. Q. Schmidt, H. Bai, Z. Lin, A. M. Risitano, P. N. Barlow et al., Rational engineering of a minimized immune inhibitor with unique triple-targeting properties, J Immunol, pp.5712-5733, 0190.

M. Fridkis-hareli, M. Storek, I. Mazsaroff, A. M. Risitano, A. S. Lundberg et al., Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases, Blood, vol.118, pp.4705-4718, 2011.

K. Li, J. Gor, V. M. Holers, M. J. Storek, and S. J. Perkins, Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d, J Mol Biol, vol.418, pp.248-63, 2012.

Y. Huang, F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson, A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury, J Immunol, issue.181, pp.8068-76, 2008.

A. M. Risitano, R. Notaro, C. Pascariello, M. Sica, L. Del-vecchio et al., The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment, Blood, vol.119, pp.6307-6323, 2012.

B. Rohrer, Q. Long, B. Coughlin, B. Renner, Y. Huang et al., A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration, Adv Exp Med Biol, vol.703, pp.137-186, 2010.

N. S. Merle, S. E. Church, V. Fremeaux-bacchi, and L. T. Roumenina, Complement system part I -molecular mechanisms of activation and regulation, Front Immunol, vol.6, p.262, 2015.

P. J. Lachmann and L. Halbwachs, The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin Exp Immunol, vol.21, pp.109-123, 1975.

G. Kroemer, L. Galluzzi, P. Vandenabeele, J. Abrams, E. S. Alnemri et al., Classification of cell death: recommendations of the nomenclature committee on cell death, Cell Death Differ, vol.16, pp.3-11, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407686

M. D. Galvan, M. C. Greenlee-wacker, and S. S. Bohlson, C1q and phagocytosis: the perfect complement to a good meal, J Leukoc Biol, vol.92, pp.489-97, 2012.

D. Ricklin, G. Hajishengallis, K. Yang, and J. D. Lambris, Complement: a key system for immune surveillance and homeostasis, Nat Immunol, vol.11, pp.785-97, 2010.

H. Païdassi, P. Tacnet-delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet et al., C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J Immunol, issue.180, pp.2329-2367, 2008.

H. Païdassi, P. Tacnet-delorme, M. Verneret, C. Gaboriaud, G. Houen et al., Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J Mol Biol, vol.408, pp.277-90, 2011.

R. Terrasse, P. Tacnet-delorme, C. Moriscot, J. Pérard, G. Schoehn et al., Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J Biol Chem, vol.287, pp.42620-42653, 2012.

M. Verneret, P. Tacnet-delorme, R. Osman, R. Awad, A. Grichine et al., Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis, J Innate Immun, vol.6, pp.426-460, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01096597

D. A. Fraser, A. K. Laust, E. L. Nelson, and A. J. Tenner, C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells, J Immunol, issue.183, pp.6175-85, 2009.

G. Castellano, A. M. Woltman, N. Schlagwein, W. Xu, F. P. Schena et al., Immune modulation of human dendritic cells by complement, Eur J Immunol, vol.37, pp.2803-2814, 2007.

M. C. Pickering, M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport, Systemic lupus erythematosus, complement deficiency, and apoptosis, Adv Immunol, vol.76, pp.227-324, 2000.

L. T. Roumenina, D. Sène, M. Radanova, J. Blouin, L. Halbwachs-mecarelli et al., Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance, J Immunol, issue.187, pp.4369-73, 2011.

C. A. Ogden, A. Decathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet et al., C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J Exp Med, vol.194, pp.781-95, 2001.

M. E. Benoit, E. V. Clarke, P. Morgado, D. A. Fraser, and A. J. Tenner, Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells, J Immunol, issue.188, pp.5682-93, 2012.

E. V. Clarke, B. M. Weist, C. M. Walsh, and A. J. Tenner, Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation, J Leukoc Biol, vol.97, pp.147-60, 2015.

M. J. Walport and . Complement, Second of two parts, N Engl J Med, vol.344, pp.1140-1144, 2001.

P. Baruah, I. E. Dumitriu, T. H. Malik, H. T. Cook, J. Dyson et al., C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells, Blood, vol.113, pp.3485-93, 2009.

A. D. Garg, D. V. Krysko, T. Verfaillie, A. Kaczmarek, G. B. Ferreira et al., A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death, EMBO J, vol.31, pp.1062-79, 2012.

G. Said, M. Guilbert, H. Morjani, R. Garnotel, P. Jeannesson et al., Extracellular matrix proteins modulate antimigratory and apoptotic effects of doxorubicin, Chemother Res Pract, p.268681, 2012.

G. Amarilyo, I. Verbovetski, M. Atallah, A. Grau, G. Wiser et al., iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade, Eur J Immunol, vol.40, pp.699-709, 2010.

D. Mevorach, J. O. Mascarenhas, D. Gershov, and K. B. Elkon, Complement-dependent clearance of apoptotic cells by human macrophages, J Exp Med, vol.188, pp.2313-2333, 1998.

A. E. Morelli, A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar et al., Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production, Blood, vol.101, pp.611-631, 2003.

I. Verbovetski, H. Bychkov, U. Trahtemberg, I. Shapira, M. Hareuveni et al., Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7, J Exp Med, vol.196, pp.1553-61, 2002.

M. K. Liszewski, M. Kolev, L. Friec, G. Leung, M. Bertram et al., Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation, Immunity, vol.39, pp.1143-57, 2013.

C. André and D. Cota, Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway, Proc Nutr Soc, vol.71, pp.502-512, 2012.

M. G. Strainic, J. Liu, D. Huang, F. An, P. N. Lalli et al., Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells, Immunity, vol.28, pp.425-460, 2008.

Q. Peng, K. Li, H. Patel, S. H. Sacks, and W. Zhou, Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype, J Immunol, issue.176, pp.3330-3371, 2006.

M. Laplante and D. M. Sabatini, mTOR signaling at a glance, J Cell Sci, vol.122, pp.3589-94, 2009.

U. Kishore, R. Ghai, T. J. Greenhough, A. K. Shrive, D. M. Bonifati et al., Structural and functional anatomy of the globular domain of complement protein C1q, Immunol Lett, vol.95, pp.113-141, 2004.

L. T. Roumenina, K. T. Popov, S. V. Bureeva, M. Kojouharova, M. Gadjeva et al., Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim Biophys Acta, vol.1784, pp.1271-1277, 2008.

S. Albertí, G. Marqués, S. Hernández-allés, X. Rubires, J. M. Tomás et al., Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36, Infect Immun, vol.64, pp.4719-4744, 1996.

R. A. Ezekowitz, Role of the mannose-binding lectin in innate immunity, J Infect Dis, vol.187, issue.2, pp.335-344, 2003.

J. D. Dimitrov, C. Planchais, L. T. Roumenina, T. L. Vassilev, S. V. Kaveri et al., Antibody polyreactivity in health and disease: statu variabilis, J Immunol, pp.993-1002, 0191.

C. Gaboriaud, N. M. Thielens, L. A. Gregory, V. Rossi, J. C. Fontecilla-camps et al., Structure and activation of the C1 complex of complement: unraveling the puzzle, Trends Immunol, vol.25, pp.368-73, 2004.

, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.

L. T. Roumenina, A. A. Kantardjiev, B. P. Atanasov, P. Waters, M. Gadjeva et al., Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q, Biochemistry, vol.44, pp.14097-109, 2005.

T. R. Kjaer, S. Thiel, and G. R. Andersen, Toward a structure-based comprehension of the lectin pathway of complement, Mol Immunol, vol.56, pp.413-435, 2013.

S. E. Degn, T. R. Kjaer, R. T. Kidmose, L. Jensen, A. G. Hansen et al., Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, Proc Natl Acad Sci U S A, vol.111, pp.13445-50, 2014.

R. T. Kidmose, N. S. Laursen, J. Dobó, T. R. Kjaer, S. Sirotkina et al., Structural basis for activation of the complement system by component C4 cleavage, Proc Natl Acad Sci U S A, vol.109, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02095670

P. Gál, V. Harmat, A. Kocsis, T. Bián, L. Barna et al., A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations, J Biol Chem, vol.280, pp.33435-33479, 2005.

T. Kinoshita, Y. Takata, H. Kozono, J. Takeda, K. S. Hong et al., C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, issue.141, pp.3895-901, 1988.

D. Bubeck, The making of a macromolecular machine: assembly of the membrane attack complex, Biochemistry, vol.53, pp.1908-1923, 2014.

K. Joiner, E. Brown, C. Hammer, K. Warren, and M. Frank, Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing, J Immunol, vol.130, pp.845-854, 1983.

S. Bhakdi, G. Kuller, M. Muhly, S. Fromm, G. Seibert et al., Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect Immun, vol.55, pp.206-216, 1987.

L. A. Lewis and S. Ram, Meningococcal disease and the complement system, Virulence, vol.5, pp.98-126, 2014.

D. S. Cole and B. P. Morgan, Beyond lysis: how complement influences cell fate, Clin Sci, issue.104, pp.455-66, 2003.

B. P. Morgan, Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem J, vol.264, pp.1-14, 1989.

D. G. Campbell, J. Gagnon, K. B. Reid, and A. F. Williams, Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region, Biochem J, vol.195, pp.15-30, 1981.

B. P. Morgan and A. K. Campbell, The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium, Biochem J, vol.231, pp.205-213, 1985.

J. F. Bohnsack, J. J. Shea, T. Takahashi, and E. J. Brown, Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1)

, J Immunol, issue.135, pp.2680-2686, 1985.

F. M. Griffin and P. J. Mullinax, High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis, J Immunol, issue.145, pp.697-701, 1990.

M. F. Tosi, H. Zakem, and M. Berger, Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch, J Clin Invest, vol.86, pp.300-308, 1990.

A. G. Dupuy and E. Caron, Integrin-dependent phagocytosis: spreading from microadhesion to new concepts, J Cell Sci, vol.121, pp.1773-83, 2008.

L. M. Uotila, M. Aatonen, and C. G. Gahmberg, Integrin CD11c/CD18 ?-chain phosphorylation is functionally important, J Biol Chem, vol.288, pp.33494-33503, 2013.

G. D. Ross, V. Vetvicka, and . Cr3-(cd11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clin Exp Immunol, vol.92, pp.181-185, 1993.

A. Aderem and D. M. Underhill, Mechanisms of phagocytosis in macrophages, Annu Rev Immunol, vol.17, pp.593-623, 1999.

N. N. Gorgani, J. Q. He, K. J. Katschke, K. Y. Helmy, H. Xi et al., Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages, J Immunol, issue.181, pp.7902-7910, 2008.

T. N. Mayadas and X. Cullere, Neutrophil beta2 integrins: moderators of life or death decisions, Trends Immunol, vol.26, pp.388-95, 2005.

A. Klos, A. J. Tenner, K. Johswich, R. R. Ager, E. S. Reis et al., The role of the anaphylatoxins in health and disease, Mol Immunol, vol.46, pp.2753-66, 2009.

A. Klos, E. Wende, K. J. Wareham, and P. N. Monk, International union of basic and clinical pharmacology

. Lxxxvii, Complement peptide C5a, C4a, and C3a receptors, Pharmacol Rev, vol.65, pp.500-543, 2013.

Y. Murakami, T. Imamichi, and S. Nagasawa, Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages, Immunology, vol.79, pp.633-641, 1993.

J. Elsner, M. Oppermann, W. Czech, G. Dobos, E. Schöpf et al., C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils, Eur J Immunol, vol.24, pp.518-540, 1994.

J. Elsner, M. Oppermann, W. Czech, and A. Kapp, C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxinsensitive G-proteins, Blood, vol.83, pp.3324-3355, 1994.

T. Kretzschmar, A. Jeromin, C. Gietz, W. Bautsch, A. Klos et al., Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a, Eur J Immunol, vol.23, pp.558-61, 1993.

S. G. El-lati, C. A. Dahinden, and M. K. Church, Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells, J Invest Dermatol, vol.102, pp.803-809, 1994.

L. G. Coulthard and T. M. Woodruff, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J Immunol, pp.3542-3550, 0194.

N. Chen, C. Mirtsos, D. Suh, Y. Lu, W. Lin et al., C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a, Nature, vol.446, pp.203-210, 2007.

P. J. Daffern, P. H. Pfeifer, J. A. Ember, and T. E. Hugli, C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation, J Exp Med, vol.181, pp.2119-2146, 1995.

T. J. Hollmann, S. L. Mueller-ortiz, M. C. Braun, and R. A. Wetsel, Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a, Mol Immunol, vol.45, pp.1907-1922, 2008.

M. Wu, F. H. Brennan, J. Lynch, S. Mantovani, S. Phipps et al., The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization, Proc Natl Acad Sci U S A, vol.110, pp.9439-9483, 2013.

T. Tsuruta, T. Yamamoto, S. Matsubara, S. Nagasawa, S. Tanase et al., Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis, Am J Pathol, vol.142, pp.1848-57, 1993.

Y. Zhao, H. Xu, W. Yu, and B. Xie, Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol Med Rep, vol.10, pp.45-52, 2014.

S. R. Barnum, C4a: an anaphylatoxin in name only, J Innate Immun, 2015.

W. D. Campbell, E. Lazoura, N. Okada, and H. Okada, Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N, Microbiol Immunol, vol.46, pp.131-135, 2002.

K. W. Matthews, S. L. Mueller-ortiz, and R. A. Wetsel, Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol Immunol, vol.40, pp.785-93, 2004.

S. L. Mueller-ortiz, D. Wang, J. E. Morales, L. Li, J. Chang et al., Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock, J Immunol, issue.182, pp.6533-6542, 2009.

Z. Shao, T. Nishimura, L. Leung, and J. Morser, Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model, J Thromb Haemost, 2015.

S. Sayah, A. C. Jauneau, C. Patte, M. C. Tonon, H. Vaudry et al., Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes, Brain Res Mol Brain Res, vol.112, pp.46-55, 2003.

J. A. Schatz-jakobsen, L. Yatime, C. Larsen, S. V. Petersen, A. Klos et al., Structural and functional characterization of human and murine C5a Frontiers in Immunology | www.frontiersin.org May 2015 | Volume 6 | Article 257 anaphylatoxins, Acta Crystallogr D Biol Crystallogr, vol.70, pp.1704-1721, 2014.

T. Crass, U. Raffetseder, U. Martin, M. Grove, A. Klos et al., Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells, Eur J Immunol, vol.26, pp.1944-50, 1996.

H. C. Wilken, O. Götze, T. Werfel, and J. Zwirner, C3a(desArg) does not bind to and signal through the human C3a receptor, Immunol Lett, vol.67, pp.141-146, 1999.

R. T. Venkatesha, B. Thangam, E. Zaidi, A. K. Ali, and H. , Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, vol.42, pp.581-588, 2005.

K. Hartmann, B. M. Henz, S. Krüger-krasagakes, J. Köhl, R. Burger et al., C3a and C5a stimulate chemotaxis of human mast cells, Blood, vol.89, pp.2863-70, 1997.

E. Asgari, L. Friec, G. Yamamoto, H. Perucha, E. Sacks et al., C3a modulates IL-1? secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation, Blood, vol.122, pp.3473-81, 2013.

T. Takabayashi, E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello et al., A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, J Immunol, issue.156, pp.3455-60, 1996.

W. H. Fischer and T. E. Hugli, Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response, J Immunol, issue.159, pp.4279-86, 1997.

Q. Peng, K. Li, K. Anderson, C. A. Farrar, B. Lu et al., Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction, Blood, vol.111, pp.2452-61, 2008.

A. Ghannam, J. Fauquert, C. Thomas, C. Kemper, and C. Drouet, Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation, Mol Immunol, vol.58, pp.98-107, 2014.
DOI : 10.1016/j.molimm.2013.11.010

P. S. Heeger and C. Kemper, Novel roles of complement in T effector cell regulation, Immunobiology, vol.217, pp.216-240, 2012.

M. S. Goligorsky, D. Patschan, and M. Kuo, Weibel-Palade bodies -sentinels of acute stress, Nat Rev Nephrol, vol.5, pp.423-429, 2009.

J. E. Sadler, Biochemistry and genetics of von Willebrand factor, Annu Rev Biochem, vol.67, pp.395-424, 1998.

I. Del-conde, Platelet activation leads to activation and propagation of the complement system, J Exp Med, vol.201, pp.871-880, 2005.

M. Morigi, M. Galbusera, S. Gastoldi, M. Locatelli, S. Buelli et al., Alternative pathway activation of complement by shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis, J Immunol, vol.187, 2011.

N. P. Gerard and C. Gerard, The chemotactic receptor for human C5a anaphylatoxin, Nature, vol.349, pp.614-621, 1991.

M. C. Perianayagam, V. S. Balakrishnan, A. J. King, B. Pereira, and B. L. Jaber, C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinasesignaling pathway, Kidney Int, vol.61, pp.456-63, 2002.

A. La-sala, M. Gadina, and B. L. Kelsall, G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinaseprotein 3 kinase B/Akt pathway and JNK, J Immunol, issue.175, pp.2994-3003, 2005.

H. Jiang, Y. Kuang, Y. Wu, W. Xie, M. I. Simon et al., Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci U S A, vol.94, pp.7971-7976, 1997.

T. J. Mullmann, M. I. Siegel, R. W. Egan, and M. M. Billah, Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides, J Immunol, issue.144, pp.1901-1909, 1990.

A. M. Buhl, N. Avdi, G. S. Worthen, and G. L. Johnson, Mapping of the C5a receptor signal transduction network in human neutrophils, Proc Natl Acad Sci U S A, vol.91, pp.9190-9194, 1994.

R. R. Aksamit, W. Falk, and E. J. Leonard, Chemotaxis by mouse macrophage cell lines, J Immunol, issue.126, pp.2194-2203, 1981.

M. U. Ehrengruber, T. Geiser, and D. A. Deranleau, Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst, FEBS Lett, vol.346, issue.94, pp.463-466, 1994.

M. A. Lett-brown and E. J. Leonard, Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J Immunol, issue.118, pp.815-823, 1977.

M. M. Markiewski, R. A. Deangelis, F. Benencia, S. K. Ricklin-lichtsteiner, A. Koutoulaki et al., Modulation of the antitumor immune response by complement, Nat Immunol, vol.9, pp.1225-1260, 2008.

S. Nataf, N. Davoust, R. S. Ames, and S. R. Barnum, Human T cells express the C5a receptor and are chemoattracted to C5a, J Immunol, issue.162, pp.4018-4041, 1999.

L. Ottonello, A. Corcione, G. Tortolina, I. Airoldi, E. Albesiano et al., rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues, J Immunol, issue.162, pp.6510-6517, 1999.

P. N. Lalli, M. G. Strainic, F. Lin, M. E. Medof, and P. S. Heeger, Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production, J Immunol, issue.179, pp.5793-802, 2007.

B. J. Czermak, V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-lang et al., Protective effects of C5a blockade in sepsis, Nat Med, vol.5, pp.788-92, 1999.

D. N. Cortright, R. Meade, S. M. Waters, B. L. Chenard, and J. E. Krause, C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells, Curr Eye Res, vol.34, pp.57-61, 2009.

U. Jain, Q. Cao, N. A. Thomas, T. M. Woodruff, W. J. Schwaeble et al., Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner, J Immunol, pp.3414-3435, 0194.

W. Cui, M. Lapointe, D. Gauvreau, D. Kalant, and K. Cianflone, Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation, Mol Immunol, vol.46, pp.3207-3224, 2009.

S. A. Cain and P. N. Monk, The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74), J Biol Chem, vol.277, pp.7165-7174, 2002.

S. Okinaga, D. Slattery, A. Humbles, Z. Zsengeller, O. Morteau et al., Biochemistry, vol.42, pp.9406-9421, 2003.

C. E. Bamberg, C. R. Mackay, H. Lee, D. Zahra, J. Jackson et al., The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction, J Biol Chem, vol.285, pp.7633-7677, 2010.

R. Wang, B. Lu, C. Gerard, and N. P. Gerard, Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis, J Immunol, pp.4001-4010, 0191.

N. P. Gerard, B. Lu, P. Liu, S. Craig, Y. Fujiwara et al., An antiinflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2, J Biol Chem, vol.280, pp.39677-80, 2005.

S. Vijayan, Y. Asare, J. Grommes, O. Soehnlein, E. Lutgens et al., High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques, Am J Pathol, vol.184, pp.2123-2156, 2014.

P. Poursharifi, M. Lapointe, D. Pétrin, D. Devost, D. Gauvreau et al., C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology, Cell Signal, vol.25, pp.910-918, 2013.

W. Hsu, Y. Lin, C. Hsieh, S. Chen, and N. , C5L2 is required for C5a-triggered receptor internalization and ERK signaling, Cell Signal, vol.26, pp.1409-1428, 2014.

K. A. Defea, J. Zalevsky, M. S. Thoma, O. Déry, R. D. Mullins et al., betaarrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2, J Cell Biol, vol.148, pp.1267-81, 2000.

S. M. Dewire, S. Ahn, and R. J. Lefkowitz, Shenoy SK. ?-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007.

X. Zhang, Y. Kimura, C. Fang, L. Zhou, G. Sfyroera et al., Regulation of toll-like receptor-mediated inflammatory response by complement in vivo, Blood, vol.110, pp.228-264, 2007.

E. Harokopakis, M. H. Albzreh, M. H. Martin, and G. Hajishengallis, TLR2 transmodulates monocyte adhesion and transmigration via Rac1-and PI3K-mediated

, J Immunol, issue.176, pp.7645-56, 2006.

J. C. Kagan and R. Medzhitov, Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling, Cell, vol.125, pp.943-55, 2006.

M. Koleva, G. Schlaf, R. Landmann, O. Götze, K. Jungermann et al., Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from kupffer cells, Gastroenterology, vol.122, pp.697-708, 2002.

H. Hawlisch, Y. Belkaid, R. Baelder, D. Hildeman, C. Gerard et al., C5a negatively regulates toll-like receptor 4-induced immune responses, Immunity, vol.22, pp.415-441, 2005.

F. Rudilla, C. Fayolle, N. Casares, M. Durantez, L. Arribillaga et al., Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses, Vaccine, vol.30, pp.2848-58, 2012.

A. Zaal, S. N. Lissenberg-thunnissen, G. Van-schijndel, D. Wouters, S. M. Van-ham et al., Crosstalk between toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production, Immunobiology, vol.218, pp.175-80, 2013.

M. B. Pepys, Role of complement in induction of antibody production in vivo effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses, J Exp Med, vol.140, pp.126-171, 1974.

M. B. Pepys and A. E. Butterworth, Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation, Clin Exp Immunol, vol.18, pp.273-82, 1974.

A. K. Matsumoto, D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn et al., Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes, J Exp Med, vol.178, pp.1407-1424, 1993.

A. Cherukuri, P. C. Cheng, and S. K. Pierce, The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens, J Immunol, issue.167, pp.163-72, 2001.

G. G. Klaus and J. H. Humphrey, A re-evaluation of the role of C3 in B-cell activation, Immunol Today, vol.7, issue.86, pp.90165-90174, 1986.

Y. Fang, C. Xu, Y. Fu, V. M. Holers, and H. Molina, Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response, J Immunol, vol.160, pp.5273-5282, 1998.

P. W. Dempsey, M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon, C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-50, 1996.

S. R. Brodeur, F. Angelini, L. B. Bacharier, A. M. Blom, E. Mizoguchi et al., C4b-binding protein (C4BP) activates B cells through the CD40 receptor, Immunity, vol.18, pp.837-885, 2003.

P. Chatterjee, A. F. Agyemang, M. B. Alimzhanov, S. Degn, S. A. Tsiftsoglou et al., Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner, Eur J Immunol, vol.43, pp.2441-50, 2013.

D. Nagro, C. J. Kolla, R. V. Rickert, and R. C. , A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis, J Immunol, vol.175, pp.5379-89, 2005.

T. Lyubchenko, J. M. Dal-porto, V. M. Holers, and J. C. Cambier, Cutting edge: complement (C3d)-linked antigens break B cell anergy, J Immunol, issue.179, pp.2695-2704, 2007.

L. C. Hundgeburth, M. Wunsch, D. Rovituso, M. S. Recks, K. Addicks et al., The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response, Clin Immunol, vol.146, pp.155-64, 2013.

C. Kemper and J. P. Atkinson, T-cell regulation: with complements from innate immunity, Nat Rev Immunol, vol.7, pp.9-18, 2007.

C. Kemper, A. C. Chan, J. M. Green, K. A. Brett, K. M. Murphy et al., Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, vol.421, pp.388-92, 2003.

B. P. Morgan, K. J. Marchbank, M. P. Longhi, C. L. Harris, and A. M. Gallimore, Complement: central to innate immunity and bridging to adaptive responses, Immunol Lett, vol.97, pp.171-180, 2005.

L. Baudino, A. Sardini, M. M. Ruseva, L. Fossati-jimack, H. T. Cook et al., C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens, Proc Natl Acad Sci U S A, vol.111, pp.1503-1511, 2014.

S. L. Mueller-ortiz, J. E. Morales, and R. A. Wetsel, The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis, J Immunol, vol.193, pp.1278-89, 2014.

W. Kwan, W. Van-der-touw, E. Paz-artal, M. O. Li, and P. S. Heeger, Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells, J Exp Med, vol.210, pp.257-68, 2013.

M. G. Strainic, E. M. Shevach, A. F. Lin, F. Medof, and M. E. , Absence of signaling into CD4 + cells via C3aR and C5aR enables autoinductive TGF-?1 signaling and induction of Foxp3 + regulatory T cells, Nat Immunol, vol.14, pp.162-71, 2013.

L. Friec, G. Sheppard, D. Whiteman, P. Karsten, C. M. Shamoun et al., The CD46-Jagged1 interaction is critical for human TH1 immunity, Nat Immunol, vol.13, pp.1213-1234, 2012.

A. Ghannam, M. Pernollet, J. Fauquert, N. Monnier, D. Ponard et al., Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells, J Immunol, issue.181, pp.5158-66, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00325814

M. Kolev, L. Friec, G. Kemper, and C. , The role of complement in CD4+ T cell homeostasis and effector functions, Semin Immunol, vol.25, pp.12-21, 2013.

J. Cardone, L. Friec, G. Vantourout, P. Roberts, A. Fuchs et al., Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nat Immunol, vol.11, pp.862-71, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00564091

P. S. Heeger, P. N. Lalli, F. Lin, A. Valujskikh, J. Liu et al., Decayaccelerating factor modulates induction of T cell immunity, J Exp Med, vol.201, 2005.

J. Liu, T. Miwa, B. Hilliard, Y. Chen, J. D. Lambris et al., The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo, J Exp Med, vol.201, pp.567-77, 2005.

J. R. Dunkelberger and W. Song, Complement and its role in innate and adaptive immune responses, Cell Res, vol.20, pp.34-50, 2009.

A. M. Lipp, K. Juhasz, C. Paar, C. Ogris, P. Eckerstorfer et al., Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in jurkat T cells, PLoS One, vol.9, p.85934, 2014.

C. Wagner, C. Ochmann, M. Schoels, T. Giese, S. Stegmaier et al., The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes, Mol Immunol, vol.43, pp.643-51, 2006.

J. Tam, S. R. Bidgood, W. A. Mcewan, and L. C. James, Intracellular sensing of complement C3 activates cell autonomous immunity, Science, vol.345, p.1256070, 2014.

J. D. Lambris, D. Ricklin, and B. V. Geisbrecht, Complement evasion by human pathogens, Nat Rev Microbiol, vol.6, pp.132-174, 2008.

P. F. Zipfel, R. Würzner, and C. Skerka, Complement evasion of pathogens: common strategies are shared by diverse organisms, Mol Immunol, vol.44, pp.3850-3857, 2007.

M. C. Schneider, R. M. Exley, H. Chan, I. Feavers, Y. Kang et al., Functional significance of factor H binding to Neisseria meningitidis, J Immunol, vol.176, pp.7566-75, 2006.

K. Berggård, E. Johnsson, F. R. Mooi, and G. Lindahl, Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin, Infect Immun, vol.65, pp.3638-3681, 1997.

D. K. Ho, M. Skurnik, A. M. Blom, and S. Meri, Yersinia pestis ail recruitment of C4b-binding protein leads to factor I-mediated inactivation of covalently and noncovalently bound C4b: immunity to infection, Eur J Immunol, vol.44, pp.742-51, 2014.

L. A. Lewis, J. Ngampasutadol, R. Wallace, J. Reid, U. Vogel et al., The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement, PLoS Pathog, vol.6, 2010.

D. Ermert, A. Weckel, V. Agarwal, I. Frick, L. Björck et al., Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells, J Biol Chem, vol.288, pp.32172-83, 2013.

, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.

A. Bhattacharjee, J. S. Oeemig, R. Kolodziejczyk, T. Meri, T. Kajander et al., Structural basis for complement evasion by lyme disease pathogen Borrelia burgdorferi, J Biol Chem, vol.288, pp.18685-95, 2013.

T. Meri, H. Amdahl, M. J. Lehtinen, S. Hyvärinen, J. V. Mcdowell et al., Microbes bind complement inhibitor factor H via a common site, PLoS Pathog, vol.9, 2013.

J. Ngampasutadol, S. Ram, S. Gulati, S. Agarwal, C. Li et al., Human factor H interacts selectively with Neisseria gonorrhoeae and results in speciesspecific complement evasion, J Immunol, issue.180, pp.3426-3461, 2008.

M. C. Schneider, B. E. Prosser, J. Caesar, E. Kugelberg, S. Li et al., Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates, Nature, vol.458, pp.890-893, 2009.

D. P. Miller, J. K. Bell, J. V. Mcdowell, D. H. Conrad, J. W. Burgner et al., Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola, J Biol Chem, vol.287, pp.12715-12737, 2012.

T. J. Foster, Immune evasion by Staphylococci, Nat Rev Microbiol, vol.3, pp.948-58, 2005.

P. S. Hair, C. K. Foley, N. K. Krishna, J. O. Nyalwidhe, J. A. Geoghegan et al., Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing, Results Immunol, vol.3, pp.114-135, 2013.

J. A. Sharp, C. G. Echague, P. S. Hair, M. D. Ward, J. O. Nyalwidhe et al., Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic, PLoS One, vol.7, p.38407, 2012.

M. K. Liszewski, M. K. Leung, R. Hauhart, R. Buller, P. Bertram et al., Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation, J Immunol, vol.176, pp.3725-3759, 2006.

J. M. Lubinski, L. Wang, A. M. Soulika, R. Burger, R. A. Wetsel et al., Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo, J Virol, vol.72, pp.8257-63, 1998.

S. Rooijakkers and J. Van-strijp, Bacterial complement evasion, Mol Immunol, vol.44, pp.23-32, 2007.

T. R. Fraga, D. Courrol, M. M. Castiblanco-valencia, I. Y. Hirata, S. A. Vasconcellos et al., Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins, J Infect Dis, vol.209, pp.876-86, 2014.

S. Rooijakkers, W. Van-wamel, M. Ruyken, K. Van-kessel, and J. Van-strijp, Anti-opsonic properties of staphylokinase, Microbes Infect, vol.7, pp.476-84, 2005.

M. Jusko, J. Potempa, T. Kantyka, E. Bielecka, H. K. Miller et al., Staphylococcal proteases aid in evasion of the human complement system, J Innate Immun, vol.6, pp.31-46, 2014.

A. J. Laarman, M. Ruyken, C. L. Malone, J. Van-strijp, A. R. Horswill et al., Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion, J Immunol, issue.186, pp.6445-53, 2011.

D. Tordello, E. Vacca, I. Ram, S. Rappuoli, R. Serruto et al., Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum, Proc Natl Acad Sci U S A, vol.111, pp.427-459, 2014.

S. Agarwal, S. Vasudhev, R. B. Deoliveira, and S. Ram, Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides, J Immunol, vol.193, pp.1855-63, 2014.

J. B. Johnson, V. Borisevich, B. Rockx, and G. D. Parks, A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b, J Virol, vol.89, pp.989-98, 2015.

M. Hammel, G. Sfyroera, D. Ricklin, P. Magotti, J. D. Lambris et al., A structural basis for complement inhibition by Staphylococcus aureus, Nat Immunol, vol.8, pp.430-437, 2007.

N. Haspel, D. Ricklin, B. V. Geisbrecht, L. E. Kavraki, and J. D. Lambris, Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d, Protein Sci, vol.17, pp.1894-906, 2008.

T. K. Koch, M. Reuter, D. Barthel, S. Böhm, J. Van-den-elsen et al., Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b, PLoS One, vol.7, p.47638, 2012.

L. Lee, X. Liang, M. Hook, and E. L. Brown, Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogenbinding protein (Efb), J Biol Chem, vol.279, pp.50710-50716, 2004.

L. Y. Lee, M. Höök, D. Haviland, R. A. Wetsel, E. O. Yonter et al., Inhibition of complement activation by a secreted Staphylococcus aureus protein, J Infect Dis, vol.190, pp.571-580, 2004.

M. Hammel, G. Sfyroera, S. Pyrpassopoulos, D. Ricklin, K. X. Ramyar et al., Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus, J Biol Chem, vol.282, pp.30051-61, 2007.

K. Haupt, M. Reuter, J. Van-den-elsen, J. Burman, S. Hälbich et al., The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b, PLoS Pathog, vol.4, 2008.

A. Upadhyay, J. D. Burman, E. A. Clark, E. Leung, D. E. Isenman et al., Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi, J Biol Chem, vol.283, pp.22113-22133, 2008.

I. Jongerius, J. Köhl, M. K. Pandey, M. Ruyken, K. Van-kessel et al., Staphylococcal complement evasion by various convertaseblocking molecules, J Exp Med, vol.204, pp.2461-71, 2007.

B. L. Garcia, K. X. Ramyar, A. Tzekou, D. Ricklin, W. J. Mcwhorter et al., Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b, J Mol Biol, vol.402, pp.17-29, 2010.

B. L. Garcia, K. X. Ramyar, D. Ricklin, J. D. Lambris, and B. V. Geisbrecht, Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of staphylococcal immune evasion proteins, Adv Exp Med Biol, vol.946, pp.113-146, 2012.

D. Ricklin, A. Tzekou, B. L. Garcia, M. Hammel, W. J. Mcwhorter et al., A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family, J Immunol, issue.183, pp.2565-74, 2009.

S. Rooijakkers, J. Wu, M. Ruyken, R. Van-domselaar, K. L. Planken et al., Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-728, 2009.

I. Jongerius, M. Puister, J. Wu, M. Ruyken, J. Van-strijp et al., Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases, J Immunol, issue.184, pp.420-425, 2010.

D. Ricklin and J. D. Lambris, Compstatin: a complement inhibitor on its way to clinical application, Adv Exp Med Biol, vol.632, pp.273-92, 2008.

D. Serruto, R. Rappuoli, M. Scarselli, P. Gros, and J. Van-strijp, Molecular mechanisms of complement evasion: learning from staphylococci and meningococci, Nat Rev Microbiol, vol.8, pp.393-402, 2010.

J. Leffler, A. A. Bengtsson, and A. M. Blom, The complement system in systemic lupus erythematosus: an update, Ann Rheum Dis, vol.73, pp.1601-1607, 2014.

L. Schejbel, L. Skattum, S. Hagelberg, A. Åhlin, B. Schiller et al., Molecular basis of hereditary C1q deficiency -revisited: identification of several novel disease-causing mutations, Genes Immun, vol.12, pp.626-660, 2011.

Y. Yin, X. Wu, G. Shan, and X. Zhang, Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis, Lupus, vol.21, pp.1088-97, 2012.

D. Vanhecke, L. T. Roumenina, H. Wan, M. Osthoff, M. Schaller et al., Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzymelinked immunosorbent assay, Arthritis Rheum, vol.64, pp.3706-3720, 2012.

, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.

M. Radanova, V. Vasilev, B. Deliyska, U. Kishore, V. Ikonomov et al., Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP, Immunobiology, vol.217, pp.684-91, 2012.

M. Mahler, R. A. Van-schaarenburg, and L. A. Trouw, Anti-C1q autoantibodies, novel tests, and clinical consequences, Front Immunol, vol.4, p.117, 2013.

L. A. Trouw, T. Groeneveld, M. A. Seelen, J. Duijs, I. M. Bajema et al., Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes, J Clin Invest, vol.114, pp.679-88, 2004.

C. Bigler, M. Schaller, I. Perahud, M. Osthoff, and M. Trendelenburg, Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells, J Immunol, issue.183, pp.3512-3533, 2009.

M. Noris and G. Remuzzi, Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.1676-87, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01793663

L. T. Roumenina, C. Loirat, M. Dragon-durey, L. Halbwachs-mecarelli, C. Sautesfridman et al., Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011.

F. Fakhouri, V. Frémeaux-bacchi, L. Noël, H. T. Cook, and M. C. Pickering, C3 glomerulopathy: a new classification, Nat Rev Nephrol, vol.6, pp.494-503, 2010.

S. Sethi and F. C. Fervenza, Membranoproliferative glomerulonephritis -a new look at an old entity, N Engl J Med, vol.366, pp.1119-1150, 2012.

M. Malina, L. T. Roumenina, T. Seeman, L. Quintrec, M. Dragon-durey et al., Genetics of hemolytic uremic syndromes, vol.1983, pp.105-119, 2012.

V. P. Ferreira, A. P. Herbert, C. Cortés, K. A. Mckee, B. S. Blaum et al., The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, issue.182, pp.7009-7027, 2009.

M. J. Lehtinen, A. L. Rops, D. E. Isenman, J. Van-der-vlag, and T. S. Jokiranta, Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome, J Biol Chem, vol.284, pp.15650-15658, 2009.

T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, M. Noris et al., Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J Clin Invest, vol.111, pp.1181-90, 2003.

F. Bienaime, M. Dragon-durey, C. H. Regnier, S. C. Nilsson, W. H. Kwan et al., Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome, Kidney Int, vol.77, pp.339-388, 2010.

S. C. Nilsson, N. Kalchishkova, L. A. Trouw, V. Fremeaux-bacchi, B. O. Villoutreix et al., Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I, Eur J Immunol, vol.40, pp.172-85, 2010.

V. Frémeaux-bacchi, E. C. Miller, M. K. Liszewski, L. Strain, J. Blouin et al., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-52, 2008.

J. E. Goicoechea-de, C. L. Harris, J. Esparza-gordillo, L. Carreras, and E. A. Arranz, Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc Natl Acad Sci U S A, vol.104, pp.240-245, 2007.

M. C. Marinozzi, L. Vergoz, T. Rybkine, S. Ngo, S. Bettoni et al., Complement factor B mutations in atypical hemolytic uremic syndromedisease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-65, 2014.

L. T. Roumenina, M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov et al., Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, pp.2837-2882, 2009.

L. T. Roumenina, M. Frimat, E. C. Miller, F. Provot, M. Dragon-durey et al., A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-91, 2012.

E. C. Schramm, L. T. Roumenina, T. Rybkine, S. Chauvet, P. Vieira-martins et al., Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-69, 2015.

M. Dragon-durey, C. Loirat, S. Cloarec, M. Macher, J. Blouin et al., Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome, J Am Soc Nephrol, vol.16, pp.555-63, 2005.

M. Dragon-durey, S. K. Sethi, A. Bagga, C. Blanc, J. Blouin et al., Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome, J Am Soc Nephrol, vol.21, pp.2180-2187, 2010.

M. Józsi, C. Licht, S. Strobel, S. Zipfel, H. Richter et al., Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency, Blood, vol.111, pp.1512-1516, 2008.

C. Blanc, L. T. Roumenina, Y. Ashraf, S. Hyvärinen, S. K. Sethi et al., Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome, J Immunol, issue.189, pp.3528-3565, 2012.

V. Fremeaux-bacchi, F. Fakhouri, A. Garnier, F. Bienaimé, M. Dragon-durey et al., Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-62, 2013.

M. Noris, J. Caprioli, E. Bresin, C. Mossali, G. Pianetti et al., Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, pp.1844-59, 2010.

E. Bresin, E. Rurali, J. Caprioli, P. Sanchez-corral, V. Fremeaux-bacchi et al., Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype, J Am Soc Nephrol, vol.24, pp.475-86, 2013.

M. Lemaire, V. Frémeaux-bacchi, F. Schaefer, M. Choi, W. H. Tang et al., Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome, Nat Genet, vol.45, pp.531-537, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01064383

S. Bruneau, M. Néel, L. T. Roumenina, M. Frimat, L. Laurent et al., Loss of DGK? induces endothelial cell activation and death independently of complement activation, Blood, vol.125, issue.6, pp.1038-1084, 2014.

S. Rodríguez-de-córdoba, M. S. Hidalgo, S. Pinto, and A. Tortajada, Genetics of atypical hemolytic uremic syndrome (aHUS), Semin Thromb Hemost, vol.40, pp.422-452, 2014.

F. H. Sansbury, H. J. Cordell, C. Bingham, G. Bromilow, A. Nicholls et al., Factors determining penetrance in familial atypical haemolytic uraemic syndrome, J Med Genet, vol.51, pp.756-64, 2014.

M. Frimat, F. Tabarin, J. D. Dimitrov, C. Poitou, L. Halbwachs-mecarelli et al., Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-92, 2013.

A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor, Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J Immunol, issue.179, pp.5543-52, 2007.

M. Dragon-durey, C. Blanc, M. C. Marinozzi, R. A. Van-schaarenburg, and L. A. Trouw, Autoantibodies against complement components and functional consequences, Mol Immunol, vol.56, pp.213-234, 2013.

D. Paixão-cavalcante, M. López-trascasa, L. Skattum, P. C. Giclas, T. H. Goodship et al., Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation, Kidney Int, vol.82, pp.1084-92, 2012.

A. Servais, L. Noël, L. T. Roumenina, L. Quintrec, M. Ngo et al., Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, vol.82, pp.454-64, 2012.

R. Martínez-barricarte, M. Heurich, F. Valdes-cañedo, E. Vazquez-martul, E. Torreira et al., Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, J Clin Invest, vol.120, pp.3702-3714, 2010.

, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.

Y. Zhang, N. C. Meyer, K. Wang, C. Nishimura, K. Frees et al., Causes of alternative pathway dysregulation in dense deposit disease, Clin J Am Soc Nephrol, vol.7, pp.265-74, 2012.

Q. Chen, M. Wiesener, H. U. Eberhardt, A. Hartmann, B. Uzonyi et al., Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J Clin Invest, vol.124, pp.145-55, 2014.

J. E. Goicoechea-de, J. Caesar, T. H. Malik, M. Patel, M. Colledge et al., Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, vol.110, pp.4685-90, 2013.

T. H. Malik, P. J. Lavin, G. De-jorge, E. Vernon, K. A. Rose et al., A hybrid CFHR3-1 gene causes familial C3 glomerulopathy, J Am Soc Nephrol, vol.23, pp.1155-60, 2012.

D. P. Gale, E. G. De-jorge, H. T. Cook, R. Martinez-barricarte, A. Hadjisavvas et al., Identification of a mutation in complement factor H-related protein 5 in patients of cypriot origin with glomerulonephritis, Lancet, vol.376, issue.10, pp.60670-60678, 2010.

A. O. Edwards, R. Ritter, K. J. Abel, A. Manning, C. Panhuysen et al., Complement factor H polymorphism and age-related macular degeneration, Science, vol.308, pp.421-425, 2005.

G. S. Hageman, D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber et al., A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, vol.102, pp.7227-7259, 2005.

J. L. Haines, M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson et al., Complement factor H variant increases the risk of age-related macular degeneration, Science, vol.308, pp.419-440, 2005.

R. J. Klein, C. Zeiss, E. Y. Chew, J. Tsai, R. S. Sackler et al., Complement factor H polymorphism in age-related macular degeneration, Science, vol.308, pp.385-394, 2005.

L. S. Lim, P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong, Age-related macular degeneration, Lancet, vol.379, pp.60282-60289, 2012.

P. X. Shaw, L. Zhang, M. Zhang, H. Du, L. Zhao et al., Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids, Proc Natl Acad Sci U S A, vol.109, pp.13757-62, 2012.

D. Weismann, K. Hartvigsen, N. Lauer, K. L. Bennett, H. Scholl et al., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011.

J. M. Seddon, Y. Yu, E. C. Miller, R. Reynolds, P. L. Tan et al., Rare variants in CFI, C3 and C9 are associated with high risk of advanced agerelated macular degeneration, Nat Genet, vol.45, 2013.

C. Skerka, Q. Chen, V. Fremeaux-bacchi, and L. T. Roumenina, Complement factor H related proteins (CFHRs), Mol Immunol, vol.56, 2013.

A. E. Hughes, N. Orr, H. Esfandiary, M. Diaz-torres, T. Goodship et al., A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration, Nat Genet, vol.38, pp.1173-1180, 2006.

L. G. Fritsche, N. Lauer, A. Hartmann, S. Stippa, C. N. Keilhauer et al., An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD), Hum Mol Genet, vol.19, pp.4694-704, 2010.

A. Tortajada, H. Yébenes, C. Abarrategui-garrido, J. Anter, J. M. García-fernández et al., C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J Clin Invest, vol.123, pp.2434-2480, 2013.

M. S. Cho, H. G. Vasquez, R. Rupaimoole, S. Pradeep, S. Wu et al., Autocrine effects of tumor-derived complement, Cell Rep, vol.6, pp.1085-95, 2014.

L. Corrales, D. Ajona, S. Rafail, J. J. Lasarte, J. I. Riezu-boj et al., Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression, J Immunol, issue.189, pp.4674-83, 2012.

S. K. Vadrevu, N. K. Chintala, S. K. Sharma, P. Sharma, C. Cleveland et al., Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche, Cancer Res, vol.74, pp.3454-65, 2014.

L. Surace, V. Lysenko, A. O. Fontana, V. Cecconi, H. Janssen et al., Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response, Immunity, vol.42, pp.767-77, 2015.

D. Ajona, Z. Castaño, M. Garayoa, E. Zudaire, M. J. Pajares et al., Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement, Cancer Res, vol.64, pp.6310-6318, 2004.

T. Cui, Y. Chen, T. Knösel, L. Yang, K. Zöller et al., Human complement factor H is a novel diagnostic marker for lung adenocarcinoma, Int J Oncol, vol.39, pp.161-169, 2011.

R. Kinders, T. Jones, R. Root, C. Bruce, H. Murchison et al., Complement factor H or a related protein is a marker for transitional cell cancer of the bladder, Clin Cancer Res, vol.4, pp.2511-2531, 1998.

P. M. Riihilä, L. M. Nissinen, R. Ala-aho, M. Kallajoki, R. Grénman et al., Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma, J Invest Dermatol, vol.134, pp.498-506, 2014.

P. K. Santhekadur, D. Rajasekaran, A. Siddiq, R. Gredler, D. Chen et al., The transcription factor LSF: a novel oncogene for hepatocellular carcinoma

, Am J Cancer Res, vol.2, pp.269-85, 2012.

N. Amornsiripanitch, S. Hong, M. J. Campa, M. M. Frank, E. B. Gottlin et al., Complement factor H autoantibodies are associated with early stage NSCLC, Clin Cancer Res, vol.16, pp.3226-3257, 2010.

E. Bonavita, S. Gentile, M. Rubino, V. Maina, R. Papait et al., PTX3 is an extrinsic oncosuppressor regulating complementdependent inflammation in cancer, Cell, vol.160, pp.700-714, 2015.

P. Riihilä, L. Nissinen, M. Farshchian, A. Kivisaari, R. Ala-aho et al., Complement factor I promotes progression of cutaneous squamous cell carcinoma, J Invest Dermatol, vol.135, pp.579-88, 2015.

P. D. Arkwright, P. Riley, S. M. Hughes, H. Alachkar, and R. F. Wynn, Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation, J Allergy Clin Immunol, vol.133, pp.265-272, 2014.

H. Longhurst and M. Cicardi, Hereditary angio-oedema, Lancet, vol.379, pp.474-81, 2012.

P. Mehta, P. J. Norsworthy, A. E. Hall, S. J. Kelly, M. J. Walport et al., SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience, Rheumatology (Oxford), vol.49, pp.823-827, 2010.

G. Ariceta, N. Besbas, S. Johnson, D. Karpman, D. Landau et al., Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome, Pediatr Nephrol, vol.24, pp.687-96, 2009.

S. Johnson, J. Stojanovic, G. Ariceta, M. Bitzan, N. Besbas et al., An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome, Pediatr Nephrol, vol.29, pp.1967-78, 2014.

J. Zuber, F. Fakhouri, L. T. Roumenina, and C. Loirat, Frémeaux-Bacchi V; French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-57, 2012.

P. Hillmen, N. S. Young, J. Schubert, R. A. Brodsky, G. Socié et al., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, pp.1233-1276, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00599451

C. M. Legendre, C. Licht, and C. Loirat, Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013.

B. Nilsson, R. Larsson, J. Hong, G. Elgue, K. N. Ekdahl et al., Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation, Blood, vol.92, pp.1661-1668, 1998.

A. M. Risitano, D. Ricklin, Y. Huang, E. S. Reis, H. Chen et al., Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood, vol.123, pp.2094-101, 2014.

Y. Zhang, C. M. Nester, D. G. Holanda, H. C. Marsh, R. A. Hammond et al., Soluble CR1 therapy improves complement regulation in C3 glomerulopathy, J Am Soc Nephrol, vol.24, pp.1820-1829, 2013.

, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.

M. Fridkis-hareli, M. Storek, I. Mazsaroff, A. M. Risitano, A. S. Lundberg et al., Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases, Blood, vol.118, pp.4705-4718, 2011.

M. Hebecker, M. Alba-domínguez, L. T. Roumenina, S. Reuter, S. Hyvärinen et al., An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H, J Immunol, pp.912-933, 0191.

A. M. Risitano, R. Notaro, C. Pascariello, M. Sica, L. Del-vecchio et al., The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complementmediated hemolysis and C3 fragment, Blood, vol.119, pp.6307-6323, 2012.

C. Q. Schmidt, H. Bai, Z. Lin, A. M. Risitano, P. N. Barlow et al., Rational engineering of a minimized immune inhibitor with unique triple-targeting properties, J Immunol, pp.5712-5733, 0190.